1	J	NNP	O	J	nn	3	SENT_1	[p1l41t82r56b107],
2	Hum	NNP	PERSON	Hum	nn	3	SENT_1	[p1l69t82r145b107],
3	Genet	NNP	PERSON	Genet	dep	7	SENT_1	[p1l159t81r249b107],
4	(	CD	NUMBER	(	dep	3	SENT_1	[p1l263t81r355b114],
5	2004	CD	DATE	2004	dep	7	SENT_1	[p1l263t81r355b114],
6	)	CD	NUMBER	)	num	7	SENT_1	[p1l263t81r355b114],
7	49:582	CD	NUMBER	49:582	dep	11	SENT_1	[p1l369t81r536b107],
8	—	NN	O	—	nn	10	SENT_1	[p1l369t81r536b107],
9	585	CD	NUMBER	585	num	10	SENT_1	[p1l369t81r536b107],
10	DOI	NNP	O	DOI	dep	7	SENT_1	[p1l42t119r110b145],
11	10.1007	CD	NUMBER	10.1007	_	0	SENT_1	[p1l127t119r530b152],
12	/	:	O	/	punct	11	SENT_1	[p1l127t119r530b152],
13	sl0038-004-0188-6	CD	NUMBER	sl0038-004-0188-6	dep	11	SENT_1	[p1l127t119r530b152],
14	SHORT	NNP	O	SHORT	nn	15	SENT_1	[p1l40t186r1057b269],
15	COMMUNICATION	NNP	O	COMMUNICATION	dep	13	SENT_1	[p1l253t211r707b241],

1	Chikako	NNP	PERSON	Chikako	nn	2	SENT_2	[p1l43t344r191b375],
2	Ishikawa	NNP	PERSON	Ishikawa	_	0	SENT_2	[p1l207t344r365b375],
3	-	:	O	-	_	0	SENT_2	[p1l382t357r387b362],
4	Hiroshi	NNP	PERSON	Hiroshi	nn	5	SENT_2	[p1l403t344r535b375],
5	Ozaki	NNP	PERSON	Ozaki	poss	24	SENT_2	[p1l551t344r658b375],
6	'	POS	O	'	_	0	SENT_2	[p1l676t357r680b362],
7	Toshiaki	NNP	PERSON	Toshiaki	nn	24	SENT_2	[p1l697t344r850b375],
8	Nakajima	NNP	PERSON	Nakajima	nn	24	SENT_2	[p1l865t344r1039b383],
9	Toshihiro	NNP	PERSON	Toshihiro	nn	24	SENT_2	[p1l41t389r208b420],
10	Ishii	NNP	PERSON	Ishii	nn	24	SENT_2	[p1l224t389r299b420],
11	-	:	O	-	_	0	SENT_2	[p1l316t402r321b407],
12	Saburo	NNP	PERSON	Saburo	nn	13	SENT_2	[p1l338t389r462b420],
13	Kanai	NNP	PERSON	Kanai	dep	24	SENT_2	[p1l478t389r582b420],
14	-	:	O	-	_	0	SENT_2	[p1l599t402r604b407],
15	Saeko	NNP	PERSON	Saeko	nn	18	SENT_2	[p1l622t389r728b420],
16	Anjo	NNP	PERSON	Anjo	nn	18	SENT_2	[p1l745t389r827b428],
17	Kohji	NNP	PERSON	Kohji	nn	18	SENT_2	[p1l41t434r135b473],
18	Shirai	NNP	PERSON	Shirai	dep	13	SENT_2	[p1l152t434r257b465],
19	-	:	O	-	_	0	SENT_2	[p1l274t447r279b452],
20	Ituro	NNP	PERSON	Ituro	nn	24	SENT_2	[p1l295t434r382b465],
21	Inoue	NNP	PERSON	Inoue	nn	24	SENT_2	[p1l399t434r495b465],
22	A	NNP	O	A	nn	24	SENT_2	[p1l40t508r80b559],
23	frameshift	NN	O	frameshift	nn	24	SENT_2	[p1l102t507r394b560],
24	variant	NN	O	variant	nsubjpass	28	SENT_2	[p1l417t508r614b560],
25	of	IN	O	of	_	0	SENT_2	[p1l639t507r694b560],
26	CYP2c8	NN	O	cyp2c8	prep_of	24	SENT_2	[p1l717t507r948b560],
27	was	VBD	O	be	auxpass	28	SENT_2	[p1l971t522r1079b560],
28	identified	VBN	O	identify	dep	2	SENT_2	[p1l1106t507r1366b560],
29	in	IN	O	in	_	0	SENT_2	[p1l1396t508r1443b559],
30	a	DT	O	a	det	31	SENT_2	[p1l1470t522r1502b560],
31	patient	NN	O	patient	prep_in	28	SENT_2	[p1l1531t508r1726b570],
32	who	WP	O	who	nsubj	33	SENT_2	[p1l1750t508r1863b560],
33	suffered	VBD	O	suffer	rcmod	31	SENT_2	[p1l1887t507r2117b560],
34	from	IN	O	from	_	0	SENT_2	[p1l40t604r171b656],
35	rhabdomyolysis	NN	O	rhabdomyolysis	prep_from	33	SENT_2	[p1l200t605r636b666],
36	after	IN	O	after	_	0	SENT_2	[p1l660t604r795b656],
37	administration	NN	O	administration	prep_after	33	SENT_2	[p1l819t605r1227b656],
38	of	IN	O	of	_	0	SENT_2	[p1l1255t604r1310b656],
39	cerivastatin	NN	O	cerivastatin	prep_of	37	SENT_2	[p1l1333t605r1661b656],

1	Received	VBN	O	receive	_	0	SENT_3	[p1l42t741r184b767],
2	:	:	O	:	_	0	SENT_3	[p1l42t741r184b767],
3	14	CD	DATE	14	num	4	SENT_3	[p1l203t742r234b767],
4	June	NNP	DATE	June	dobj	1	SENT_3	[p1l246t742r315b767],
5	2004	CD	DATE	2004	dep	4	SENT_3	[p1l329t741r416b774],
6	/	:	O	/	punct	5	SENT_3	[p1l329t741r416b774],
7	Accepted	JJ	O	accepted	dep	5	SENT_3	[p1l429t741r576b774],
8	:	:	O	:	_	0	SENT_3	[p1l429t741r576b774],
9	16	CD	DATE	16	dep	7	SENT_3	[p1l595t742r625b767],
10	July	NNP	DATE	July	tmod	9	SENT_3	[p1l639t741r701b774],
11	2004	CD	DATE	2004	num	10	SENT_3	[p1l714t742r783b767],
12	/	:	O	/	punct	5	SENT_3	[p1l791t741r801b774],
13	Published	VBN	O	publish	dep	5	SENT_3	[p1l808t741r955b767],
14	onlinez	NN	O	onlinez	nn	16	SENT_3	[p1l969t741r1068b767],
15	9	CD	DATE	9	num	16	SENT_3	[p1l1084t742r1099b767],
16	September	NNP	DATE	September	dep	13	SENT_3	[p1l1114t741r1272b774],
17	2004	CD	DATE	2004	num	18	SENT_3	[p1l1286t742r1355b767],
18	©	CD	NUMBER	©	dep	16	SENT_3	[p1l42t780r67b805],
19	The	DT	O	the	det	21	SENT_3	[p1l81t779r139b805],
20	Japan	NNP	ORGANIZATION	Japan	nn	21	SENT_3	[p1l152t780r241b812],
21	Society	NNP	ORGANIZATION	Society	dep	16	SENT_3	[p1l256t779r363b812],
22	of	IN	ORGANIZATION	of	_	0	SENT_3	[p1l376t779r409b805],
23	Human	JJ	ORGANIZATION	human	amod	24	SENT_3	[p1l419t780r533b805],
24	Genetics	NNP	ORGANIZATION	Genetics	prep_of	21	SENT_3	[p1l547t779r675b805],
25	and	CC	O	and	_	0	SENT_3	[p1l689t779r744b805],
26	Springer-Verlag	NNP	O	Springer-Verlag	prep_of	21	SENT_3	[p1l759t779r997b812],
27	2004	CD	DATE	2004	num	26	SENT_3	[p1l1011t779r1080b805],

1	Abstract	JJ	O	abstract	amod	4	SENT_4	[p1l7t934r326b997],
2	A	NN	O	a	nn	4	SENT_4	[p1l354t932r421b996],
3	hypercholesterolemic	JJ	O	hypercholesterolemic	amod	4	SENT_4	[p1l450t932r1252b1014],
4	patient	NN	O	patient	nsubj	11	SENT_4	[p1l1280t932r1544b1014],
5	medicated	VBN	O	medicate	partmod	4	SENT_4	[p1l1572t932r1958b997],
6	with	IN	O	with	_	0	SENT_4	[p1l1986t932r2152b997],
7	cerivastatin	NN	O	cerivastatin	prep_with	5	SENT_4	[p1l8t1031r443b1095],
8	for	IN	O	for	_	0	SENT_4	[p1l477t1031r587b1095],
9	22	CD	DURATION	22	num	10	SENT_4	[p1l622t1032r706b1094],
10	days	NNS	NUMBER	day	prep_for	7	SENT_4	[p1l742t1030r910b1112],
11	resulted	VBD	O	result	_	0	SENT_4	[p1l945t1030r1240b1095],
12	in	IN	O	in	_	0	SENT_4	[p1l1275t1031r1345b1094],
13	acute	JJ	O	acute	amod	14	SENT_4	[p1l1381t1040r1577b1095],
14	rhabdomyolysis	NN	O	rhabdomyolysis	prep_in	11	SENT_4	[p1l1612t1030r2148b1112, p1l10t1128r116b1193],
15	.	.	O	.	_	0	SENT_4	[p1l1612t1030r2148b1112, p1l10t1128r116b1193],

1	CYP2C8	NN	O	cyp2c8	nsubj	7	SENT_5	[p1l187t1129r518b1193],
2	and	CC	O	and	_	0	SENT_5	[p1l587t1128r725b1193],
3	CYP3A4	NN	O	cyp3a4	conj_and	1	SENT_5	[p1l790t1128r1130b1193],
4	are	VBP	O	be	cop	7	SENT_5	[p1l1195t1149r1308b1193],
5	the	DT	O	the	det	7	SENT_5	[p1l1372t1128r1485b1193],
6	major	JJ	O	major	amod	7	SENT_5	[p1l1549t1128r1772b1210],
7	enzymes	NNS	O	enzyme	_	0	SENT_5	[p1l1836t1149r2149b1210],
8	responsible	JJ	O	responsible	amod	7	SENT_5	[p1l9t1227r431b1309],
9	for	IN	O	for	_	0	SENT_5	[p1l481t1227r591b1291],
10	the	DT	O	the	det	11	SENT_5	[p1l640t1227r753b1291],
11	metabolism	NN	O	metabolism	prep_for	8	SENT_5	[p1l801t1227r1241b1291],
12	of	IN	O	of	_	0	SENT_5	[p1l1292t1227r1374b1291],
13	cerivastatin	NN	O	cerivastatin	prep_of	11	SENT_5	[p1l1414t1227r1869b1305],
14	,	,	O	,	_	0	SENT_5	[p1l1414t1227r1869b1305],
15	and	CC	O	and	_	0	SENT_5	[p1l1923t1226r2061b1291],
16	a	DT	O	a	det	17	SENT_5	[p1l2111t1248r2151b1291],
17	transporter	NN	O	transporter	nsubj	21	SENT_5	[p1l9t1333r454b1406],
18	,	,	O	,	_	0	SENT_5	[p1l9t1333r454b1406],
19	OATP2	NN	O	oatp2	appos	17	SENT_5	[p1l497t1324r808b1402],
20	,	,	O	,	_	0	SENT_5	[p1l497t1324r808b1402],
21	contributes	VBZ	O	contribute	conj_and	7	SENT_5	[p1l850t1324r1273b1389],
22	to	TO	O	to	_	0	SENT_5	[p1l1313t1333r1385b1389],
23	uptake	NN	O	uptake	prep_to	21	SENT_5	[p1l1425t1324r1683b1406],
24	of	IN	O	of	_	0	SENT_5	[p1l1723t1324r1805b1389],
25	cerivastatin	NN	O	cerivastatin	prep_of	23	SENT_5	[p1l1835t1324r2149b1389, p1l10t1423r152b1487],
26	to	TO	O	to	_	0	SENT_5	[p1l193t1432r265b1487],
27	the	DT	O	the	det	28	SENT_5	[p1l307t1423r420b1487],
28	liver	NN	O	liver	prep_to	21	SENT_5	[p1l460t1423r641b1487],
29	.	.	O	.	_	0	SENT_5	[p1l460t1423r641b1487],

1	In	IN	O	in	_	0	SENT_6	[p1l687t1425r766b1486],
2	this	DT	O	this	det	3	SENT_6	[p1l806t1423r938b1487],
3	study	NN	O	study	prep_in	10	SENT_6	[p1l981t1422r1203b1504],
4	,	,	O	,	_	0	SENT_6	[p1l981t1422r1203b1504],
5	the	DT	O	the	det	6	SENT_6	[p1l1246t1423r1360b1487],
6	patient	NN	O	patient	poss	8	SENT_6	[p1l1398t1423r1719b1505],
7	’s	POS	O	’s	_	0	SENT_6	[p1l1398t1423r1719b1505],
8	DNA	NN	MISC	dna	nsubjpass	10	SENT_6	[p1l1761t1423r1972b1487],
9	was	VBD	O	be	auxpass	10	SENT_6	[p1l2010t1444r2150b1487],
10	sequenced	VBN	O	sequence	_	0	SENT_6	[p1l10t1520r393b1602],
11	in	IN	O	in	_	0	SENT_6	[p1l423t1520r493b1584],
12	order	NN	O	order	prep_in	10	SENT_6	[p1l527t1520r728b1585],
13	to	TO	O	to	aux	14	SENT_6	[p1l759t1529r831b1585],
14	identify	VB	O	identify	xcomp	10	SENT_6	[p1l864t1520r1151b1602],
15	a	DT	O	a	det	16	SENT_6	[p1l1184t1541r1223b1585],
16	variant	NN	O	variant	dobj	14	SENT_6	[p1l1254t1520r1522b1585],
17	that	WDT	O	that	nsubj	19	SENT_6	[p1l1554t1520r1703b1585],
18	would	MD	O	would	aux	19	SENT_6	[p1l1733t1520r1966b1585],
19	lead	VB	O	lead	rcmod	16	SENT_6	[p1l1997t1520r2151b1585],
20	to	TO	O	to	_	0	SENT_6	[p1l9t1628r81b1684],
21	the	DT	O	the	det	23	SENT_6	[p1l132t1618r245b1684],
22	adverse	JJ	O	adverse	amod	23	SENT_6	[p1l295t1618r574b1684],
23	effect	NN	O	effect	prep_to	19	SENT_6	[p1l623t1619r820b1684],
24	of	IN	O	of	_	0	SENT_6	[p1l869t1619r952b1684],
25	cerivastatin	NN	O	cerivastatin	prep_of	23	SENT_6	[p1l990t1619r1444b1684],
26	.	.	O	.	_	0	SENT_6	[p1l990t1619r1444b1684],

1	Three	CD	NUMBER	three	num	3	SENT_7	[p1l1497t1619r1714b1684],
2	nucleotide	NN	O	nucleotide	nn	3	SENT_7	[p1l1762t1618r2150b1684],
3	variants	NNS	O	variant	nsubjpass	14	SENT_7	[p1l7t1717r332b1795],
4	,	,	O	,	_	0	SENT_7	[p1l7t1717r332b1795],
5	475delA	NN	O	475delum	appos	3	SENT_7	[p1l372t1717r705b1795],
6	,	,	O	,	_	0	SENT_7	[p1l372t1717r705b1795],
7	G874C	NN	O	g874c	conj_and	5	SENT_7	[p1l747t1718r1033b1795],
8	,	,	O	,	_	0	SENT_7	[p1l747t1718r1033b1795],
9	and	CC	O	and	_	0	SENT_7	[p1l1075t1717r1214b1782],
10	T155	NN	O	t155	nn	11	SENT_7	[p1l1251t1719r1438b1782],
11	1C	NN	O	1c	conj_and	5	SENT_7	[p1l1453t1718r1570b1795],
12	,	,	O	,	_	0	SENT_7	[p1l1453t1718r1570b1795],
13	were	VBD	O	be	auxpass	14	SENT_7	[p1l1610t1738r1783b1782],
14	found	VBN	O	find	_	0	SENT_7	[p1l1821t1717r2044b1782],
15	in	IN	O	in	_	0	SENT_7	[p1l2081t1717r2151b1781],
16	the	DT	O	the	det	17	SENT_7	[p1l9t1816r122b1880],
17	exons	NNS	O	exon	prep_in	14	SENT_7	[p1l153t1837r365b1880],
18	of	IN	O	of	_	0	SENT_7	[p1l399t1816r481b1880],
19	CYP2C8	NN	O	cyp2c8	prep_of	17	SENT_7	[p1l504t1817r859b1880],
20	.	.	O	.	_	0	SENT_7	[p1l504t1817r859b1880],

1	The	DT	O	the	det	2	SENT_8	[p1l894t1816r1037b1880],
2	patient	NN	O	patient	nsubj	4	SENT_8	[p1l1068t1816r1332b1898],
3	was	VBD	O	be	cop	4	SENT_8	[p1l1360t1837r1500b1880],
4	homozygous	JJ	O	homozygous	_	0	SENT_8	[p1l1531t1816r2009b1898],
5	for	IN	O	for	_	0	SENT_8	[p1l2042t1816r2152b1880],
6	475delA	NN	O	475delum	nn	7	SENT_8	[p1l8t1913r321b1978],
7	variant	NN	O	variant	prep_for	4	SENT_8	[p1l353t1913r622b1978],
8	that	WDT	O	that	nsubj	9	SENT_8	[p1l656t1913r805b1978],
9	leads	VBZ	O	lead	rcmod	7	SENT_8	[p1l838t1913r1026b1978],
10	to	TO	O	to	_	0	SENT_8	[p1l1060t1922r1133b1978],
11	frameshift	NN	O	frameshift	nn	14	SENT_8	[p1l1169t1913r1554b1978],
12	and	CC	O	and	_	0	SENT_8	[p1l1589t1913r1727b1978],
13	premature	JJ	O	premature	conj_and	11	SENT_8	[p1l1760t1922r2150b1995],
14	termination	NN	O	termination	prep_to	9	SENT_8	[p1l9t2012r471b2076],
15	.	.	O	.	_	0	SENT_8	[p1l9t2012r471b2076],

1	Accordingly	RB	O	accordingly	advmod	7	SENT_9	[p1l537t2011r1022b2094],
2	,	,	O	,	_	0	SENT_9	[p1l537t2011r1022b2094],
3	the	DT	O	the	det	4	SENT_9	[p1l1088t2012r1201b2076],
4	patient	NN	O	patient	nsubj	7	SENT_9	[p1l1262t2012r1526b2094],
5	is	VBZ	O	be	cop	7	SENT_9	[p1l1587t2012r1641b2076],
6	most	RBS	O	most	advmod	7	SENT_9	[p1l1703t2020r1888b2076],
7	likely	JJ	O	likely	_	0	SENT_9	[p1l1949t2012r2151b2093],
8	lacking	VBG	O	lack	xcomp	7	SENT_9	[p1l8t2109r281b2191],
9	the	DT	O	the	det	11	SENT_9	[p1l313t2109r427b2173],
10	enzyme	NN	O	enzyme	nn	11	SENT_9	[p1l461t2130r740b2191],
11	activity	NN	O	activity	dobj	8	SENT_9	[p1l775t2109r1070b2191],
12	.	.	O	.	_	0	SENT_9	[p1l775t2109r1070b2191],

1	The	DT	O	the	det	2	SENT_10	[p1l1109t2109r1253b2173],
2	patient	NN	O	patient	poss	4	SENT_10	[p1l1285t2109r1605b2191],
3	’s	POS	O	’s	_	0	SENT_10	[p1l1285t2109r1605b2191],
4	children	NNS	O	child	nsubj	7	SENT_10	[p1l1639t2109r1945b2174],
5	were	VBD	O	be	cop	7	SENT_10	[p1l1977t2130r2150b2174],
6	both	DT	O	both	dep	7	SENT_10	[p1l9t2207r183b2272],
7	heterozygous	JJ	O	heterozygous	_	0	SENT_10	[p1l230t2207r727b2289],
8	for	IN	O	for	_	0	SENT_10	[p1l775t2207r885b2272],
9	the	DT	O	the	det	10	SENT_10	[p1l932t2207r1046b2272],
10	mutation	NN	O	mutation	prep_for	7	SENT_10	[p1l1092t2207r1459b2272],
11	.	.	O	.	_	0	SENT_10	[p1l1092t2207r1459b2272],

1	The	DT	O	the	det	2	SENT_11	[p1l1511t2207r1654b2272],
2	patient	NN	O	patient	nsubj	3	SENT_11	[p1l1701t2207r1965b2290],
3	had	VBD	O	have	_	0	SENT_11	[p1l2011t2207r2151b2272],
4	three	CD	NUMBER	three	num	6	SENT_11	[p1l9t2305r195b2370],
5	nucleotide	NN	O	nucleotide	nn	6	SENT_11	[p1l228t2305r616b2370],
6	variants	NNS	O	variant	dobj	3	SENT_11	[p1l647t2305r949b2370],
7	in	IN	O	in	_	0	SENT_11	[p1l981t2305r1051b2369],
8	exon	NN	O	exon	prep_in	6	SENT_11	[p1l1083t2326r1261b2370],
9	4	CD	NUMBER	4	number	10	SENT_11	[p1l1293t2307r1334b2369],
10	(	CD	NUMBER	(	num	12	SENT_11	[p1l1368t2305r1695b2387],
11	A388G	NN	O	a388g	nn	12	SENT_11	[p1l1368t2305r1695b2387],
12	)	NN	O	)	dep	8	SENT_11	[p1l1368t2305r1695b2387],
13	and	CC	O	and	_	0	SENT_11	[p1l1730t2305r1868b2370],
14	exon	NN	O	exon	prep_in	6	SENT_11	[p1l1900t2326r2079b2370],
15	5	CD	NUMBER	5	number	16	SENT_11	[p1l2114t2308r2149b2370],
16	(	CD	NUMBER	(	num	17	SENT_11	[p1l10t2404r292b2486],
17	C57lT	NN	O	c57lt	dep	14	SENT_11	[p1l10t2404r292b2486],
18	and	CC	O	and	_	0	SENT_11	[p1l332t2403r470b2468],
19	C597T	NN	O	c597t	nn	20	SENT_11	[p1l510t2404r789b2485],
20	)	NN	O	)	conj_and	6	SENT_11	[p1l510t2404r789b2485],
21	of	IN	O	of	_	0	SENT_11	[p1l832t2403r914b2468],
22	OATP2	NN	O	oatp2	prep_of	20	SENT_11	[p1l945t2403r1235b2468],
23	that	WDT	O	that	nsubj	26	SENT_11	[p1l1274t2403r1424b2468],
24	were	VBD	O	be	cop	26	SENT_11	[p1l1461t2425r1633b2468],
25	all	DT	O	all	dep	26	SENT_11	[p1l1674t2404r1762b2468],
26	heterozygous	JJ	O	heterozygous	rcmod	20	SENT_11	[p1l1800t2403r2149b2485, p1l9t2522r201b2583],
27	.	.	O	.	_	0	SENT_11	[p1l1800t2403r2149b2485, p1l9t2522r201b2583],

1	No	DT	O	no	det	3	SENT_12	[p1l241t2504r358b2566],
2	nucleotide	NN	O	nucleotide	nn	3	SENT_12	[p1l396t2501r784b2566],
3	variation	NN	O	variation	nsubjpass	10	SENT_12	[p1l819t2501r1162b2566],
4	in	IN	O	in	_	0	SENT_12	[p1l1196t2501r1266b2565],
5	the	DT	O	the	det	6	SENT_12	[p1l1302t2501r1415b2565],
6	exons	NNS	O	exon	prep_in	3	SENT_12	[p1l1451t2522r1662b2566],
7	of	IN	O	of	_	0	SENT_12	[p1l1701t2501r1783b2566],
8	CYP3A4	NN	O	cyp3a4	prep_of	6	SENT_12	[p1l1811t2501r2151b2566],
9	was	VBD	O	be	auxpass	10	SENT_12	[p1l7t2621r147b2664],
10	identiﬁed	VBN	O	identiﬁed	_	0	SENT_12	[p1l179t2599r548b2664],
11	.	.	O	.	_	0	SENT_12	[p1l179t2599r548b2664],

1	To	TO	O	to	_	0	SENT_13	[p1l586t2602r688b2664],
2	our	PRP$	O	we	poss	3	SENT_13	[p1l724t2621r852b2664],
3	knowledge	NN	O	knowledge	prep_to	9	SENT_13	[p1l884t2599r1309b2681],
4	,	,	O	,	_	0	SENT_13	[p1l884t2599r1309b2681],
5	this	DT	O	this	nsubj	9	SENT_13	[p1l1344t2599r1477b2664],
6	is	VBZ	O	be	cop	9	SENT_13	[p1l1509t2600r1564b2664],
7	the	DT	O	the	det	9	SENT_13	[p1l1597t2599r1710b2664],
8	ﬁrst	NN	O	ﬁrst	nn	9	SENT_13	[p1l1742t2600r1887b2664],
9	report	NN	O	report	_	0	SENT_13	[p1l1918t2608r2152b2681],
10	showing	VBG	O	show	partmod	9	SENT_13	[p1l10t2697r320b2779],
11	that	IN	O	that	complm	19	SENT_13	[p1l355t2697r505b2762],
12	the	DT	O	the	det	14	SENT_13	[p1l539t2697r652b2761],
13	adverse	JJ	O	adverse	amod	14	SENT_13	[p1l689t2697r969b2762],
14	effect	NN	O	effect	nsubjpass	19	SENT_13	[p1l1004t2697r1201b2762],
15	of	IN	O	of	_	0	SENT_13	[p1l1237t2697r1319b2762],
16	cerivastatin	NN	O	cerivastatin	prep_of	14	SENT_13	[p1l1345t2697r1779b2762],
17	might	MD	O	might	aux	19	SENT_13	[p1l1813t2697r2032b2779],
18	be	VB	O	be	auxpass	19	SENT_13	[p1l2066t2697r2150b2762],
19	caused	VBN	O	cause	ccomp	10	SENT_13	[p1l8t2795r261b2860],
20	by	IN	O	by	_	0	SENT_13	[p1l294t2795r384b2877],
21	the	DT	O	the	det	23	SENT_13	[p1l418t2795r531b2860],
22	genetic	JJ	O	genetic	amod	23	SENT_13	[p1l566t2796r827b2877],
23	variant	NN	O	variant	agent	19	SENT_13	[p1l860t2796r1129b2860],
24	of	IN	O	of	_	0	SENT_13	[p1l1164t2795r1246b2860],
25	CYP2C8	NN	O	cyp2c8	prep_of	23	SENT_13	[p1l1273t2797r1627b2860],
26	.	.	O	.	_	0	SENT_13	[p1l1273t2797r1627b2860],

1	C.	NNP	PERSON	C.	nn	2	SENT_14	[p1l9t3085r75b3139],
2	Ishikawa	NNP	PERSON	Ishikawa	_	0	SENT_14	[p1l108t3084r394b3139],
3	-	:	O	-	_	0	SENT_14	[p1l425t3107r434b3116],
4	S.	NNP	ORGANIZATION	S.	nn	6	SENT_14	[p1l466t3085r518b3139],
5	Anjo	NNP	ORGANIZATION	Anjo	nn	6	SENT_14	[p1l550t3084r707b3154],
6	Department	NNP	ORGANIZATION	Department	dep	2	SENT_14	[p1l9t3172r394b3240],
7	of	IN	ORGANIZATION	of	_	0	SENT_14	[p1l423t3170r492b3225],
8	Clinical	JJ	ORGANIZATION	clinical	amod	9	SENT_14	[p1l515t3170r757b3225],
9	Pharmaceutics	NNS	ORGANIZATION	pharmaceutic	prep_of	6	SENT_14	[p1l785t3170r1266b3236],
10	,	,	O	,	_	0	SENT_14	[p1l785t3170r1266b3236],
11	Faculty	NNP	ORGANIZATION	Faculty	appos	9	SENT_14	[p1l9t3256r250b3326],
12	of	IN	ORGANIZATION	of	_	0	SENT_14	[p1l279t3256r348b3311],
13	Pharmaceutical	NNP	ORGANIZATION	Pharmaceutical	nn	14	SENT_14	[p1l369t3256r862b3311],
14	Sciences	NNPS	ORGANIZATION	Sciences	prep_of	11	SENT_14	[p1l893t3256r1168b3323],
15	,	,	O	,	_	0	SENT_14	[p1l893t3256r1168b3323],
16	Toho	NNP	ORGANIZATION	Toho	nn	17	SENT_14	[p1l8t3342r177b3397],
17	University	NNP	ORGANIZATION	University	appos	9	SENT_14	[p1l208t3342r556b3412],
18	,	,	O	,	_	0	SENT_14	[p1l208t3342r556b3412],
19	Chiba	NNP	O	Chiba	nn	21	SENT_14	[p1l589t3342r797b3409],
20	,	,	O	,	_	0	SENT_14	[p1l589t3342r797b3409],
21	Japan	NNP	LOCATION	Japan	appos	17	SENT_14	[p1l827t3344r1016b3412],

1	H.	NNP	PERSON	H.	nn	3	SENT_15	[p1l8t3478r83b3530],
2	Ozaki	NNP	PERSON	Ozaki	nn	3	SENT_15	[p1l116t3475r302b3530],
3	°	NNP	O	°	_	0	SENT_15	[p1l332t3499r341b3508],
4	K.	NNP	ORGANIZATION	K.	nn	7	SENT_15	[p1l372t3478r446b3530],
5	Shirai	NNP	ORGANIZATION	Shirai	nn	7	SENT_15	[p1l481t3475r665b3531],
6	Internal	NNP	ORGANIZATION	Internal	nn	7	SENT_15	[p1l9t3557r262b3611],
7	Medicine	NNP	ORGANIZATION	Medicine	dep	3	SENT_15	[p1l291t3556r600b3623],
8	,	,	O	,	_	0	SENT_15	[p1l291t3556r600b3623],
9	Sakura	NNP	LOCATION	Sakura	nn	10	SENT_15	[p1l633t3556r857b3612],
10	Hospital	NNP	LOCATION	Hospital	appos	7	SENT_15	[p1l885t3557r1176b3626],
11	,	,	O	,	_	0	SENT_15	[p1l885t3557r1176b3626],
12	School	NNP	ORGANIZATION	School	appos	7	SENT_15	[p1l10t3637r224b3692],
13	of	IN	ORGANIZATION	of	_	0	SENT_15	[p1l254t3637r323b3692],
14	Medicine	NNP	ORGANIZATION	Medicine	prep_of	12	SENT_15	[p1l344t3637r654b3704],
15	,	,	O	,	_	0	SENT_15	[p1l344t3637r654b3704],
16	Toho	NNP	ORGANIZATION	Toho	nn	21	SENT_15	[p1l685t3637r855b3692],
17	University	NNP	ORGANIZATION	University	nn	21	SENT_15	[p1l886t3637r1233b3707],
18	,	,	O	,	_	0	SENT_15	[p1l886t3637r1233b3707],
19	Chiba	NNP	O	Chiba	dep	21	SENT_15	[p1l9t3718r217b3784],
20	,	,	O	,	_	0	SENT_15	[p1l9t3718r217b3784],
21	Japan	NNP	LOCATION	Japan	appos	7	SENT_15	[p1l248t3720r436b3788],

1	T.	NNP	PERSON	T.	nn	2	SENT_16	[p2l8t49r71b102],
2	Nakajima	NNP	PERSON	Nakajima	_	0	SENT_16	[p2l103t47r418b117],
3	-	:	O	-	_	0	SENT_16	[p2l450t71r458b80],
4	I.	NN	PERSON	i.	dep	9	SENT_16	[p2l489t49r530b102],
5	Inoue	NNP	PERSON	Inoue	dep	4	SENT_16	[p2l563t49r745b102],
6	(	CD	NUMBER	(	num	7	SENT_16	[p2l775t46r904b117],
7	E	NN	O	e	dep	9	SENT_16	[p2l775t46r904b117],
8	)	CD	NUMBER	)	num	9	SENT_16	[p2l775t46r904b117],
9	Division	NN	O	division	dep	46	SENT_16	[p2l8t128r277b183],
10	of	IN	O	of	_	0	SENT_16	[p2l307t128r376b183],
11	Genetic	JJ	MISC	genetic	amod	12	SENT_16	[p2l399t128r641b183],
12	Diagnosis	NN	MISC	diagnosis	prep_of	9	SENT_16	[p2l669t128r1001b198],
13	,	,	O	,	_	0	SENT_16	[p2l669t128r1001b198],
14	The	DT	ORGANIZATION	the	det	15	SENT_16	[p2l8t209r129b264],
15	Institute	NNP	ORGANIZATION	Institute	appos	12	SENT_16	[p2l158t209r423b264],
16	of	IN	ORGANIZATION	of	_	0	SENT_16	[p2l453t209r522b264],
17	Medical	NNP	ORGANIZATION	Medical	nn	18	SENT_16	[p2l544t209r799b264],
18	Science	NNP	ORGANIZATION	Science	prep_of	15	SENT_16	[p2l830t209r1077b275],
19	,	,	O	,	_	0	SENT_16	[p2l830t209r1077b275],
20	The	NNP	ORGANIZATION	The	nn	21	SENT_16	[p2l8t290r129b345],
21	University	NNP	ORGANIZATION	University	appos	18	SENT_16	[p2l158t290r489b359],
22	of	IN	ORGANIZATION	of	_	0	SENT_16	[p2l519t290r588b345],
23	Tokyo	NNP	ORGANIZATION	Tokyo	prep_of	21	SENT_16	[p2l608t290r835b359],
24	,	,	O	,	_	0	SENT_16	[p2l608t290r835b359],
25	4-6-1	CD	NUMBER	4-6-1	num	26	SENT_16	[p2l866t291r1018b345],
26	Shirokanedai	NN	O	shirokanedaus	appos	18	SENT_16	[p2l1056t290r1494b356],
27	,	,	O	,	_	0	SENT_16	[p2l1056t290r1494b356],
28	Minato-ku	NN	O	minato-ku	appos	18	SENT_16	[p2l9t371r370b438],
29	,	,	O	,	_	0	SENT_16	[p2l9t371r370b438],
30	Tokyo	NNP	LOCATION	Tokyo	appos	18	SENT_16	[p2l401t371r608b441],
31	108-8639	CD	NUMBER	108-8639	num	30	SENT_16	[p2l646t373r940b438],
32	,	,	O	,	_	0	SENT_16	[p2l646t373r940b438],
33	Japan	NNP	LOCATION	Japan	appos	18	SENT_16	[p2l971t373r1159b441],
34	E-mail	NN	O	e-mail	dep	33	SENT_16	[p2l9t452r236b507],
35	:	:	O	:	_	0	SENT_16	[p2l9t452r236b507],
36	ituro@ims.u-tokyo.ac.jp	JJ	O	ituro@ims.u-tokyo.ac.jp	amod	37	SENT_16	[p2l268t452r1054b522],
37	Tel.	NNP	O	Tel.	dep	18	SENT_16	[p2l8t532r144b587],
38	:	:	O	:	_	0	SENT_16	[p2l8t532r144b587],
39	+81	CD	NUMBER	+81	number	40	SENT_16	[p2l190t533r710b587],
40	-3	CD	NUMBER	-3	dep	18	SENT_16	[p2l190t533r710b587],
41	-54495325	CD	NUMBER	-54495325	num	42	SENT_16	[p2l190t533r710b587],
42	Fax	NN	O	fax	dep	40	SENT_16	[p2l9t615r146b668],
43	:	:	O	:	_	0	SENT_16	[p2l9t615r146b668],
44	+81	CD	NUMBER	+81	dep	18	SENT_16	[p2l192t614r713b668],
45	-3	CD	NUMBER	-3	num	46	SENT_16	[p2l192t614r713b668],
46	-54495764	CD	NUMBER	-54495764	dep	2	SENT_16	[p2l192t614r713b668],

1	T.	NNP	PERSON	T.	nn	2	SENT_17	[p2l8t748r71b800],
2	Ishii	NNP	PERSON	Ishii	_	0	SENT_17	[p2l104t746r240b801],
3	-	:	O	-	_	0	SENT_17	[p2l271t769r280b778],
4	S.	NNP	ORGANIZATION	S.	nn	6	SENT_17	[p2l313t747r364b801],
5	Kanai	NNP	ORGANIZATION	Kanai	nn	6	SENT_17	[p2l397t746r591b801],
6	Department	NNP	ORGANIZATION	Department	dep	2	SENT_17	[p2l9t829r394b897],
7	of	IN	ORGANIZATION	of	_	0	SENT_17	[p2l423t827r492b882],
8	Pharmacy	NNP	ORGANIZATION	Pharmacy	nn	10	SENT_17	[p2l513t827r850b897],
9	,	,	O	,	_	0	SENT_17	[p2l513t827r850b897],
10	Faculty	NNP	ORGANIZATION	Faculty	prep_of	6	SENT_17	[p2l883t827r1124b897],
11	of	IN	ORGANIZATION	of	_	0	SENT_17	[p2l1153t827r1222b882],
12	Medicine	NNP	ORGANIZATION	Medicine	prep_of	10	SENT_17	[p2l1243t827r1553b893],
13	,	,	O	,	_	0	SENT_17	[p2l1243t827r1553b893],
14	Sakura	NNP	ORGANIZATION	Sakura	nn	15	SENT_17	[p2l10t907r233b963],
15	Hospital	NNP	ORGANIZATION	Hospital	appos	12	SENT_17	[p2l262t908r553b977],
16	,	,	O	,	_	0	SENT_17	[p2l262t908r553b977],
17	Toho	NNP	ORGANIZATION	Toho	nn	18	SENT_17	[p2l584t907r753b962],
18	University	NNP	ORGANIZATION	University	appos	12	SENT_17	[p2l784t908r1132b977],
19	,	,	O	,	_	0	SENT_17	[p2l784t908r1132b977],
20	Chiba	NNP	O	Chiba	appos	12	SENT_17	[p2l1165t907r1372b974],
21	,	,	O	,	_	0	SENT_17	[p2l1165t907r1372b974],
22	Japan	NNP	LOCATION	Japan	appos	12	SENT_17	[p2l1403t910r1591b977],

1	Introduction	NN	O	introduction	_	0	SENT_18	[p2l11t1194r463b1262],

1	All	DT	O	all	det	4	SENT_19	[p2l7t1395r121b1459],
2	hydroxymethylglutaryl-CoA	NN	O	hydroxymethylglutaryl-coa	nn	4	SENT_19	[p2l197t1395r1275b1477],
3	reductase	NN	O	reductase	nn	4	SENT_19	[p2l1351t1395r1704b1460],
4	inhibitors	NNS	O	inhibitor	nsubj	5	SENT_19	[p2l1781t1395r2143b1460],
5	(	VBP	O	(	_	0	SENT_19	[p2l10t1495r308b1577],
6	statins	NNS	O	statin	nsubj	9	SENT_19	[p2l10t1495r308b1577],
7	)	JJ	O	)	amod	6	SENT_19	[p2l10t1495r308b1577],
8	potentially	RB	O	potentially	advmod	7	SENT_19	[p2l351t1495r755b1577],
9	cause	VB	O	cause	ccomp	5	SENT_19	[p2l798t1516r999b1559],
10	rhabdomyolysis	NN	O	rhabdomyolysis	dobj	9	SENT_19	[p2l1042t1494r1641b1576],
11	as	IN	O	as	_	0	SENT_19	[p2l1685t1516r1758b1559],
12	a	DT	O	a	det	15	SENT_19	[p2l1802t1516r1842b1559],
13	serious	JJ	O	serious	amod	15	SENT_19	[p2l1886t1495r2143b1559],
14	adverse	JJ	O	adverse	amod	15	SENT_19	[p2l10t1593r288b1658],
15	effect	NN	O	effect	prep_as	9	SENT_19	[p2l369t1593r566b1658],
16	(	CD	NUMBER	(	num	17	SENT_19	[p2l648t1593r1079b1675],
17	Rossenson	NNP	O	Rossenson	dep	15	SENT_19	[p2l648t1593r1079b1675],
18	2004	CD	DATE	2004	num	17	SENT_19	[p2l1159t1593r1382b1675],
19	)	CD	NUMBER	)	dep	17	SENT_19	[p2l1159t1593r1382b1675],
20	.	.	O	.	_	0	SENT_19	[p2l1159t1593r1382b1675],

1	Cerivastatin	NNP	O	Cerivastatin	nsubjpass	19	SENT_20	[p2l1469t1593r1926b1658],
2	was	VBD	O	be	auxpass	3	SENT_20	[p2l2004t1614r2144b1658],
3	developed	VBN	O	develop	_	0	SENT_20	[p2l9t1692r387b1775],
4	as	IN	O	as	_	0	SENT_20	[p2l454t1714r527b1757],
5	a	DT	O	a	det	15	SENT_20	[p2l595t1714r634b1757],
6	highly	RB	O	highly	advmod	13	SENT_20	[p2l700t1692r932b1775],
7	potent	JJ	O	potent	dep	13	SENT_20	[p2l997t1701r1260b1775],
8	,	,	O	,	_	0	SENT_20	[p2l997t1701r1260b1775],
9	lipophilic	JJ	O	lipophilic	amod	15	SENT_20	[p2l1330t1693r1703b1775],
10	,	,	O	,	_	0	SENT_20	[p2l1330t1693r1703b1775],
11	and	CC	O	and	_	0	SENT_20	[p2l1773t1692r1911b1757],
12	pure	JJ	O	pure	amod	15	SENT_20	[p2l1976t1714r2144b1775],
13	enantiomeric	JJ	O	enantiomeric	amod	15	SENT_20	[p2l9t1791r499b1855],
14	reductase	NN	O	reductase	nn	15	SENT_20	[p2l527t1791r880b1855],
15	inhibitor	NN	O	inhibitor	prep_as	3	SENT_20	[p2l908t1791r1239b1855],
16	and	CC	O	and	_	0	SENT_20	[p2l1267t1791r1405b1855],
17	has	VBZ	O	have	aux	19	SENT_20	[p2l1433t1791r1556b1855],
18	been	VBN	O	be	auxpass	19	SENT_20	[p2l1585t1791r1757b1855],
19	evaluated	VBN	O	evaluate	conj_and	3	SENT_20	[p2l1785t1791r2144b1856],
20	in	IN	O	in	_	0	SENT_20	[p2l8t1891r78b1954],
21	clinical	JJ	O	clinical	amod	22	SENT_20	[p2l129t1891r393b1955],
22	efﬁcacy	NN	O	efﬁcacy	prep_in	19	SENT_20	[p2l445t1891r721b1972],
23	and	CC	O	and	_	0	SENT_20	[p2l773t1890r910b1955],
24	safety	NN	O	safety	nn	25	SENT_20	[p2l964t1891r1180b1972],
25	trials	NNS	O	trial	conj_and	22	SENT_20	[p2l1231t1891r1417b1955],
26	since	IN	O	since	_	0	SENT_20	[p2l1471t1891r1650b1955],
27	1993	CD	DATE	1993	num	28	SENT_20	[p2l1711t1892r1873b1955],
28	(	CD	NUMBER	(	prep_since	22	SENT_20	[p2l1929t1891r2145b1973],
29	Stein	NNP	PERSON	Stein	tmod	19	SENT_20	[p2l1929t1891r2145b1973],
30	1998	CD	DATE	1998	num	29	SENT_20	[p2l17t1989r232b2071],
31	)	CD	NUMBER	)	dobj	3	SENT_20	[p2l17t1989r232b2071],
32	.	.	O	.	_	0	SENT_20	[p2l17t1989r232b2071],

1	Its	PRP$	O	its	poss	3	SENT_21	[p2l279t1992r372b2053],
2	dual	JJ	O	dual	amod	3	SENT_21	[p2l415t1989r577b2054],
3	mechanism	NN	O	mechanism	nsubjpass	13	SENT_21	[p2l618t1989r1042b2054],
4	of	IN	O	of	_	0	SENT_21	[p2l1086t1989r1167b2054],
5	elimination	NN	O	elimination	prep_of	3	SENT_21	[p2l1201t1989r1627b2054],
6	mediated	VBN	O	mediate	partmod	5	SENT_21	[p2l1667t1989r2013b2054],
7	by	IN	O	by	_	0	SENT_21	[p2l2055t1989r2145b2071],
8	CYP2C8	NN	O	cyp2c8	agent	6	SENT_21	[p2l10t2090r341b2153],
9	and	CC	O	and	_	0	SENT_21	[p2l374t2088r512b2153],
10	CYP3A4	NN	O	cyp3a4	agent	6	SENT_21	[p2l542t2089r880b2153],
11	was	VBD	O	be	auxpass	13	SENT_21	[p2l908t2110r1047b2153],
12	originally	RB	O	originally	advmod	13	SENT_21	[p2l1079t2089r1436b2171],
13	thought	VBN	O	think	_	0	SENT_21	[p2l1465t2088r1762b2171],
14	to	TO	O	to	aux	15	SENT_21	[p2l1790t2098r1862b2153],
15	impart	VB	O	impart	xcomp	13	SENT_21	[p2l1893t2089r2145b2171],
16	a	DT	O	a	det	18	SENT_21	[p2l10t2208r49b2252],
17	safety	NN	O	safety	nn	18	SENT_21	[p2l115t2187r331b2269],
18	beneﬁt	NN	O	beneﬁt	dobj	15	SENT_21	[p2l396t2187r647b2252],
19	relative	JJ	O	relative	advmod	15	SENT_21	[p2l712t2187r986b2252],
20	to	TO	O	to	_	0	SENT_21	[p2l1052t2196r1124b2252],
21	other	JJ	O	other	amod	22	SENT_21	[p2l1192t2187r1389b2252],
22	statins	NNS	O	statin	prep_to	19	SENT_21	[p2l1454t2187r1693b2252],
23	that	WDT	O	that	nsubjpass	26	SENT_21	[p2l1759t2187r1908b2252],
24	were	VBD	O	be	auxpass	26	SENT_21	[p2l1971t2208r2144b2252],
25	exclusively	RB	O	exclusively	advmod	26	SENT_21	[p2l9t2286r411b2368],
26	metabolized	VBN	O	metabolize	rcmod	22	SENT_21	[p2l483t2286r940b2351],
27	via	IN	O	via	_	0	SENT_21	[p2l1013t2287r1124b2351],
28	the	DT	O	the	det	30	SENT_21	[p2l1197t2286r1310b2351],
29	CYP3A4	NN	O	cyp3a4	nn	30	SENT_21	[p2l1386t2286r1725b2351],
30	pathway	NN	O	pathway	prep_via	26	SENT_21	[p2l1798t2286r2139b2369],
31	.	.	O	.	_	0	SENT_21	[p2l1798t2286r2139b2369],

1	However	RB	O	however	advmod	10	SENT_22	[p2l9t2388r369b2463],
2	,	,	O	,	_	0	SENT_22	[p2l9t2388r369b2463],
3	despite	IN	O	despite	_	0	SENT_22	[p2l407t2385r666b2467],
4	the	DT	O	the	det	7	SENT_22	[p2l701t2385r814b2450],
5	dual	JJ	O	dual	amod	7	SENT_22	[p2l850t2385r1013b2450],
6	metabolizing	VBG	O	metabolize	amod	7	SENT_22	[p2l1046t2385r1533b2467],
7	pathways	NNS	O	pathway	prep_despite	10	SENT_22	[p2l1567t2385r1944b2467],
8	,	,	O	,	_	0	SENT_22	[p2l1567t2385r1944b2467],
9	cerivastatin	NN	O	cerivastatin	nsubj	10	SENT_22	[p2l1982t2385r2142b2450, p2l7t2484r305b2549],
10	caused	VBD	O	cause	_	0	SENT_22	[p2l354t2484r605b2549],
11	rhabdomyolysis	NN	O	rhabdomyolysis	dobj	10	SENT_22	[p2l654t2484r1253b2566],
12	more	RBR	O	more	advmod	13	SENT_22	[p2l1301t2506r1494b2549],
13	frequently	RB	O	frequently	advmod	10	SENT_22	[p2l1543t2484r1928b2566],
14	than	IN	O	than	_	0	SENT_22	[p2l1976t2484r2144b2549],
15	other	JJ	O	other	amod	16	SENT_22	[p2l10t2583r207b2648],
16	statins	NNS	O	statin	prep_than	10	SENT_22	[p2l243t2583r503b2661],
17	,	,	O	,	_	0	SENT_22	[p2l243t2583r503b2661],
18	especially	RB	O	especially	advmod	19	SENT_22	[p2l542t2583r900b2665],
19	when	WRB	O	when	advmod	22	SENT_22	[p2l933t2583r1131b2648],
20	cerivastatin	NN	O	cerivastatin	nsubjpass	22	SENT_22	[p2l1166t2583r1599b2648],
21	was	VBD	O	be	auxpass	22	SENT_22	[p2l1633t2604r1772b2648],
22	given	VBN	O	give	dep	16	SENT_22	[p2l1808t2583r2005b2665],
23	together	RB	O	together	_	0	SENT_22	[p2l2040t2592r2143b2648, p2l9t2682r241b2764],
24	with	IN	O	with	_	0	SENT_22	[p2l290t2682r455b2747],
25	other	JJ	O	other	amod	26	SENT_22	[p2l508t2682r705b2747],
26	drugs	NNS	O	drug	prep_together_with	22	SENT_22	[p2l756t2682r962b2764],
27	such	JJ	O	such	_	0	SENT_22	[p2l1017t2682r1183b2747],
28	as	IN	O	as	_	0	SENT_22	[p2l1235t2704r1307b2747],
29	gemﬁbrozil	NN	O	gemﬁbrozil	prep_such_as	26	SENT_22	[p2l1361t2682r1782b2764],
30	(	CD	NUMBER	(	num	29	SENT_22	[p2l1836t2683r2145b2765],
31	Farmer	NNP	O	Farmer	dep	29	SENT_22	[p2l1836t2683r2145b2765],
32	2001	CD	DATE	2001	num	31	SENT_22	[p2l9t2783r203b2859],
33	;	:	O	;	_	0	SENT_22	[p2l9t2783r203b2859],
34	Staffa	NNP	O	Staffa	dep	29	SENT_22	[p2l236t2781r451b2846],
35	et	FW	O	et	nn	36	SENT_22	[p2l478t2790r543b2846],
36	al.	FW	O	al.	dep	34	SENT_22	[p2l570t2781r652b2846],
37	2002	CD	DATE	2002	num	38	SENT_22	[p2l685t2781r907b2863],
38	)	CD	NUMBER	)	dep	34	SENT_22	[p2l685t2781r907b2863],
39	.	.	O	.	_	0	SENT_22	[p2l685t2781r907b2863],

1	In	FW	O	in	nn	3	SENT_23	[p2l940t2784r1019b2845],
2	vitro	FW	O	vitro	nn	3	SENT_23	[p2l1044t2781r1221b2846],
3	experiment	NN	O	experiment	nsubj	8	SENT_23	[p2l1250t2781r1668b2863],
4	with	IN	O	with	_	0	SENT_23	[p2l1692t2781r1857b2846],
5	human	JJ	O	human	amod	7	SENT_23	[p2l1883t2781r2145b2846],
6	liver	NN	O	liver	nn	7	SENT_23	[p2l8t2880r171b2945],
7	microsome	NN	O	microsome	prep_with	3	SENT_23	[p2l197t2880r609b2945],
8	demonstrated	VBD	O	demonstrate	_	0	SENT_23	[p2l639t2880r1155b2945],
9	that	IN	O	that	complm	11	SENT_23	[p2l1184t2880r1333b2945],
10	gemﬁbrozil	NN	O	gemﬁbrozil	nsubj	11	SENT_23	[p2l1361t2880r1782b2962],
11	inhibited	VBD	O	inhibit	ccomp	8	SENT_23	[p2l1810t2880r2145b2945],
12	CYP2C8	NN	O	cyp2c8	nn	13	SENT_23	[p2l10t2981r341b3045],
13	activity	NN	O	activity	dobj	11	SENT_23	[p2l375t2980r649b3062],
14	leading	VBG	O	lead	partmod	13	SENT_23	[p2l678t2980r949b3062],
15	to	TO	O	to	_	0	SENT_23	[p2l978t2989r1051b3044],
16	a	DT	O	a	det	18	SENT_23	[p2l1083t3001r1123b3044],
17	decreased	VBN	O	decrease	amod	18	SENT_23	[p2l1152t2980r1514b3044],
18	level	NN	O	level	prep_to	14	SENT_23	[p2l1544t2980r1710b3044],
19	of	IN	O	of	_	0	SENT_23	[p2l1741t2980r1823b3044],
20	M-23	NN	O	m-23	prep_of	18	SENT_23	[p2l1844t2981r2042b3044],
21	in	IN	O	in	_	0	SENT_23	[p2l2075t2980r2145b3043],
22	the	DT	O	the	det	24	SENT_23	[p2l9t3078r122b3143],
23	cerivastatin-metabolizing	JJ	O	cerivastatin-metabolizing	amod	24	SENT_23	[p2l175t3078r1128b3160],
24	pathway	NN	O	pathway	prep_in	14	SENT_23	[p2l1179t3078r1523b3160],
25	,	,	O	,	_	0	SENT_23	[p2l1179t3078r1523b3160],
26	which	WDT	O	which	nsubj	30	SENT_23	[p2l1578t3078r1801b3143],
27	at	IN	O	at	advmod	30	SENT_23	[p2l1855t3087r1925b3143],
28	least	JJS	O	least	pobj	27	SENT_23	[p2l1977t3078r2145b3143],
29	partially	RB	O	partially	advmod	27	SENT_23	[p2l7t3178r324b3260],
30	explains	VBZ	O	explain	rcmod	24	SENT_23	[p2l378t3178r681b3260],
31	the	DT	O	the	det	32	SENT_23	[p2l736t3178r849b3242],
32	interaction	NN	O	interaction	dobj	30	SENT_23	[p2l902t3178r1311b3242],
33	between	IN	O	between	_	0	SENT_23	[p2l1364t3178r1670b3242],
34	gemﬁbrozil	NN	O	gemﬁbrozil	prep_between	32	SENT_23	[p2l1723t3178r2144b3260],
35	and	CC	O	and	_	0	SENT_23	[p2l10t3276r147b3341],
36	cerivastatin	NN	O	cerivastatin	nn	38	SENT_23	[p2l183t3277r616b3341],
37	(	CD	NUMBER	(	num	38	SENT_23	[p2l654t3277r904b3359],
38	Wang	NNP	PERSON	Wang	dobj	30	SENT_23	[p2l654t3277r904b3359],
39	et	FW	O	et	nn	40	SENT_23	[p2l940t3285r1005b3341],
40	al.	FW	O	al.	dep	38	SENT_23	[p2l1041t3276r1124b3341],
41	2002	CD	DATE	2002	num	42	SENT_23	[p2l1166t3277r1387b3358],
42	)	CD	NUMBER	)	dep	38	SENT_23	[p2l1166t3277r1387b3358],
43	.	.	O	.	_	0	SENT_23	[p2l1166t3277r1387b3358],

1	Because	IN	O	because	_	0	SENT_24	[p2l1430t3279r1728b3341],
2	of	IN	O	of	_	0	SENT_24	[p2l1766t3276r1848b3341],
3	the	DT	O	the	det	5	SENT_24	[p2l1876t3276r1988b3341],
4	adverse	JJ	O	adverse	amod	5	SENT_24	[p2l2026t3276r2143b3341, p2l7t3397r195b3440],
5	effects	NNS	O	effect	prep_because_of	14	SENT_24	[p2l252t3376r482b3440],
6	in	IN	O	in	_	0	SENT_24	[p2l539t3376r610b3439],
7	the	DT	O	the	det	8	SENT_24	[p2l666t3376r779b3440],
8	muscles	NNS	O	muscle	prep_in	5	SENT_24	[p2l835t3376r1125b3440],
9	causing	VBG	O	cause	partmod	8	SENT_24	[p2l1183t3376r1464b3458],
10	rhabdomyolysis	NN	O	rhabdomyolysis	dobj	9	SENT_24	[p2l1521t3376r2141b3458],
11	,	,	O	,	_	0	SENT_24	[p2l1521t3376r2141b3458],
12	cerivastatin	NN	O	cerivastatin	nsubjpass	14	SENT_24	[p2l8t3474r441b3539],
13	was	VBD	O	be	auxpass	14	SENT_24	[p2l477t3495r616b3539],
14	withdrawn	VBN	O	withdraw	_	0	SENT_24	[p2l652t3474r1058b3539],
15	from	IN	O	from	_	0	SENT_24	[p2l1094t3474r1277b3539],
16	the	DT	O	the	det	17	SENT_24	[p2l1314t3474r1427b3539],
17	market	NN	O	market	prep_from	14	SENT_24	[p2l1463t3474r1731b3539],
18	in	IN	O	in	_	0	SENT_24	[p2l1766t3474r1836b3538],
19	August	NNP	DATE	August	prep_in	17	SENT_24	[p2l1872t3474r2145b3556],
20	2001	CD	DATE	2001	num	19	SENT_24	[p2l9t3575r201b3639],
21	.	.	O	.	_	0	SENT_24	[p2l9t3575r201b3639],

1	In	IN	O	in	_	0	SENT_25	[p2l234t3576r313b3637],
2	the	DT	O	the	det	4	SENT_25	[p2l340t3574r453b3638],
3	metabolic	JJ	O	metabolic	amod	4	SENT_25	[p2l479t3574r849b3638],
4	pathway	NN	O	pathway	prep_in	13	SENT_25	[p2l874t3574r1197b3656],
5	of	IN	O	of	_	0	SENT_25	[p2l1225t3574r1307b3638],
6	cerivastatin	NN	O	cerivastatin	prep_of	4	SENT_25	[p2l1325t3574r1779b3652],
7	,	,	O	,	_	0	SENT_25	[p2l1325t3574r1779b3652],
8	CYP2C8	NN	O	cyp2c8	nsubj	13	SENT_25	[p2l1810t3575r2141b3639],
9	and	CC	O	and	_	0	SENT_25	[p2l10t3672r147b3737],
10	CYP3A4	NN	O	cyp3a4	conj_and	8	SENT_25	[p2l181t3672r519b3737],
11	are	VBP	O	be	cop	13	SENT_25	[p2l553t3693r665b3737],
12	equally	RB	O	equally	advmod	13	SENT_25	[p2l697t3672r969b3754],
13	important	JJ	O	important	_	0	SENT_25	[p2l999t3672r1380b3754],
14	in	IN	O	in	_	0	SENT_25	[p2l1411t3672r1481b3736],
15	the	DT	O	the	det	16	SENT_25	[p2l1513t3672r1625b3737],
16	formation	NN	O	formation	prep_in	13	SENT_25	[p2l1659t3672r2038b3737],
17	of	IN	O	of	prep	16	SENT_25	[p2l2072t3672r2153b3737],

1	M-l	NN	O	m-l	nsubjpass	17	SENT_26	[p3l9t17r158b79],
2	and	CC	O	and	_	0	SENT_26	[p3l204t16r342b80],
3	the	DT	O	the	det	5	SENT_26	[p3l379t16r491b80],
4	subsequent	JJ	O	subsequent	amod	5	SENT_26	[p3l531t16r947b98],
5	formation	NN	O	formation	conj_and	1	SENT_26	[p3l983t16r1362b80],
6	of	IN	O	of	_	0	SENT_26	[p3l1401t16r1482b80],
7	M-23	NN	O	m-23	prep_of	5	SENT_26	[p3l1510t17r1733b94],
8	,	,	O	,	_	0	SENT_26	[p3l1510t17r1733b94],
9	the	DT	O	the	det	11	SENT_26	[p3l1773t16r1886b80],
10	major	JJ	O	major	amod	11	SENT_26	[p3l1922t16r2145b98],
11	metabolite	NN	O	metabolite	appos	1	SENT_26	[p3l7t114r405b179],
12	of	IN	O	of	_	0	SENT_26	[p3l485t114r567b179],
13	cerivastatin	NN	O	cerivastatin	prep_of	11	SENT_26	[p3l635t114r1088b192],
14	,	,	O	,	_	0	SENT_26	[p3l635t114r1088b192],
15	is	VBZ	O	be	auxpass	17	SENT_26	[p3l1169t114r1223b179],
16	mainly	RB	O	mainly	advmod	17	SENT_26	[p3l1300t114r1557b196],
17	mediated	VBN	O	mediate	_	0	SENT_26	[p3l1632t114r1977b179],
18	by	IN	O	by	_	0	SENT_26	[p3l2055t114r2145b196],
19	CYP2C8	NN	O	cyp2c8	nn	21	SENT_26	[p3l10t215r341b279],
20	(	CD	NUMBER	(	num	21	SENT_26	[p3l412t214r662b296],
21	Muck	NN	O	muck	agent	17	SENT_26	[p3l412t214r662b296],
22	2000	CD	DATE	2000	num	23	SENT_26	[p3l729t214r951b296],
23	)	NN	O	)	dep	21	SENT_26	[p3l729t214r951b296],
24	.	.	O	.	_	0	SENT_26	[p3l729t214r951b296],

1	It	PRP	O	it	nsubjpass	4	SENT_27	[p3l1023t216r1084b278],
2	was	VBD	O	be	auxpass	4	SENT_27	[p3l1148t235r1287b278],
3	also	RB	O	also	advmod	4	SENT_27	[p3l1356t214r1501b278],
4	suggested	VBN	O	suggest	_	0	SENT_27	[p3l1571t214r1929b296],
5	that	IN	O	that	complm	10	SENT_27	[p3l1996t214r2145b278],
6	transporters	NNS	O	transporter	nn	7	SENT_27	[p3l9t321r465b394],
7	OATP2	NN	O	oatp2	nsubj	10	SENT_27	[p3l503t312r792b377],
8	and	CC	O	and	_	0	SENT_27	[p3l830t312r968b377],
9	MPR2	NN	O	mpr2	nsubj	10	SENT_27	[p3l1004t314r1253b376],
10	contributed	VBD	O	contribute	ccomp	4	SENT_27	[p3l1290t312r1728b377],
11	to	TO	O	to	_	0	SENT_27	[p3l1764t321r1836b377],
12	hepatic	JJ	O	hepatic	amod	13	SENT_27	[p3l1874t312r2145b394],
13	clearance	NN	O	clearance	prep_to	10	SENT_27	[p3l8t412r357b476],
14	of	IN	O	of	_	0	SENT_27	[p3l389t412r471b476],
15	cerivastatin	NN	O	cerivastatin	nn	17	SENT_27	[p3l492t412r925b476],
16	(	CD	NUMBER	(	num	17	SENT_27	[p3l957t411r1418b494],
17	Matushima	NNP	O	Matushima	prep_of	13	SENT_27	[p3l957t411r1418b494],
18	et	FW	O	et	nn	19	SENT_27	[p3l1449t421r1514b476],
19	al.	FW	O	al.	dep	17	SENT_27	[p3l1545t412r1627b476],
20	2002	CD	DATE	2002	num	21	SENT_27	[p3l1663t412r1886b494],
21	)	CD	NUMBER	)	dep	19	SENT_27	[p3l1663t412r1886b494],
22	.	.	O	.	_	0	SENT_27	[p3l1663t412r1886b494],

1	In	IN	O	in	_	0	SENT_28	[p3l1922t414r2001b475],
2	the	DT	O	the	det	4	SENT_28	[p3l2031t411r2144b476],
3	present	JJ	DATE	present	amod	4	SENT_28	[p3l7t519r279b592],
4	study	NN	O	study	prep_in	7	SENT_28	[p3l318t510r539b592],
5	,	,	O	,	_	0	SENT_28	[p3l318t510r539b592],
6	we	PRP	O	we	nsubj	7	SENT_28	[p3l578t531r677b575],
7	sequenced	VBD	O	sequence	_	0	SENT_28	[p3l716t510r1096b592],
8	the	DT	O	the	det	11	SENT_28	[p3l1134t510r1246b575],
9	above	JJ	O	above	amod	11	SENT_28	[p3l1285t510r1505b575],
10	candidate	NN	O	candidate	nn	11	SENT_28	[p3l1542t510r1906b575],
11	genes	NNS	O	gene	dobj	7	SENT_28	[p3l1943t531r2143b592],
12	in	IN	O	in	_	0	SENT_28	[p3l8t610r78b673],
13	the	DT	O	the	det	14	SENT_28	[p3l112t610r225b674],
14	DNA	NN	O	dna	prep_in	7	SENT_28	[p3l261t610r472b674],
15	of	IN	O	of	_	0	SENT_28	[p3l508t610r590b674],
16	a	DT	O	a	det	17	SENT_28	[p3l617t631r656b674],
17	patient	NN	O	patient	prep_of	14	SENT_28	[p3l690t610r952b692],
18	who	WP	O	who	nsubj	19	SENT_28	[p3l985t610r1143b674],
19	suffered	VBD	O	suffer	rcmod	17	SENT_28	[p3l1181t609r1474b674],
20	from	IN	O	from	_	0	SENT_28	[p3l1509t610r1692b674],
21	rhabdomyolysis	NN	O	rhabdomyolysis	prep_from	19	SENT_28	[p3l1726t609r2143b691, p3l10t708r214b790],
22	after	IN	O	after	_	0	SENT_28	[p3l250t708r422b773],
23	taking	VBG	O	take	prepc_after	19	SENT_28	[p3l456t708r693b790],
24	cerivastatin	NN	O	cerivastatin	dobj	23	SENT_28	[p3l726t708r1179b773],
25	.	.	O	.	_	0	SENT_28	[p3l726t708r1179b773],

1	Subjects	NNS	O	subject	_	0	SENT_29	[p3l6t1006r325b1088],
2	and	CC	O	and	_	0	SENT_29	[p3l358t1007r491b1075],
3	methods	NNS	O	method	conj_and	1	SENT_29	[p3l529t1007r845b1076],

1	Subject	NNP	O	Subject	nn	2	SENT_30	[p3l11t1208r280b1289],
2	A	NNP	O	A	nsubjpass	23	SENT_30	[p3l371t1207r437b1271],
3	74-year-old	JJ	DURATION	74-year-old	amod	5	SENT_30	[p3l506t1207r934b1289],
4	hypercholesterolemic	JJ	O	hypercholesterolemic	amod	5	SENT_30	[p3l1002t1207r1800b1289],
5	woman	NN	O	woman	dep	2	SENT_30	[p3l1867t1228r2145b1272],
6	who	WP	O	who	nsubj	7	SENT_30	[p3l7t1305r164b1370],
7	showed	VBD	O	show	rcmod	2	SENT_30	[p3l220t1305r498b1370],
8	rhabdomyolysis	NN	O	rhabdomyolysis	dobj	7	SENT_30	[p3l549t1305r1148b1387],
9	after	IN	O	after	_	0	SENT_30	[p3l1201t1306r1374b1370],
10	taking	VBG	O	take	prepc_after	7	SENT_30	[p3l1424t1305r1661b1388],
11	cerivastatin	NN	O	cerivastatin	dobj	10	SENT_30	[p3l1711t1306r2145b1370],
12	for	IN	O	for	_	0	SENT_30	[p3l8t1404r118b1468],
13	22	CD	DURATION	22	num	14	SENT_30	[p3l146t1405r230b1467],
14	days	NNS	NUMBER	day	prep_for	10	SENT_30	[p3l258t1404r447b1486],
15	,	,	O	,	_	0	SENT_30	[p3l258t1404r447b1486],
16	her	PRP$	O	she	poss	17	SENT_30	[p3l477t1404r597b1468],
17	son	NN	O	son	prep_for	10	SENT_30	[p3l626t1425r773b1482],
18	,	,	O	,	_	0	SENT_30	[p3l626t1425r773b1482],
19	and	CC	O	and	_	0	SENT_30	[p3l805t1404r943b1468],
20	her	PRP$	O	she	poss	21	SENT_30	[p3l970t1404r1090b1468],
21	daughter	NN	O	daughter	prep_for	10	SENT_30	[p3l1117t1404r1453b1486],
22	were	VBD	O	be	auxpass	23	SENT_30	[p3l1479t1425r1651b1468],
23	recruited	VBN	O	recruit	_	0	SENT_30	[p3l1680t1404r2015b1468],
24	for	IN	O	for	_	0	SENT_30	[p3l2042t1404r2152b1468],
25	the	DT	O	the	det	26	SENT_30	[p3l9t1501r122b1566],
26	study	NN	O	study	prep_for	23	SENT_30	[p3l221t1501r442b1583],
27	.	.	O	.	_	0	SENT_30	[p3l221t1501r442b1583],

1	Serum	NN	MISC	serum	nn	3	SENT_31	[p3l547t1502r785b1566],
2	creatinine	NN	O	creatinine	nn	3	SENT_31	[p3l882t1501r1250b1566],
3	phosphokinase	NN	O	phosphokinase	nsubj	6	SENT_31	[p3l1347t1501r1914b1583],
4	was	VBD	O	be	cop	6	SENT_31	[p3l2010t1522r2150b1566],
5	19,190	CD	NUMBER	19,190	num	6	SENT_31	[p3l17t1601r250b1678],
6	IU/l	NN	O	iu/l	_	0	SENT_31	[p3l287t1600r464b1682],
7	,	,	O	,	_	0	SENT_31	[p3l287t1600r464b1682],
8	and	CC	O	and	_	0	SENT_31	[p3l501t1600r640b1664],
9	myoglobin	NN	O	myoglobin	nn	10	SENT_31	[p3l671t1600r1077b1682],
10	level	NN	O	level	nsubj	11	SENT_31	[p3l1109t1600r1276b1664],
11	was	VBD	O	be	conj_and	6	SENT_31	[p3l1308t1621r1447b1664],
12	over	IN	O	over	_	0	SENT_31	[p3l1482t1621r1645b1664],
13	3,000	CD	NUMBER	3,000	num	14	SENT_31	[p3l1680t1602r1874b1678],
14	ng/ml	NN	O	ng/ml	prep_over	11	SENT_31	[p3l1909t1600r2146b1682],
15	.	.	O	.	_	0	SENT_31	[p3l1909t1600r2146b1682],

1	The	DT	O	the	det	2	SENT_32	[p3l8t1697r152b1762],
2	participants	NNS	O	participant	nsubj	3	SENT_32	[p3l190t1697r639b1779],
3	gave	VBD	O	give	_	0	SENT_32	[p3l679t1718r846b1779],
4	informed	VBN	O	inform	amod	5	SENT_32	[p3l885t1697r1230b1762],
5	consent	NN	O	consent	dobj	3	SENT_32	[p3l1269t1706r1575b1775],
6	,	,	O	,	_	0	SENT_32	[p3l1269t1706r1575b1775],
7	and	CC	O	and	_	0	SENT_32	[p3l1618t1697r1757b1762],
8	the	DT	O	the	det	9	SENT_32	[p3l1795t1697r1908b1762],
9	study	NN	O	study	nsubjpass	11	SENT_32	[p3l1949t1697r2152b1779],
10	was	VBD	O	be	auxpass	11	SENT_32	[p3l7t1817r146b1860],
11	performed	VBN	O	perform	conj_and	3	SENT_32	[p3l197t1796r593b1878],
12	according	VBG	O	accord	_	0	SENT_32	[p3l645t1796r1014b1878],
13	to	TO	O	to	prepc_according_to	11	SENT_32	[p3l1064t1805r1137b1860],
14	the	DT	O	the	det	17	SENT_32	[p3l1191t1796r1304b1860],
15	Institutional	JJ	ORGANIZATION	institutional	amod	17	SENT_32	[p3l1356t1796r1824b1860],
16	Review	NNP	ORGANIZATION	Review	nn	17	SENT_32	[p3l1877t1796r2151b1860],
17	Board	NNP	ORGANIZATION	Board	pobj	11	SENT_32	[p3l10t1893r242b1958],
18	of	IN	ORGANIZATION	of	_	0	SENT_32	[p3l282t1893r364b1958],
19	Toho	NNP	ORGANIZATION	Toho	nn	20	SENT_32	[p3l393t1893r594b1958],
20	University	NNP	ORGANIZATION	University	prep_of	17	SENT_32	[p3l635t1893r1048b1975],
21	.	.	O	.	_	0	SENT_32	[p3l635t1893r1048b1975],

1	The	DT	O	the	det	2	SENT_33	[p3l1091t1893r1234b1958],
2	patient	NN	O	patient	nsubj	4	SENT_33	[p3l1272t1893r1536b1975],
3	had	VBD	O	have	aux	4	SENT_33	[p3l1573t1893r1713b1958],
4	taken	VBN	O	take	_	0	SENT_33	[p3l1751t1893r1959b1958],
5	pravastatin	NN	O	pravastatin	dobj	4	SENT_33	[p3l1995t1914r2149b1975, p3l7t1992r306b2056],
6	for	IN	O	for	_	0	SENT_33	[p3l337t1992r447b2056],
7	the	DT	DURATION	the	det	10	SENT_33	[p3l477t1992r590b2056],
8	previous	JJ	DURATION	previous	amod	10	SENT_33	[p3l622t1992r942b2074],
9	2	CD	DURATION	2	num	10	SENT_33	[p3l975t1993r1014b2055],
10	years	NNS	NUMBER	year	prep_for	5	SENT_33	[p3l1045t2013r1238b2074],
11	and	CC	O	and	_	0	SENT_33	[p3l1271t1992r1409b2056],
12	simvastatin	NN	O	simvastatin	conj_and	5	SENT_33	[p3l1442t1992r1870b2056],
13	for	IN	O	for	_	0	SENT_33	[p3l1901t1992r2011b2056],
14	1.5	CD	DURATION	1.5	num	15	SENT_33	[p3l2050t1994r2149b2056],
15	years	NNS	NUMBER	year	prep_for	12	SENT_33	[p3l8t2110r200b2171],
16	before	IN	O	before	_	0	SENT_33	[p3l267t2089r503b2154],
17	administration	NN	O	administration	prep_before	4	SENT_33	[p3l569t2089r1125b2154],
18	of	IN	O	of	_	0	SENT_33	[p3l1191t2089r1273b2154],
19	cerivastatin	NN	O	cerivastatin	prep_of	17	SENT_33	[p3l1329t2089r1784b2167],
20	,	,	O	,	_	0	SENT_33	[p3l1329t2089r1784b2167],
21	and	CC	O	and	_	0	SENT_33	[p3l1854t2089r1992b2154],
22	no	DT	O	no	det	23	SENT_33	[p3l2056t2111r2149b2154],
23	complaints	NNS	O	complaint	nsubjpass	28	SENT_33	[p3l8t2188r421b2270],
24	with	IN	O	with	_	0	SENT_33	[p3l461t2188r627b2252],
25	those	DT	O	those	det	26	SENT_33	[p3l667t2188r864b2252],
26	drugs	NNS	O	drug	prep_with	23	SENT_33	[p3l906t2187r1112b2270],
27	were	VBD	O	be	auxpass	28	SENT_33	[p3l1153t2209r1327b2252],
28	reported	VBN	O	report	conj_and	4	SENT_33	[p3l1368t2187r1707b2270],
29	.	.	O	.	_	0	SENT_33	[p3l1368t2187r1707b2270],

1	A	DT	O	a	det	3	SENT_34	[p3l1752t2188r1819b2251],
2	consanguineous	JJ	O	consanguineous	amod	3	SENT_34	[p3l1859t2209r2149b2252, p3l9t2285r343b2367],
3	marriage	NN	O	marriage	nsubjpass	5	SENT_34	[p3l382t2285r719b2367],
4	was	VBD	O	be	auxpass	5	SENT_34	[p3l758t2306r898b2350],
5	described	VBN	O	describe	_	0	SENT_34	[p3l939t2285r1292b2350],
6	for	IN	O	for	_	0	SENT_34	[p3l1333t2285r1443b2350],
7	the	DT	O	the	det	8	SENT_34	[p3l1482t2285r1595b2350],
8	patient	NN	O	patient	poss	10	SENT_34	[p3l1635t2285r1955b2367],
9	’s	POS	O	’s	_	0	SENT_34	[p3l1635t2285r1955b2367],
10	parents	NNS	O	parent	prep_for	5	SENT_34	[p3l1995t2306r2149b2367, p3l9t2392r176b2448],
11	.	.	O	.	_	0	SENT_34	[p3l1995t2306r2149b2367, p3l9t2392r176b2448],

1	PCR	NN	O	pcr	nn	2	SENT_35	[p3l9t2560r193b2622],
2	condition	NN	O	condition	nsubjpass	11	SENT_35	[p3l234t2557r568b2622],
3	and	CC	O	and	_	0	SENT_35	[p3l609t2557r746b2622],
4	primer	NN	O	primer	nn	9	SENT_35	[p3l769t2562r1020b2639],
5	design	NN	O	design	nn	9	SENT_35	[p3l1061t2557r1286b2639],
6	Puregene	NN	O	puregene	nn	9	SENT_35	[p3l1380t2560r1725b2639],
7	DNA	NN	O	dna	nn	9	SENT_35	[p3l1766t2557r1978b2621],
8	isolation	NN	O	isolation	nn	9	SENT_35	[p3l2017t2557r2149b2622, p3l8t2656r226b2721],
9	kit	NN	O	kit	conj_and	2	SENT_35	[p3l288t2656r387b2721],
10	was	VBD	O	be	auxpass	11	SENT_35	[p3l447t2678r586b2721],
11	used	VBN	O	use	_	0	SENT_35	[p3l648t2656r817b2721],
12	to	TO	O	to	aux	13	SENT_35	[p3l879t2665r952b2721],
13	isolate	VB	O	isolate	xcomp	11	SENT_35	[p3l1014t2657r1255b2721],
14	genomic	JJ	O	genomic	amod	15	SENT_35	[p3l1318t2656r1633b2738],
15	DNA	NN	O	dna	dobj	13	SENT_35	[p3l1695t2656r1906b2720],
16	from	IN	O	from	_	0	SENT_35	[p3l1968t2656r2151b2721],
17	peripheral	JJ	O	peripheral	amod	21	SENT_35	[p3l7t2755r393b2837],
18	blood	NN	O	blood	nn	21	SENT_35	[p3l447t2755r664b2820],
19	(	NN	O	(	nn	21	SENT_35	[p3l720t2755r1014b2837],
20	Gentra	NNP	ORGANIZATION	Gentra	nn	21	SENT_35	[p3l720t2755r1014b2837],
21	systems	NNS	O	system	prep_from	13	SENT_35	[p3l1071t2764r1375b2837],
22	,	,	O	,	_	0	SENT_35	[p3l1071t2764r1375b2837],
23	Inc.	NNP	ORGANIZATION	Inc.	appos	21	SENT_35	[p3l1434t2758r1596b2833],
24	,	,	O	,	_	0	SENT_35	[p3l1434t2758r1596b2833],
25	Minneapolis	NNP	LOCATION	Minneapolis	appos	21	SENT_35	[p3l1655t2755r2148b2837],
26	,	,	O	,	_	0	SENT_35	[p3l1655t2755r2148b2837],
27	MN	NN	O	mn	appos	21	SENT_35	[p3l9t2857r187b2933],
28	,	,	O	,	_	0	SENT_35	[p3l9t2857r187b2933],
29	USA	NNP	LOCATION	USA	appos	21	SENT_35	[p3l234t2854r469b2936],
30	)	CD	NUMBER	)	num	29	SENT_35	[p3l234t2854r469b2936],
31	.	.	O	.	_	0	SENT_35	[p3l234t2854r469b2936],

1	Taq	NN	O	taq	nn	7	SENT_36	[p3l516t2857r666b2936],
2	DNA	NN	O	dna	nn	7	SENT_36	[p3l709t2854r920b2918],
3	polymerase	NN	O	polymerase	nn	7	SENT_36	[p3l961t2854r1390b2937],
4	(	CD	NUMBER	(	num	7	SENT_36	[p3l1435t2855r1588b2937],
5	EX	NNP	O	EX	nn	7	SENT_36	[p3l1435t2855r1588b2937],
6	Taq	NN	O	taq	nn	7	SENT_36	[p3l1629t2857r1779b2936],
7	HS	NN	O	h	nsubj	13	SENT_36	[p3l1822t2855r1967b2936],
8	)	CD	NUMBER	)	dep	7	SENT_36	[p3l1822t2855r1967b2936],
9	was	VBD	O	be	cop	13	SENT_36	[p3l2010t2876r2150b2919],
10	from	IN	O	from	_	0	SENT_36	[p3l8t2953r192b3018],
11	Takara	NNP	PERSON	Takara	prep_from	13	SENT_36	[p3l240t2953r513b3018],
12	(	CD	NUMBER	(	num	11	SENT_36	[p3l564t2953r855b3035],
13	Kyoto	NNP	LOCATION	Kyoto	_	0	SENT_36	[p3l564t2953r855b3035],
14	,	,	O	,	_	0	SENT_36	[p3l564t2953r855b3035],
15	Japan	NNP	LOCATION	Japan	appos	13	SENT_36	[p3l907t2953r1180b3035],
16	)	CD	NUMBER	)	num	15	SENT_36	[p3l907t2953r1180b3035],
17	.	.	O	.	_	0	SENT_36	[p3l907t2953r1180b3035],

1	PCR	NN	O	pcr	nn	2	SENT_37	[p3l1233t2954r1418b3018],
2	ampliﬁcation	NN	O	ampliﬁcation	_	0	SENT_37	[p3l1466t2953r1963b3035],
3	was	VBD	O	be	partmod	2	SENT_37	[p3l2010t2974r2150b3018],
4	under	IN	O	under	_	0	SENT_37	[p3l8t3052r226b3117],
5	the	DT	O	the	det	7	SENT_37	[p3l251t3052r364b3117],
6	following	JJ	O	following	amod	7	SENT_37	[p3l390t3052r746b3134],
7	conditions	NNS	O	condition	prep_under	3	SENT_37	[p3l770t3052r1183b3117],
8	:	:	O	:	_	0	SENT_37	[p3l770t3052r1183b3117],
9	94	CD	NUMBER	94	num	11	SENT_37	[p3l1215t3054r1398b3117],
10	°	NN	O	°	nn	11	SENT_37	[p3l1215t3054r1398b3117],
11	C	NN	O	c	dep	2	SENT_37	[p3l1215t3054r1398b3117],
12	for	IN	O	for	_	0	SENT_37	[p3l1423t3052r1533b3117],
13	l	NN	O	l	nn	14	SENT_37	[p3l1566t3054r1590b3116],
14	min	NN	DURATION	min	prep_for	11	SENT_37	[p3l1631t3052r1796b3130],
15	,	,	O	,	_	0	SENT_37	[p3l1631t3052r1796b3130],
16	40	CD	NUMBER	40	num	17	SENT_37	[p3l1824t3054r1908b3117],
17	cycles	NNS	O	cycle	appos	14	SENT_37	[p3l1934t3053r2149b3134],
18	583	CD	NUMBER	583	dep	17	SENT_37	[p3l2045t3174r2148b3227],

1	of	IN	O	of	_	0	SENT_38	[p3l10t3345r92b3410],
2	94	CD	NUMBER	94	number	3	SENT_38	[p3l111t3346r294b3410],
3	°	CD	NUMBER	°	num	4	SENT_38	[p3l111t3346r294b3410],
4	C	NN	O	c	prep_of	11	SENT_38	[p3l111t3346r294b3410],
5	for	IN	O	for	_	0	SENT_38	[p3l322t3345r432b3410],
6	30	CD	NUMBER	30	num	7	SENT_38	[p3l460t3347r542b3410],
7	s	NNS	O	s	prep_for	4	SENT_38	[p3l579t3366r628b3423],
8	,	,	O	,	_	0	SENT_38	[p3l579t3366r628b3423],
9	62	CD	NUMBER	62	num	10	SENT_38	[p3l660t3346r842b3410],
10	°	NN	O	°	nsubj	11	SENT_38	[p3l660t3346r842b3410],
11	C	NN	O	c	_	0	SENT_38	[p3l660t3346r842b3410],
12	for	IN	O	for	_	0	SENT_38	[p3l870t3345r980b3410],
13	30	CD	NUMBER	30	num	14	SENT_38	[p3l1008t3347r1089b3410],
14	s	NNS	O	s	prep_for	11	SENT_38	[p3l1127t3366r1176b3423],
15	,	,	O	,	_	0	SENT_38	[p3l1127t3366r1176b3423],
16	and	CC	O	and	_	0	SENT_38	[p3l1207t3345r1345b3410],
17	72	CD	NUMBER	72	num	19	SENT_38	[p3l1373t3346r1556b3410],
18	°	NN	O	°	nn	19	SENT_38	[p3l1373t3346r1556b3410],
19	C	NN	O	c	prep_for	11	SENT_38	[p3l1373t3346r1556b3410],
20	for	IN	O	for	_	0	SENT_38	[p3l1583t3345r1693b3410],
21	1	CD	DURATION	1	num	22	SENT_38	[p3l1728t3346r1752b3409],
22	min	NN	DURATION	min	prep_for	11	SENT_38	[p3l1792t3345r1957b3423],
23	,	,	O	,	_	0	SENT_38	[p3l1792t3345r1957b3423],
24	then	RB	O	then	prep	11	SENT_38	[p3l1988t3345r2151b3410],
25	72	CD	NUMBER	72	num	27	SENT_38	[p3l10t3444r193b3508],
26	°	NN	O	°	nn	27	SENT_38	[p3l10t3444r193b3508],
27	C	NN	O	c	pobj	24	SENT_38	[p3l10t3444r193b3508],
28	for	IN	O	for	_	0	SENT_38	[p3l223t3443r334b3508],
29	5	CD	DURATION	5	num	30	SENT_38	[p3l367t3446r402b3508],
30	min	NN	DURATION	min	prep_for	27	SENT_38	[p3l437t3443r600b3507],
31	.	.	O	.	_	0	SENT_38	[p3l437t3443r600b3507],

1	Primer	NN	O	primer	nn	2	SENT_39	[p3l635t3443r892b3508],
2	sequences	NNS	O	sequence	nsubjpass	4	SENT_39	[p3l924t3464r1290b3525],
3	are	VBP	O	be	auxpass	4	SENT_39	[p3l1323t3464r1435b3508],
4	shown	VBN	O	show	_	0	SENT_39	[p3l1469t3443r1709b3508],
5	in	IN	O	in	_	0	SENT_39	[p3l1739t3443r1809b3507],
6	Table	NNP	O	Table	prep_in	4	SENT_39	[p3l1839t3443r2051b3508],
7	1	CD	NUMBER	1	num	6	SENT_39	[p3l2095t3445r2146b3507],
8	.	.	O	.	_	0	SENT_39	[p3l2095t3445r2146b3507],

1	Nucleotide	NN	O	nucleotide	nn	2	SENT_40	[p3l8t3543r421b3607],
2	variations	NNS	O	variation	nsubjpass	4	SENT_40	[p3l517t3543r892b3607],
3	were	VBD	O	be	auxpass	4	SENT_40	[p3l988t3564r1161b3607],
4	searched	VBN	O	search	_	0	SENT_40	[p3l1260t3543r1583b3607],
5	with	IN	O	with	_	0	SENT_40	[p3l1678t3543r1844b3607],
6	direct	JJ	O	direct	amod	7	SENT_40	[p3l1939t3543r2151b3607],
7	sequencing	NN	O	sequencing	prep_with	4	SENT_40	[p4l10t24r423b106],
8	using	VBG	O	use	partmod	7	SENT_40	[p4l465t24r664b106],
9	BigDye	NNP	MISC	BigDye	nn	12	SENT_40	[p4l709t24r988b106],
10	Terminator	NNP	MISC	Terminator	nn	12	SENT_40	[p4l1033t24r1468b89],
11	cycle	NN	O	cycle	nn	12	SENT_40	[p4l1511t24r1693b106],
12	sequencing	NN	O	sequencing	dobj	8	SENT_40	[p4l1739t24r2151b106],
13	on	IN	O	on	_	0	SENT_40	[p4l10t145r103b188],
14	an	DT	O	a	det	19	SENT_40	[p4l144t145r233b188],
15	ABI	NNP	MISC	ABI	nn	19	SENT_40	[p4l271t124r430b187],
16	PRISM	NNP	O	PRISM	nn	19	SENT_40	[p4l470t125r759b188],
17	3700	CD	NUMBER	3700	num	19	SENT_40	[p4l804t125r974b189],
18	DNA	NN	O	dna	nn	19	SENT_40	[p4l1016t124r1227b188],
19	analyzer	NN	O	analyzer	prep_on	12	SENT_40	[p4l1268t124r1583b205],
20	(	CD	NUMBER	(	dep	19	SENT_40	[p4l1624t123r1952b206],
21	Applied	NNP	O	Applied	nn	26	SENT_40	[p4l1624t123r1952b206],
22	Biosystems	NNP	O	Biosystems	nn	26	SENT_40	[p4l1993t124r2149b188, p4l10t231r316b304],
23	,	,	O	,	_	0	SENT_40	[p4l1993t124r2149b188, p4l10t231r316b304],
24	Tokyo	NNP	LOCATION	Tokyo	appos	26	SENT_40	[p4l353t222r621b304],
25	,	,	O	,	_	0	SENT_40	[p4l353t222r621b304],
26	Japan	NNP	LOCATION	Japan	dep	20	SENT_40	[p4l658t222r931b304],
27	)	CD	NUMBER	)	num	26	SENT_40	[p4l658t222r931b304],
28	.	.	O	.	_	0	SENT_40	[p4l658t222r931b304],

1	Results	NNS	O	result	_	0	SENT_41	[p4l10t522r280b591],
2	and	CC	O	and	_	0	SENT_41	[p4l312t522r445b591],
3	discussion	NN	O	discussion	conj_and	1	SENT_41	[p4l482t522r872b591],

1	The	DT	O	the	det	3	SENT_42	[p4l8t725r152b790],
2	hypercholesterolemic	JJ	O	hypercholesterolemic	amod	3	SENT_42	[p4l187t725r988b807],
3	patient	NN	O	patient	nsubj	4	SENT_42	[p4l1021t725r1285b807],
4	showed	VBD	O	show	_	0	SENT_42	[p4l1322t725r1602b790],
5	severe	JJ	O	severe	amod	6	SENT_42	[p4l1638t746r1862b790],
6	rhabdomyolysis	NN	O	rhabdomyolysis	dobj	4	SENT_42	[p4l1898t725r2149b790, p4l10t825r382b906],
7	after	IN	O	after	_	0	SENT_42	[p4l427t825r600b889],
8	taking	VBG	O	take	prepc_after	4	SENT_42	[p4l644t824r881b907],
9	cerivastatin	NN	O	cerivastatin	dobj	8	SENT_42	[p4l924t825r1378b889],
10	.	.	O	.	_	0	SENT_42	[p4l924t825r1378b889],

1	Cerivastatin	NNP	O	Cerivastatin	nsubj	5	SENT_43	[p4l1428t825r1886b889],
2	is	VBZ	O	be	cop	3	SENT_43	[p4l1928t825r1982b889],
3	uptaken	NN	O	uptaken	_	0	SENT_43	[p4l2026t846r2149b907, p4l9t923r216b988],
4	and	CC	O	and	_	0	SENT_43	[p4l243t923r381b988],
5	metabolized	VBN	O	metabolize	conj_and	3	SENT_43	[p4l404t923r863b988],
6	in	IN	O	in	_	0	SENT_43	[p4l887t923r957b987],
7	liver	NN	O	liver	prep_in	5	SENT_43	[p4l982t923r1145b988],
8	by	IN	O	by	_	0	SENT_43	[p4l1170t923r1260b1005],
9	OATP2	NN	O	oatp2	prep_by	5	SENT_43	[p4l1286t923r1597b1001],
10	,	,	O	,	_	0	SENT_43	[p4l1286t923r1597b1001],
11	CYP2C8	NN	O	cyp2c8	conj_and	9	SENT_43	[p4l1628t924r1983b1001],
12	,	,	O	,	_	0	SENT_43	[p4l1628t924r1983b1001],
13	and	CC	O	and	_	0	SENT_43	[p4l2013t923r2151b988],
14	CYP3A4	NN	O	cyp3a4	conj_and	9	SENT_43	[p4l10t1023r369b1087],
15	.	.	O	.	_	0	SENT_43	[p4l10t1023r369b1087],

1	To	TO	O	to	aux	2	SENT_44	[p4l428t1025r530b1087],
2	clarify	VB	O	clarify	purpcl	17	SENT_44	[p4l587t1023r824b1104],
3	the	DT	O	the	det	5	SENT_44	[p4l878t1023r992b1087],
4	genetic	JJ	O	genetic	amod	5	SENT_44	[p4l1047t1023r1308b1105],
5	susceptibility	NN	O	susceptibility	dobj	2	SENT_44	[p4l1364t1022r1854b1105],
6	to	TO	O	to	_	0	SENT_44	[p4l1908t1032r1981b1087],
7	the	DT	O	the	det	9	SENT_44	[p4l2037t1022r2150b1087],
8	adverse	JJ	O	adverse	amod	9	SENT_44	[p4l10t1121r289b1186],
9	effect	NN	O	effect	prep_to	2	SENT_44	[p4l319t1121r516b1186],
10	of	IN	O	of	_	0	SENT_44	[p4l546t1121r628b1186],
11	cerivastatin	NN	O	cerivastatin	prep_of	9	SENT_44	[p4l648t1121r1104b1199],
12	,	,	O	,	_	0	SENT_44	[p4l648t1121r1104b1199],
13	these	DT	O	these	det	15	SENT_44	[p4l1136t1121r1323b1186],
14	candidate	NN	O	candidate	nn	15	SENT_44	[p4l1352t1121r1717b1186],
15	genes	NNS	O	gene	nsubjpass	17	SENT_44	[p4l1747t1142r1948b1203],
16	were	VBD	O	be	auxpass	17	SENT_44	[p4l1977t1142r2150b1186],
17	analyzed	VBN	O	analyze	_	0	SENT_44	[p4l10t1220r339b1302],
18	by	IN	O	by	_	0	SENT_44	[p4l388t1220r479b1302],
19	direct	JJ	O	direct	amod	20	SENT_44	[p4l528t1220r740b1285],
20	sequencing	NN	O	sequencing	agent	17	SENT_44	[p4l790t1221r1202b1303],
21	in	IN	O	in	_	0	SENT_44	[p4l1250t1221r1321b1284],
22	the	DT	O	the	det	23	SENT_44	[p4l1370t1221r1483b1285],
23	patient	NN	O	patient	prep_in	20	SENT_44	[p4l1531t1221r1795b1303],
24	and	CC	O	and	_	0	SENT_44	[p4l1845t1220r1983b1285],
25	her	PRP$	O	she	poss	26	SENT_44	[p4l2032t1221r2151b1285],
26	children	NNS	O	child	conj_and	23	SENT_44	[p4l8t1319r333b1383],
27	.	.	O	.	_	0	SENT_44	[p4l8t1319r333b1383],

1	Table	NNP	O	Table	nn	3	SENT_45	[p4l41t1459r124b1484],
2	1	CD	NUMBER	1	num	3	SENT_45	[p4l139t1458r152b1484],
3	Primers	NNS	O	primer	nsubj	14	SENT_45	[p4l173t1458r288b1484],
4	used	VBN	O	use	partmod	3	SENT_45	[p4l301t1458r368b1484],
5	for	IN	O	for	_	0	SENT_45	[p4l382t1458r426b1484],
6	sequencing	NN	O	sequencing	nn	7	SENT_45	[p4l440t1458r604b1491],
7	CYP2C8	NN	O	cyp2c8	prep_for	4	SENT_45	[p4l617t1458r759b1489],
8	,	,	O	,	_	0	SENT_45	[p4l617t1458r759b1489],
9	CYP3A4	NN	O	cyp3a4	prep_for	4	SENT_45	[p4l774t1458r918b1489],
10	,	,	O	,	_	0	SENT_45	[p4l774t1458r918b1489],
11	and	CC	O	and	_	0	SENT_45	[p4l933t1458r988b1484],
12	OATP2	NN	O	oatp2	nn	13	SENT_45	[p4l1002t1458r1117b1484],
13	exons	NNS	O	exon	prep_for	4	SENT_45	[p4l1131t1466r1215b1484],
14	Exon	VBP	PERSON	exon	_	0	SENT_45	[p4l42t1533r157b1566],
15	(	NN	O	(	nn	16	SENT_45	[p4l42t1533r157b1566],
16	s	NNS	O	s	nsubj	17	SENT_45	[p4l42t1533r157b1566],
17	)	VBP	O	)	ccomp	14	SENT_45	[p4l42t1533r157b1566],
18	Forward	RB	O	forward	advmod	17	SENT_45	[p4l296t1533r427b1559],
19	primer	NN	O	primer	dep	18	SENT_45	[p4l440t1533r541b1566],
20	(	CD	NUMBER	(	num	21	SENT_45	[p4l555t1531r660b1566],
21	5	CD	NUMBER	5	dobj	17	SENT_45	[p4l555t1531r660b1566],
22	'	''	O	'	_	0	SENT_45	[p4l555t1531r660b1566],
23	.	.	O	.	_	0	SENT_45	[p4l555t1531r660b1566],

1	—	NN	O	—	_	0	SENT_46	[p4l555t1531r660b1566],
2	.	.	O	.	_	0	SENT_46	[p4l555t1531r660b1566],

1	3	CD	NUMBER	3	_	0	SENT_47	[p4l555t1531r660b1566],
2	'	''	O	'	_	0	SENT_47	[p4l555t1531r660b1566],
3	)	VBP	O	)	rcmod	1	SENT_47	[p4l555t1531r660b1566],
4	a	DT	O	a	nsubj	5	SENT_47	[p4l555t1531r660b1566],
5	Reverse	JJ	MISC	reverse	ccomp	3	SENT_47	[p4l1135t1534r1251b1559],
6	primer	NN	O	primer	iobj	5	SENT_47	[p4l1264t1533r1365b1566],
7	(	NN	O	(	dobj	5	SENT_47	[p4l1378t1531r1484b1566],
8	5	CD	NUMBER	5	num	7	SENT_47	[p4l1378t1531r1484b1566],
9	'	''	O	'	_	0	SENT_47	[p4l1378t1531r1484b1566],
10	.	.	O	.	_	0	SENT_47	[p4l1378t1531r1484b1566],

1	—	NN	O	—	_	0	SENT_48	[p4l1378t1531r1484b1566],
2	.	.	O	.	_	0	SENT_48	[p4l1378t1531r1484b1566],

1	3	CD	NUMBER	3	_	0	SENT_49	[p4l1378t1531r1484b1566],
2	'	''	O	'	_	0	SENT_49	[p4l1378t1531r1484b1566],
3	)	VBP	O	)	prep	1	SENT_49	[p4l1378t1531r1484b1566],
4	a	DT	O	a	det	6	SENT_49	[p4l1378t1531r1484b1566],
5	Product	NNP	O	Product	nn	6	SENT_49	[p4l1990t1533r2111b1559],
6	size	NN	O	size	dep	3	SENT_49	[p4l1991t1578r2043b1604],
7	(	CD	NUMBER	(	num	9	SENT_49	[p4l2058t1578r2118b1611],
8	bp	NN	O	bp	nn	9	SENT_49	[p4l2058t1578r2118b1611],
9	)	NN	O	)	dep	1	SENT_49	[p4l2058t1578r2118b1611],

1	CTPZC8	NN	O	ctpzc8	_	0	SENT_50	[p4l6t1689r295b1746],

1	l	NN	O	l	nn	2	SENT_51	[p4l79t1775r100b1832],
2	CAATTGGCTGGAGGAACATAA	NN	ORGANIZATION	caattggctggaggaacataa	dep	8	SENT_51	[p4l578t1774r1846b1833],
3	2	CD	NUMBER	2	num	4	SENT_51	[p4l72t1875r107b1932],
4	TAGGGCTCTGTTTTCCATCC	NN	ORGANIZATION	tagggctctgttttccatcc	dep	2	SENT_51	[p4l577t1874r1730b1933],
5	3	CD	NUMBER	3	num	6	SENT_51	[p4l74t1975r104b2032],
6	TTTCTCCCTCACAACCTTGC	NN	ORGANIZATION	tttctccctcacaaccttgc	dep	8	SENT_51	[p4l577t1974r1713b2033],
7	4	CD	NUMBER	4	num	8	SENT_51	[p4l71t2075r108b2132],
8	AAACCAAGTCTTCCCTACAACC	NN	ORGANIZATION	aaaccaagtcttccctacaacc	dep	12	SENT_51	[p4l576t2073r1862b2133],
9	5	CD	NUMBER	5	num	10	SENT_51	[p4l75t2176r105b2233],
10	CGATGAATCACAAAATGGACA	NN	ORGANIZATION	cgatgaatcacaaaatggaca	dep	8	SENT_51	[p4l578t2174r1842b2233],
11	6	CD	NUMBER	6	num	12	SENT_51	[p4l73t2275r107b2333],
12	GTGGAGGATACTGGCACCAT	NN	O	gtggaggatactggcaccat	dep	14	SENT_51	[p4l578t2274r1784b2333],
13	7	CD	NUMBER	7	num	14	SENT_51	[p4l73t2376r106b2432],
14	GTTGGAACCAAACCAGCACT	NN	ORGANIZATION	gttggaaccaaaccagcact	dep	16	SENT_51	[p4l578t2373r1772b2433],
15	8	CD	NUMBER	8	num	16	SENT_51	[p4l74t2475r105b2532],
16	CCAGAGGAGGTGCCATGTAA	NN	ORGANIZATION	ccagaggaggtgccatgtaa	dep	18	SENT_51	[p4l578t2473r1793b2533],
17	9-1	CD	NUMBER	9-1	num	18	SENT_51	[p4l72t2575r167b2633],
18	TGGGAAGATTTGATGAGAGG	NN	O	tgggaagatttgatgagagg	dep	20	SENT_51	[p4l577t2574r1802b2633],
19	9-2	CD	NUMBER	9-2	num	20	SENT_51	[p4l72t2675r174b2733],
20	TGAACCAGCAATTAATAACACTTTTT	NN	O	tgaaccagcaattaataacacttttt	_	0	SENT_51	[p4l577t2674r2087b2733],

1	CYP3A4	NN	O	cyp3a4	_	0	SENT_52	[p4l6t2773r310b2833],

1	l	NN	O	l	_	0	SENT_53	[p4l79t2875r100b2932],
2	AAGGGAAAGAGAGGCCTGAT	NNP	MISC	AAGGGAAAGAGAGGCCTGAT	nn	5	SENT_53	[p4l576t2873r1813b2933],
3	CCCCTGAGGAGAAGCATTTT	NNP	MISC	CCCCTGAGGAGAAGCATTTT	nn	5	SENT_53	[p4l578t2974r1764b3033],
4	TGTGCAGTGGGGTAAACTCA	NNP	MISC	TGTGCAGTGGGGTAAACTCA	nn	5	SENT_53	[p4l577t3074r1781b3133],
5	TTTCAACACATGAATGCTTACCC	NNP	MISC	TTTCAACACATGAATGCTTACCC	dep	1	SENT_53	[p4l577t3174r1911b3233],
6	ACACTGGGCATCTGGGATAA	NNP	MISC	ACACTGGGCATCTGGGATAA	nn	10	SENT_53	[p4l576t3274r1781b3333],
7	TTACCACAGCCCTCCTTTTG	NNP	MISC	TTACCACAGCCCTCCTTTTG	nn	10	SENT_53	[p4l577t3374r1723b3433],
8	ATGTGGGTTTCCTGTTGCAT	NNP	MISC	ATGTGGGTTTCCTGTTGCAT	nn	10	SENT_53	[p4l576t3474r1743b3533],
9	TGAGCAGTCTTCATGTTAAAAGC	NNP	MISC	TGAGCAGTCTTCATGTTAAAAGC	nn	10	SENT_53	[p4l577t3574r1936b3633],
10	AGATCAAGGACCACGCTTGT	NNP	MISC	AGATCAAGGACCACGCTTGT	dep	1	SENT_53	[p4l576t3674r1772b3733],

1	©	NN	O	©	nn	2	SENT_54	[p4l71t2976r108b3732],
2	OO	NN	O	oo	_	0	SENT_54	[p4l71t2976r108b3732],
3	\	CD	NUMBER	\	number	4	SENT_54	[p4l71t2976r108b3732],
4	]	CD	NUMBER	]	num	5	SENT_54	[p4l71t2976r108b3732],
5	O	NN	O	o	dep	2	SENT_54	[p4l71t2976r108b3732],
6	\	CD	NUMBER	\	num	7	SENT_54	[p4l71t2976r108b3732],
7	U1-l	NN	O	u1-l	dep	5	SENT_54	[p4l71t2976r108b3732],
8	>	JJR	O	>	amod	9	SENT_54	[p4l71t2976r108b3732],
9	UJ	NN	O	uj	dep	2	SENT_54	[p4l71t2976r108b3732],
10	[	CD	NUMBER	[	num	11	SENT_54	[p4l71t2976r108b3732],
11	\	NN	O	\	dep	9	SENT_54	[p4l71t2976r108b3732],
12	.	.	O	.	_	0	SENT_54	[p4l71t2976r108b3732],

1	>	JJR	O	>	_	0	SENT_55	[p4l71t2976r108b3732],

1	10	CD	NUMBER	10	num	2	SENT_56	[p5l39t29r107b86],
2	TTTTTCTTTTCAGAGCCTTCC	NN	ORGANIZATION	tttttcttttcagagccttcc	_	0	SENT_56	[p5l577t27r1758b86],
3	1	CD	NUMBER	1	number	4	SENT_56	[p5l39t129r60b185],
4	1	CD	NUMBER	1	num	5	SENT_56	[p5l79t129r101b185],
5	GGCAGAATATGCTTGAACCAG	NN	ORGANIZATION	ggcagaatatgcttgaaccag	dep	2	SENT_56	[p5l578t127r1843b186],
6	12	CD	NUMBER	12	num	7	SENT_56	[p5l39t228r107b285],
7	TTTGGCCCAGAGAACAAATTA	NN	ORGANIZATION	tttggcccagagaacaaatta	dep	2	SENT_56	[p5l577t227r1826b286],
8	1	CD	NUMBER	1	number	9	SENT_56	[p5l39t328r60b385],
9	3	CD	NUMBER	3	num	11	SENT_56	[p5l74t329r104b386],
10	CCTCCTCACACTGATTTGGTC	NN	O	cctcctcacactgatttggtc	nn	11	SENT_56	[p5l578t327r1787b386],
11	OATP2	NN	O	oatp2	dep	7	SENT_56	[p5l6t427r266b486],

1	1-1	CD	NUMBER	1-1	num	2	SENT_57	[p5l79t529r167b585],
2	AGAGCTTCATTTTTGAGACTTGA	NN	O	agagcttcatttttgagacttga	dep	9	SENT_57	[p5l576t527r1924b586],
3	1	CD	NUMBER	1	num	5	SENT_57	[p5l79t628r100b685],
4	-2	CD	NUMBER	-2	num	5	SENT_57	[p5l113t628r174b685],
5	TGTTCTTTTTAACAACTTGCTTTTC	NN	O	tgttctttttaacaacttgcttttc	dep	2	SENT_57	[p5l577t627r1984b686],
6	2	CD	NUMBER	2	num	7	SENT_57	[p5l72t728r107b785],
7	TTTTTAACTTTGCAAGTTTGGTT	NN	ORGANIZATION	tttttaactttgcaagtttggtt	dep	9	SENT_57	[p5l577t727r1890b786],
8	3	CD	NUMBER	3	num	9	SENT_57	[p5l74t828r104b885],
9	TGGGTATCTTCTCAAAAGGTAACTG	NN	ORGANIZATION	tgggtatcttctcaaaaggtaactg	dep	11	SENT_57	[p5l577t826r2056b886],
10	4	CD	NUMBER	4	dep	9	SENT_57	[p5l71t928r108b985],
11	TGTTGTTAATGGGCGAACTG	NN	ORGANIZATION	tgttgttaatgggcgaactg	dep	13	SENT_57	[p5l577t926r1769b986],
12	5	CD	NUMBER	5	num	11	SENT_57	[p5l75t1030r105b1086],
13	CCAAGAATGCATGGTTCTTATTC	NN	ORGANIZATION	ccaagaatgcatggttcttattc	dep	15	SENT_57	[p5l578t1027r1919b1086],
14	6	CD	NUMBER	6	num	13	SENT_57	[p5l73t1129r107b1186],
15	GGAGCTGGATTTTATATTTATTCTGA	NN	ORGANIZATION	ggagctggattttatatttattctga	dep	17	SENT_57	[p5l578t1127r2092b1186],
16	7	CD	NUMBER	7	num	15	SENT_57	[p5l73t1229r106b1285],
17	GCAAAAGAAAGCCAACTCCA	NN	ORGANIZATION	gcaaaagaaagccaactcca	dep	19	SENT_57	[p5l578t1226r1785b1286],
18	8	CD	NUMBER	8	num	17	SENT_57	[p5l74t1328r105b1385],
19	GAGCAATAGTGACATCACAAGTTTTA	NN	ORGANIZATION	gagcaatagtgacatcacaagtttta	dep	21	SENT_57	[p5l578t1326r2121b1386],
20	9	CD	NUMBER	9	num	19	SENT_57	[p5l72t1428r106b1486],
21	TTTAGTTAAAATTGTTTTCTGCCTTA	NN	ORGANIZATION	tttagttaaaattgttttctgcctta	dep	23	SENT_57	[p5l577t1427r2059b1486],
22	10	CD	NUMBER	10	num	21	SENT_57	[p5l39t1529r107b1586],
23	CATCACACCCATCACAATAACA	NN	ORGANIZATION	catcacacccatcacaataaca	dep	26	SENT_57	[p5l578t1527r1866b1586],
24	1	CD	NUMBER	1	num	23	SENT_57	[p5l39t1628r60b1685],
25	1	CD	NUMBER	1	num	26	SENT_57	[p5l79t1628r100b1685],
26	CAGCCTTGAGAGTTCATAGTAATTTT	NN	ORGANIZATION	cagccttgagagttcatagtaatttt	dep	31	SENT_57	[p5l578t1627r2096b1686],
27	12	CD	NUMBER	12	num	28	SENT_57	[p5l39t1728r107b1785],
28	TCGAATTCTCCTTTAGGTCCA	NN	ORGANIZATION	tcgaattctcctttaggtcca	dep	26	SENT_57	[p5l577t1727r1788b1786],
29	1	CD	NUMBER	1	number	30	SENT_57	[p5l39t1829r60b1885],
30	3	CD	NUMBER	3	dep	28	SENT_57	[p5l74t1829r104b1886],
31	TGACATGAGGAGAGTTTTGGAA	NN	ORGANIZATION	tgacatgaggagagttttggaa	dep	36	SENT_57	[p5l577t1827r1908b1886],
32	14-1	CD	NUMBER	14-1	num	31	SENT_57	[p5l39t1928r167b1985],
33	TGGATCATATAGTCTAACCTTAACCAC	NN	O	tggatcatatagtctaaccttaaccac	nn	36	SENT_57	[p5l577t1927r2153b1986],
34	14-2	CD	NUMBER	14-2	num	36	SENT_57	[p5l39t2028r174b2085],
35	TGGAATGTCTTTATTTCTTCCACA	NN	O	tggaatgtctttatttcttccaca	nn	36	SENT_57	[p5l577t2027r1952b2086],
36	GGCTTCAATGGAACCTTTTG	NN	ORGANIZATION	ggcttcaatggaaccttttg	dep	41	SENT_57	[p5l9t2128r1240b2189],
37	1	CD	NUMBER	1	number	38	SENT_57	[p5l2037t2129r2060b2188],
38	56	CD	NUMBER	56	dep	36	SENT_57	[p5l2075t2130r2151b2189],
39	TTGCTGCTATTTGCATTTCC	NN	O	ttgctgctatttgcatttcc	dep	38	SENT_57	[p5l8t2231r1199b2292],
40	212	CD	NUMBER	212	num	39	SENT_57	[p5l2030t2232r2151b2291],
41	TGCTTCAAATCTCCCTCCAC	NN	O	tgcttcaaatctccctccac	dep	43	SENT_57	[p5l8t2334r1208b2397],
42	200	CD	NUMBER	200	num	41	SENT_57	[p5l2030t2336r2151b2397],
43	TTTTTGGACACATGGGGAAT	NN	O	tttttggacacatggggaat	dep	45	SENT_57	[p5l8t2439r1252b2502],
44	250	CD	NUMBER	250	num	43	SENT_57	[p5l2030t2441r2151b2502],
45	ATTTCAATCAGGGCTTGGTG	NN	O	atttcaatcagggcttggtg	dep	47	SENT_57	[p5l7t2544r1248b2605],
46	209	CD	NUMBER	209	num	45	SENT_57	[p5l2030t2545r2150b2605],
47	TGTCCAGTATCTCTTTTGGCTAAC	NN	O	tgtccagtatctcttttggctaac	dep	49	SENT_57	[p5l8t2647r1457b2708],
48	264	CD	NUMBER	264	num	47	SENT_57	[p5l2030t2648r2152b2708],
49	GGCCATGAATTGCTATGACA	NN	O	ggccatgaattgctatgaca	dep	51	SENT_57	[p5l9t2750r1257b2813],
50	268	CD	NUMBER	268	num	49	SENT_57	[p5l2030t2752r2148b2812],
51	GCGCTACGTGATGTCCACTA	NN	O	gcgctacgtgatgtccacta	dep	53	SENT_57	[p5l9t2855r1248b2916],
52	256	CD	NUMBER	256	num	51	SENT_57	[p5l2030t2856r2151b2915],
53	TGCATATTCTGTTTGTGCAAGTC	NN	O	tgcatattctgtttgtgcaagtc	dep	55	SENT_57	[p5l8t2958r1407b3019],
54	340	CD	NUMBER	340	num	53	SENT_57	[p5l2033t2959r2151b3019],
55	TGAAGAATGCTAGCCCATCTG	NN	O	tgaagaatgctagcccatctg	_	0	SENT_57	[p5l8t3061r1318b3122],
56	320	CD	NUMBER	320	num	55	SENT_57	[p5l2032t3063r2151b3122],

1	AAAGCTCCATGCACATAGCC	NN	ORGANIZATION	aaagctccatgcacatagcc	dep	8	SENT_58	[p5l7t3241r1252b3304],
2	1	CD	NUMBER	1	num	1	SENT_58	[p5l2038t3243r2060b3303],
3	73	CD	NUMBER	73	num	4	SENT_58	[p5l2073t3243r2148b3303],
4	TCGTTCTCTTGAGCATTCCA	NN	O	tcgttctcttgagcattcca	dep	1	SENT_58	[p5l8t3333r1213b3394],
5	210	CD	NUMBER	210	num	6	SENT_58	[p5l2030t3335r2151b3394],
6	CCCTTTTCAAATACCTCCTCTG	NN	O	cccttttcaaatacctcctctg	dep	8	SENT_58	[p5l9t3436r1321b3497],
7	220	CD	NUMBER	220	num	8	SENT_58	[p5l2030t3438r2151b3497],
8	TGTGTATTGTACAACTAAGGGATTATG	NN	O	tgtgtattgtacaactaagggattatg	dep	13	SENT_58	[p5l8t3539r1684b3600],
9	1	CD	NUMBER	1	number	10	SENT_58	[p5l2038t3540r2060b3599],
10	82	CD	NUMBER	82	dep	8	SENT_58	[p5l2074t3540r2151b3600],
11	CAGTGGACTACCCCTTGGAA	NN	O	cagtggactaccccttggaa	dep	10	SENT_58	[p5l9t3642r1257b3703],
12	250	CD	NUMBER	250	num	11	SENT_58	[p5l2030t3643r2151b3703],
13	GCCATGTCCTTCTGGGACTA	NN	O	gccatgtccttctgggacta	_	0	SENT_58	[p5l9t3745r1239b3806],
14	220	CD	NUMBER	220	num	13	SENT_58	[p5l2030t3747r2151b3806],

1	AAAGCAGTTATTTTTAAGAGAGCAAGA	NNP	MISC	AAAGCAGTTATTTTTAAGAGAGCAAGA	nn	7	SENT_59	[p6l7t35r1705b96],
2	GAAGGAATGGCTTCCAGTTG	NNP	MISC	GAAGGAATGGCTTCCAGTTG	nn	7	SENT_59	[p6l9t138r1270b199],
3	GCATGCCTCTAGAAAGTGCC	NNP	MISC	GCATGCCTCTAGAAAGTGCC	nn	7	SENT_59	[p6l9t241r1256b302],
4	AGGGATTTGAGGGCTTCACT	NNP	MISC	AGGGATTTGAGGGCTTCACT	nn	7	SENT_59	[p6l7t344r1261b405],
5	TCTCTGGAGCTCCTAATACTTCA	NNP	MISC	TCTCTGGAGCTCCTAATACTTCA	nn	7	SENT_59	[p6l8t447r1403b508],
6	AATGACCAGCCCACAAAAGT	NNP	MISC	AATGACCAGCCCACAAAAGT	nn	7	SENT_59	[p6l7t550r1265b611],
7	GTCCCCTCAACACTGAAGGA	NNP	MISC	GTCCCCTCAACACTGAAGGA	_	0	SENT_59	[p6l9t653r1257b714],

1	CTTGTTGCAGTTGCTGTAGGA	NNP	MISC	CTTGTTGCAGTTGCTGTAGGA	nn	16	SENT_60	[p6l9t833r1309b894],
2	TTCATGTAATCTGGTGTGTGATTC	NNP	MISC	TTCATGTAATCTGGTGTGTGATTC	nn	16	SENT_60	[p6l8t923r1471b984],
3	TGGCTGAGTAGTAGTACCTGGTAAA	NNP	MISC	TGGCTGAGTAGTAGTACCTGGTAAA	nn	16	SENT_60	[p6l8t1026r1580b1087],
4	TCAATGAGTGGTCTAATGTAGGTGA	NNP	MISC	TCAATGAGTGGTCTAATGTAGGTGA	nn	16	SENT_60	[p6l8t1129r1576b1192],
5	GGGGAAGATAATGGTGCAAA	NNP	MISC	GGGGAAGATAATGGTGCAAA	nn	16	SENT_60	[p6l9t1234r1300b1297],
6	TGTCAAAGTTTGCAAAGTGAA	NNP	MISC	TGTCAAAGTTTGCAAAGTGAA	nn	16	SENT_60	[p6l8t1339r1322b1400],
7	TTGTATGATCACTTTCCCTTTGTC	NNP	MISC	TTGTATGATCACTTTCCCTTTGTC	nn	16	SENT_60	[p6l8t1442r1436b1503],
8	TCATACCATTATTTCCCTGAACC	NNP	MISC	TCATACCATTATTTCCCTGAACC	nn	16	SENT_60	[p6l8t1545r1389b1608],
9	CAGGCTATTCTCACTCTTTGTGTT	NNP	MISC	CAGGCTATTCTCACTCTTTGTGTT	nn	16	SENT_60	[p6l9t1650r1449b1713],
10	TTGAATAAATTTGATTGACATACATTG	NNP	MISC	TTGAATAAATTTGATTGACATACATTG	nn	16	SENT_60	[p6l8t1755r1662b1816],
11	GGCAAAGATGGAGAGCGTAA	NNP	MISC	GGCAAAGATGGAGAGCGTAA	nn	16	SENT_60	[p6l9t1858r1305b1919],
12	AGTTTGAACAAGTGAGACTTCACTAAA	NNP	MISC	AGTTTGAACAAGTGAGACTTCACTAAA	nn	16	SENT_60	[p6l7t1961r1692b2022],
13	TGAAATCATGATGCATTGAATAAA	NNP	MISC	TGAAATCATGATGCATTGAATAAA	nn	16	SENT_60	[p6l8t2064r1502b2125],
14	TCAATGTGGAATATCATGCAGTT	NNP	MISC	TCAATGTGGAATATCATGCAGTT	nn	16	SENT_60	[p6l8t2167r1429b2228],
15	GGATCTGGATACTGGAGAAAATG	NNP	MISC	GGATCTGGATACTGGAGAAAATG	nn	16	SENT_60	[p6l9t2270r1474b2331],
16	GTTTCCAAACAGCATTGCAT	NNP	MISC	GTTTCCAAACAGCATTGCAT	_	0	SENT_60	[p6l9t2373r1234b2434],

1	260 400 266 250	CD	NUMBER	260 400 266 250	number	2	SENT_61	[p6l2030t1131r2151b1192],[p6l2030t835r2151b894],
2	294 320 260 320	CD	NUMBER	294 320 260 320	num	3	SENT_61	[p6l2032t1547r2151b1608],[p6l2030t1236r2152b1296],
3	370 270 400 320	CD	NUMBER	370 270 400 320	nsubj	16	SENT_61	[p6l2033t1962r2151b2022],[p6l2032t1652r2151b1713],
4	250 330 430 460	CD	NUMBER	250 330 430 460	number	5	SENT_61	[p6l2029t2374r2151b2434],[p6l2030t2065r2151b2125],
5	“	CD	NUMBER	“	num	3	SENT_61	[p6l41t2483r141b2511],
6	These	DT	O	these	det	7	SENT_61	[p6l41t2483r141b2511],
7	primers	NNS	O	primer	nsubjpass	9	SENT_61	[p6l154t2484r267b2518],
8	were	VBD	O	be	auxpass	9	SENT_61	[p6l281t2493r350b2511],
9	designed	VBN	O	design	rcmod	3	SENT_61	[p6l363t2484r493b2518],
10	with	IN	O	with	_	0	SENT_61	[p6l506t2484r571b2511],
11	gene	NN	O	gene	nn	12	SENT_61	[p6l585t2493r651b2518],
12	arrangement	NN	O	arrangement	prep_with	9	SENT_61	[p6l665t2488r856b2518],
13	of	IN	O	of	_	0	SENT_61	[p6l869t2484r902b2511],
14	complementary	JJ	O	complementary	amod	15	SENT_61	[p6l912t2485r1145b2518],
15	DNA	NN	O	dna	prep_of	12	SENT_61	[p6l1159t2484r1243b2511],
16	expect	VBP	O	expect	_	0	SENT_61	[p6l1256t2488r1351b2518],
17	CYP2C8	NN	O	cyp2c8	nn	18	SENT_61	[p6l1364t2485r1496b2511],
18	exon	NN	O	exon	dobj	16	SENT_61	[p6l1511t2493r1582b2511],
19	3	CD	NUMBER	3	dep	18	SENT_61	[p6l1597t2485r1610b2511],
20	and	CC	O	and	_	0	SENT_61	[p6l1626t2484r1681b2511],
21	CYP3A4	NN	O	cyp3a4	nn	22	SENT_61	[p6l1694t2484r1830b2511],
22	exons	NNS	O	exon	conj_and	18	SENT_61	[p6l1843t2493r1927b2511],
23	5	CD	NUMBER	5	dep	22	SENT_61	[p6l1942t2486r1966b2516],
24	,	,	O	,	_	0	SENT_61	[p6l1942t2486r1966b2516],
25	7	CD	NUMBER	7	appos	23	SENT_61	[p6l1981t2486r2005b2516],
26	,	,	O	,	_	0	SENT_61	[p6l1981t2486r2005b2516],
27	and	CC	NUMBER	and	_	0	SENT_61	[p6l2020t2484r2075b2511],
28	9	CD	NUMBER	9	number	29	SENT_61	[p6l2089t2485r2104b2511],
29	584	CD	NUMBER	584	dep	22	SENT_61	[p6l44t2537r94b2562],

1	475delA	NN	O	475delum	_	0	SENT_62	[p6l693t2629r811b2654],

1	2247bp	JJ	O	2247bp	amod	2	SENT_63	[p6l870t2694r954b2720],
2	Exon	NN	O	exon	_	0	SENT_63	[p6l729t2759r789b2779],
3	3	CD	NUMBER	3	dep	2	SENT_63	[p6l797t2759r809b2779],
4	A	DT	O	a	det	6	SENT_63	[p6l866t2727r952b2790],
5	150	CD	NUMBER	150	num	6	SENT_63	[p6l732t2829r771b2849],
6	bp	NN	O	bp	dep	2	SENT_63	[p6l779t2829r807b2855],

1	171bp	NN	O	171bp	_	0	SENT_64	[p6l590t2954r658b2980],
2	*	CD	NUMBER	*	number	3	SENT_64	[p6l695t2954r725b2978],
3	3	CD	NUMBER	3	dep	1	SENT_64	[p6l695t2954r725b2978],
4	(	NN	O	(	nn	6	SENT_64	[p6l737t2954r858b2984],
5	G416A	NN	O	g416a	nn	6	SENT_64	[p6l737t2954r858b2984],
6	)	NN	O	)	dep	3	SENT_64	[p6l737t2954r858b2984],
7	.	.	O	.	_	0	SENT_64	[p6l1023t2966r1026b2981],

1	*	NN	O	*	nsubj	17	SENT_65	[p6l1505t2954r1536b2978],
2	4	CD	NUMBER	4	number	3	SENT_65	[p6l1505t2954r1536b2978],
3	(	CD	NUMBER	(	num	4	SENT_65	[p6l1547t2954r1666b2984],
4	C792G	NN	O	c792g	dep	1	SENT_65	[p6l1547t2954r1666b2984],
5	)	CD	NUMBER	)	num	6	SENT_65	[p6l1547t2954r1666b2984],
6	C389A	NN	O	c389a	dep	1	SENT_65	[p6l693t2995r792b3020],
7	/	:	O	/	punct	9	SENT_65	[p6l974t2986r1058b3025],
8	*	CD	NUMBER	*	number	9	SENT_65	[p6l974t2986r1058b3025],
9	‘	CD	NUMBER	‘	dep	1	SENT_65	[p6l974t2986r1058b3025],
10	~	NN	O	~	nn	11	SENT_65	[p6l1064t3005r1162b3025],
11	~	NN	O	~	dep	9	SENT_65	[p6l1064t3005r1162b3025],
12	~	CD	NUMBER	~	num	14	SENT_65	[p6l1064t3005r1162b3025],
13	~	NN	O	~	nn	14	SENT_65	[p6l1064t3005r1162b3025],
14	~	NN	O	~	dep	9	SENT_65	[p6l1064t3005r1162b3025],
15	s	VBZ	O	s	cop	17	SENT_65	[p6l1168t3023r1203b3032],
16	‘	CD	NUMBER	‘	num	17	SENT_65	[p6l1168t3023r1203b3032],
17	*	NN	O	*	_	0	SENT_65	[p6l1505t3001r1536b3025],
18	2	CD	NUMBER	2	num	20	SENT_65	[p6l1505t3001r1536b3025],
19	(	CD	NUMBER	(	num	20	SENT_65	[p6l1547t2997r1666b3031],
20	A8O5T	NN	O	a8o5t	dep	17	SENT_65	[p6l1547t2997r1666b3031],
21	)	CD	NUMBER	)	num	22	SENT_65	[p6l1547t2997r1666b3031],
22	G462T	NN	O	g462t	dep	20	SENT_65	[p6l694t3037r790b3061],
23	,	,	O	,	_	0	SENT_65	[p6l880t3044r932b3071],
24	/	:	O	/	punct	25	SENT_65	[p6l880t3044r932b3071],
25	~	FW	O	~	dep	20	SENT_65	[p6l1230t3034r1389b3065],
26	~	FW	O	~	nn	31	SENT_65	[p6l1230t3034r1389b3065],
27	~	FW	O	~	nn	31	SENT_65	[p6l1230t3034r1389b3065],
28	~	FW	O	~	nn	31	SENT_65	[p6l1230t3034r1389b3065],
29	~	FW	O	~	nn	31	SENT_65	[p6l1230t3034r1389b3065],
30	~	FW	O	~	nn	31	SENT_65	[p6l1230t3034r1389b3065],
31	~	FW	O	~	dep	25	SENT_65	[p6l1230t3034r1389b3065],
32	\	SYM	O	\	dep	17	SENT_65	[p6l1395t3064r1431b3073],

1	GAGGAGTTGAGAAAAACCAAGGCTTCACCCTGTGATCCCACTTTCATCCTGGGCTGTGCTCCCTGCAATGTGATCTGC	NNP	O	GAGGAGTTGAGAAAAACCAAGGCTTCACCCTGTGATCCCACTTTCATCCTGGGCTGTGCTCCCTGCAATGTGATCTGC	nn	8	SENT_66	[p6l359t3163r1877b3184],
2	Glu	NNP	O	Glu	nn	8	SENT_66	[p6l359t3208r401b3228],
3	Glu	NNP	O	Glu	nn	8	SENT_66	[p6l424t3208r466b3228],
4	Leu	NNP	O	Leu	nn	8	SENT_66	[p6l481t3208r525b3228],
5	Arg	NN	O	arg	nn	8	SENT_66	[p6l540t3208r584b3234],
6	Lys	NNP	O	Lys	nn	8	SENT_66	[p6l599t3208r641b3234],
7	Thr	NNP	O	Thr	nn	8	SENT_66	[p6l664t3208r706b3228],
8	L	NNP	O	L	nsubj	11	SENT_66	[p6l727t3208r744b3228],
9	s	VBZ	O	s	cop	11	SENT_66	[p6l760t3214r769b3228],
10	la	NNP	O	la	nn	11	SENT_66	[p6l806t3208r826b3228],
11	Ser	NNP	O	Ser	_	0	SENT_66	[p6l849t3208r886b3228],
12	Pro	FW	O	pro	dep	11	SENT_66	[p6l908t3208r947b3228],
13	Cys	NN	O	cy	nn	14	SENT_66	[p6l963t3208r1006b3234],
14	Asp	NN	O	asp	dep	22	SENT_66	[p6l1022t3208r1067b3234],
15	Pro	FW	O	pro	nn	18	SENT_66	[p6l1075t3208r1114b3228],
16	Thr	FW	O	thr	nn	18	SENT_66	[p6l1130t3208r1171b3228],
17	Pm	NN	O	pm	nn	18	SENT_66	[p6l1193t3208r1232b3228],
18	Ile	NN	O	ile	dep	14	SENT_66	[p6l1240t3208r1269b3228],
19	Leu	NNP	O	Leu	dep	22	SENT_66	[p6l1299t3208r1343b3228],
20	Gly	NNP	O	Gly	nn	22	SENT_66	[p6l1359t3208r1400b3234],
21	Cys	NN	O	cy	nn	22	SENT_66	[p6l1416t3208r1459b3234],
22	Ala	NNP	PERSON	Ala	dep	28	SENT_66	[p6l1475t3208r1516b3228],
23	Pro	FW	PERSON	pro	dep	22	SENT_66	[p6l1531t3208r1570b3228],
24	Cys	NN	PERSON	cy	nn	28	SENT_66	[p6l1586t3208r1629b3234],
25	Asn	NN	PERSON	asn	nn	28	SENT_66	[p6l1644t3208r1690b3228],
26	Val	NN	PERSON	val	nn	28	SENT_66	[p6l1705t3208r1746b3228],
27	Ile	NN	PERSON	ile	nn	28	SENT_66	[p6l1767t3208r1796b3228],
28	Cys	NN	PERSON	cy	dep	37	SENT_66	[p6l1818t3208r1862b3234],
29	Glu	NNP	PERSON	Glu	nn	35	SENT_66	[p6l359t3237r401b3257],
30	Glu	NNP	PERSON	Glu	nn	35	SENT_66	[p6l424t3237r466b3257],
31	Leu	NNP	PERSON	Leu	nn	35	SENT_66	[p6l481t3237r525b3257],
32	Arg	NN	PERSON	arg	nn	35	SENT_66	[p6l541t3237r584b3263],
33	Lys	NNP	PERSON	Lys	nn	35	SENT_66	[p6l600t3237r642b3263],
34	Pro	FW	O	pro	nn	35	SENT_66	[p6l692t3237r731b3257],
35	Leu	NNP	O	Leu	dep	28	SENT_66	[p6l813t3237r857b3257],
36	His	PRP$	O	he	poss	37	SENT_66	[p6l879t3237r918b3257],
37	Pro	FW	O	pro	dep	39	SENT_66	[p6l934t3237r973b3257],
38	Val	NN	O	val	dep	37	SENT_66	[p6l989t3237r1029b3257],
39	He	PRP	O	he	dep	49	SENT_66	[p6l1052t3237r1081b3257],
40	Pro	FW	O	pro	dep	39	SENT_66	[p6l1104t3237r1143b3257],
41	Leu	NNP	O	Leu	nn	49	SENT_66	[p6l1158t3237r1202b3257],
42	Ser	NNP	PERSON	Ser	nn	49	SENT_66	[p6l1226t3237r1263b3257],
43	Ser	NNP	PERSON	Ser	nn	49	SENT_66	[p6l1271t3237r1309b3257],
44	Trp	NNP	PERSON	Trp	nn	49	SENT_66	[p6l1331t3237r1371b3263],
45	Ala	NNP	PERSON	Ala	nn	49	SENT_66	[p6l1394t3237r1436b3257],
46	Val	NN	PERSON	val	nn	49	SENT_66	[p6l1451t3237r1491b3257],
47	Leu	NNP	PERSON	Leu	nn	49	SENT_66	[p6l1506t3237r1550b3257],
48	Pro	FW	PERSON	pro	nn	49	SENT_66	[p6l1566t3237r1605b3257],
49	Ala	NNP	PERSON	Ala	dep	11	SENT_66	[p6l1620t3237r1662b3257],
50	Met	NNP	O	Met	nn	51	SENT_66	[p6l1676t3237r1722b3257],
51	Stop	NNP	O	Stop	dep	49	SENT_66	[p6l1731t3237r1783b3263],

1	G874C	NN	O	g874c	_	0	SENT_67	[p6l324t3338r421b3363],
2	C1497T	NN	O	c1497t	nn	3	SENT_67	[p6l1450t3338r1562b3363],
3	T155lC	NN	O	t155lc	dep	1	SENT_67	[p6l1679t3338r1790b3363],

1	Exon	NN	O	exon	_	0	SENT_68	[p6l365t3493r425b3513],
2	6	CD	NUMBER	6	number	3	SENT_68	[p6l433t3493r446b3513],
3	142	CD	NUMBER	142	dep	1	SENT_68	[p6l368t3563r407b3583],
4	bp	NN	O	bp	dep	3	SENT_68	[p6l415t3563r443b3589],

1	Fig	NN	O	fig	_	0	SENT_69	[p7l7t102r126b170],
2	.	.	O	.	_	0	SENT_69	[p7l7t102r126b170],

1	1	CD	NUMBER	1	num	3	SENT_70	[p7l155t102r182b154],
2	Schematic	JJ	O	schematic	amod	3	SENT_70	[p7l229t100r549b155],
3	drawing	NN	O	drawing	_	0	SENT_70	[p7l571t100r829b170],
4	of	IN	O	of	_	0	SENT_70	[p7l853t100r922b155],
5	the	DT	O	the	det	7	SENT_70	[p7l938t100r1033b155],
6	CYPZC8	NN	O	cypzc8	nn	7	SENT_70	[p7l1058t101r1336b155],
7	gene	NN	O	gene	prep_of	3	SENT_70	[p7l1362t118r1503b170],
8	and	CC	O	and	_	0	SENT_70	[p7l1527t100r1643b155],
9	Variant	JJ	O	variant	amod	10	SENT_70	[p7l1665t100r1891b155],
10	sites	NNS	O	site	prep_of	3	SENT_70	[p7l1915t100r2062b155],
11	.	.	O	.	_	0	SENT_70	[p7l1915t100r2062b155],

1	T	NN	O	t	_	0	SENT_71	[p7l2090t86r2147b155],
2	:	:	O	:	_	0	SENT_71	[p7l2090t86r2147b155],
3	Exonic	JJ	O	exonic	amod	5	SENT_71	[p7l9t182r229b236],
4	nucleotide	NN	O	nucleotide	nn	5	SENT_71	[p7l277t181r604b236],
5	substitutions	NNS	O	substitution	dep	1	SENT_71	[p7l656t181r1060b236],
6	reported	VBN	O	report	partmod	5	SENT_71	[p7l1110t181r1380b251],
7	by	IN	O	by	_	0	SENT_71	[p7l1429t181r1505b251],
8	others	NNS	O	other	agent	6	SENT_71	[p7l1556t181r1766b236],
9	.	.	O	.	_	0	SENT_71	[p7l1556t181r1766b236],

1	1	CD	NUMBER	1	num	2	SENT_72	[p7l1821t169r1877b237],
2	»	CD	NUMBER	»	_	0	SENT_72	[p7l1821t169r1877b237],
3	:	:	O	:	_	0	SENT_72	[p7l1821t169r1877b237],
4	Exonic	JJ	O	exonic	amod	6	SENT_72	[p7l1932t182r2152b236],
5	nucleotide	NN	O	nucleotide	nn	6	SENT_72	[p7l8t262r335b317],
6	substitutions	NNS	O	substitution	nsubj	7	SENT_72	[p7l358t262r762b317],
7	indicated	VBD	O	indicate	dep	2	SENT_72	[p7l784t262r1075b317],
8	in	IN	O	in	_	0	SENT_72	[p7l1096t262r1156b316],
9	this	DT	O	this	det	10	SENT_72	[p7l1178t262r1289b317],
10	study	NN	O	study	prep_in	7	SENT_72	[p7l1313t262r1499b331],
11	.	.	O	.	_	0	SENT_72	[p7l1313t262r1499b331],

1	475delA	NN	O	475delum	nsubjpass	3	SENT_73	[p7l1524t262r1787b317],
2	was	VBD	O	be	auxpass	3	SENT_73	[p7l1807t280r1925b317],
3	shown	VBN	O	show	_	0	SENT_73	[p7l1949t262r2152b317],
4	in	IN	O	in	_	0	SENT_73	[p7l8t343r67b397],
5	underlined	VBN	O	underline	prep_in	3	SENT_73	[p7l91t343r431b398],
6	bold	JJ	O	bold	amod	5	SENT_73	[p7l456t343r597b398],
7	and	CC	O	and	_	0	SENT_73	[p7l624t343r740b398],
8	subsequent	JJ	O	subsequent	amod	5	SENT_73	[p7l767t343r1118b412],
9	truncated	VBN	O	truncate	partmod	5	SENT_73	[p7l1143t343r1445b398],
10	peptide	NN	O	peptide	nn	11	SENT_73	[p7l1470t343r1702b413],
11	sequence	NN	O	sequence	nsubjpass	13	SENT_73	[p7l1729t361r2009b412],
12	was	VBD	O	be	auxpass	13	SENT_73	[p7l2033t361r2151b398],
13	depicted	VBN	O	depict	ccomp	9	SENT_73	[p7l8t424r273b494],
14	underneath	IN	O	underneath	_	0	SENT_73	[p7l301t424r663b479],
15	the	DT	O	the	det	17	SENT_73	[p7l691t424r786b479],
16	nucleotide	NN	O	nucleotide	nn	17	SENT_73	[p7l815t424r1141b479],
17	sequence	NN	O	sequence	prep_underneath	13	SENT_73	[p7l1172t442r1451b494],

1	CYP2C8	NN	O	cyp2c8	nsubjpass	8	SENT_74	[p7l122t631r478b707],
2	,	,	O	,	_	0	SENT_74	[p7l122t631r478b707],
3	comprising	VBG	O	comprise	partmod	1	SENT_74	[p7l529t629r949b712],
4	nine	CD	NUMBER	nine	num	5	SENT_74	[p7l996t629r1153b694],
5	exons	NNS	O	exon	dobj	3	SENT_74	[p7l1202t651r1436b707],
6	,	,	O	,	_	0	SENT_74	[p7l1202t651r1436b707],
7	was	VBD	O	be	auxpass	8	SENT_74	[p7l1485t651r1625b694],
8	screened	VBN	O	screen	_	0	SENT_74	[p7l1676t629r1994b694],
9	for	IN	O	for	_	0	SENT_74	[p7l2042t629r2152b694],
10	molecular	JJ	O	molecular	amod	11	SENT_74	[p7l7t728r383b793],
11	Variant	JJ	O	variant	prep_for	8	SENT_74	[p7l454t728r724b793],
12	as	IN	O	as	mark	13	SENT_74	[p7l797t749r869b793],
13	shown	VBN	O	show	advcl	8	SENT_74	[p7l946t728r1186b793],
14	in	IN	O	in	_	0	SENT_74	[p7l1259t728r1329b792],
15	Fig	NN	O	fig	nn	16	SENT_74	[p7l1403t728r1644b810],
16	.1	NN	NUMBER	.1	prep_in	13	SENT_74	[p7l1403t728r1644b810],
17	.	.	O	.	_	0	SENT_74	[p7l1403t728r1644b810],

1	The	DT	O	the	det	3	SENT_75	[p7l1722t728r1866b793],
2	direct	JJ	O	direct	amod	3	SENT_75	[p7l1939t728r2152b793],
3	sequencing	NN	O	sequencing	nsubj	8	SENT_75	[p7l10t826r423b909],
4	of	IN	O	of	_	0	SENT_75	[p7l484t826r566b891],
5	the	DT	O	the	det	7	SENT_75	[p7l618t826r731b891],
6	patient	NN	O	patient	nn	7	SENT_75	[p7l790t826r1054b909],
7	DNA	NN	O	dna	prep_of	3	SENT_75	[p7l1114t826r1326b890],
8	demonstrated	VBD	O	demonstrate	_	0	SENT_75	[p7l1386t826r1903b891],
9	three	CD	NUMBER	three	dobj	8	SENT_75	[p7l1964t826r2150b891],

1	Fig	NN	O	fig	_	0	SENT_76	[p7l7t1055r126b1123],
2	.	.	O	.	_	0	SENT_76	[p7l7t1055r126b1123],

1	2	CD	NUMBER	2	amod	4	SENT_77	[p7l163t1055r197b1108],
2	The	DT	O	the	det	4	SENT_77	[p7l238t1053r359b1108],
3	nucleotide	NN	O	nucleotide	nn	4	SENT_77	[p7l393t1053r720b1108],
4	sequencing	NN	O	sequencing	nsubj	17	SENT_77	[p7l757t1053r1103b1123],
5	of	IN	O	of	_	0	SENT_77	[p7l1139t1053r1208b1108],
6	CYP2C8	NN	O	cyp2c8	prep_of	4	SENT_77	[p7l1237t1054r1515b1108],
7	in	IN	O	in	_	0	SENT_77	[p7l1552t1053r1611b1107],
8	the	DT	O	the	det	9	SENT_77	[p7l1646t1053r1741b1108],
9	patient	NN	O	patient	prep_in	6	SENT_77	[p7l1776t1053r2014b1123],
10	,	,	O	,	_	0	SENT_77	[p7l1776t1053r2014b1123],
11	her	PRP$	O	she	poss	12	SENT_77	[p7l2051t1053r2152b1108],
12	children	NNS	O	child	prep_in	6	SENT_77	[p7l8t1134r282b1201],
13	,	,	O	,	_	0	SENT_77	[p7l8t1134r282b1201],
14	and	CC	O	and	_	0	SENT_77	[p7l325t1134r441b1189],
15	a	DT	O	a	det	16	SENT_77	[p7l481t1152r514b1189],
16	control	NN	O	control	prep_in	6	SENT_77	[p7l552t1134r781b1189],
17	(	VBD	O	(	_	0	SENT_77	[p7l821t1135r991b1204],
18	a	DT	O	a	det	21	SENT_77	[p7l821t1135r991b1204],
19	—	NN	O	—	nn	21	SENT_77	[p7l821t1135r991b1204],
20	c	NN	O	c	nn	21	SENT_77	[p7l821t1135r991b1204],
21	)	NN	O	)	dobj	17	SENT_77	[p7l821t1135r991b1204],
22	.	.	O	.	_	0	SENT_77	[p7l821t1135r991b1204],

1	A-1	NN	O	a-1	nsubj	9	SENT_78	[p7l1033t1134r1168b1201],
2	,	,	O	,	_	0	SENT_78	[p7l1033t1134r1168b1201],
3	A-2	NN	O	a-2	nsubj	9	SENT_78	[p7l1209t1134r1345b1201],
4	,	,	O	,	_	0	SENT_78	[p7l1209t1134r1345b1201],
5	A-3	NN	O	a-3	nsubj	9	SENT_78	[p7l1385t1134r1521b1201],
6	,	,	O	,	_	0	SENT_78	[p7l1385t1134r1521b1201],
7	and	CC	O	and	_	0	SENT_78	[p7l1564t1134r1681b1189],
8	B	NN	O	b	conj_and	1	SENT_78	[p7l1720t1136r1764b1188],
9	denote	VBP	O	denote	_	0	SENT_78	[p7l1805t1134r2016b1189],
10	the	DT	O	the	det	11	SENT_78	[p7l2056t1134r2151b1189],
11	patient	NN	O	patient	dobj	9	SENT_78	[p7l7t1215r246b1285],
12	,	,	O	,	_	0	SENT_78	[p7l7t1215r246b1285],
13	her	PRP$	O	she	poss	14	SENT_78	[p7l274t1215r375b1270],
14	son	NN	O	son	dobj	9	SENT_78	[p7l401t1233r526b1281],
15	,	,	O	,	_	0	SENT_78	[p7l401t1233r526b1281],
16	her	PRP$	O	she	poss	17	SENT_78	[p7l553t1215r654b1270],
17	daughter	NN	O	daughter	dobj	9	SENT_78	[p7l679t1215r979b1285],
18	,	,	O	,	_	0	SENT_78	[p7l679t1215r979b1285],
19	and	CC	O	and	_	0	SENT_78	[p7l1009t1215r1125b1270],
20	the	DT	O	the	det	21	SENT_78	[p7l1150t1215r1246b1270],
21	control	NN	O	control	conj_and	11	SENT_78	[p7l1271t1215r1517b1281],
22	,	,	O	,	_	0	SENT_78	[p7l1271t1215r1517b1281],
23	respectivly	NN	O	respectivly	appos	21	SENT_78	[p7l1545t1215r1896b1285],
24	.	.	O	.	_	0	SENT_78	[p7l1545t1215r1896b1285],

1	Arrows	NNS	O	arrow	nsubj	2	SENT_79	[p7l1926t1217r2152b1270],
2	indicate	VBP	O	indicate	_	0	SENT_79	[p7l8t1296r256b1351],
3	the	DT	O	the	det	5	SENT_79	[p7l285t1296r380b1351],
4	nucleotide	NN	O	nucleotide	nn	5	SENT_79	[p7l409t1296r735b1351],
5	positions	NNS	O	position	dobj	2	SENT_79	[p7l763t1296r1050b1366],
6	of	IN	O	of	_	0	SENT_79	[p7l1080t1296r1149b1351],
7	the	DT	O	the	det	11	SENT_79	[p7l1170t1296r1266b1351],
8	Variant	JJ	O	variant	amod	11	SENT_79	[p7l1294t1296r1520b1351],
9	ta	NN	O	ta	nn	11	SENT_79	[p7l7t1462r86b1522],
10	)	NN	O	)	nn	11	SENT_79	[p7l7t1462r86b1522],
11	4Ti	NN	O	4tus	prep_of	5	SENT_79	[p7l403t1450r771b1530],
12	'	''	O	'	_	0	SENT_79	[p7l403t1450r771b1530],
13	5delA	NN	O	5delum	dep	5	SENT_79	[p7l403t1450r771b1530],
14	(	CD	NUMBER	(	num	13	SENT_79	[p7l1620t1463r1701b1526],
15	I	PRP	O	I	dep	13	SENT_79	[p7l1620t1463r1701b1526],
16	:	:	O	:	_	0	SENT_79	[p7l1620t1463r1701b1526],
17	-1	CD	NUMBER	-1	dep	5	SENT_79	[p7l1620t1463r1701b1526],
18	:	:	O	:	_	0	SENT_79	[p7l1620t1463r1701b1526],
19	G37t4C	NN	O	g37t4c	dep	5	SENT_79	[p7l1841t1450r2145b1530],

1	*	NN	O	*	_	0	SENT_80	[p8l292t1007r355b1058],
2	3	CD	NUMBER	3	num	5	SENT_80	[p8l292t1007r355b1058],
3	(	NN	O	(	nn	5	SENT_80	[p8l381t1007r692b1069],
4	All96G	NN	O	all96g	nn	5	SENT_80	[p8l381t1007r692b1069],
5	)	NN	O	)	dep	1	SENT_80	[p8l381t1007r692b1069],
6	,	,	O	,	_	0	SENT_80	[p8l381t1007r692b1069],
7	Cl2l0G	NN	O	cl2l0g	nn	9	SENT_80	[p8l715t1007r960b1058],
8	C1497T	NN	O	c1497t	nn	9	SENT_80	[p8l1294t1015r1530b1066],
9	Tl169C	NN	O	tl169c	appos	5	SENT_80	[p8l288t1097r524b1149],
10	,	,	O	,	_	0	SENT_80	[p8l548t1139r558b1157],
11	Al232T	NN	O	al232t	appos	5	SENT_80	[p8l599t1098r840b1148],

1	nucleotide	NN	O	nucleotide	nn	2	SENT_81	[p8l6t1264r395b1329],
2	Variations	NNS	O	variation	_	0	SENT_81	[p8l453t1264r851b1342],
3	,	,	O	,	_	0	SENT_81	[p8l453t1264r851b1342],
4	475delA	NN	O	475delum	appos	2	SENT_81	[p8l914t1264r1246b1342],
5	,	,	O	,	_	0	SENT_81	[p8l914t1264r1246b1342],
6	G874T	NN	O	g874t	conj_and	4	SENT_81	[p8l1310t1265r1592b1342],
7	,	,	O	,	_	0	SENT_81	[p8l1310t1265r1592b1342],
8	and	CC	O	and	_	0	SENT_81	[p8l1656t1264r1795b1329],
9	Tl55lC	NN	O	tl55lc	appos	2	SENT_81	[p8l1853t1265r2151b1329],
10	(	CD	NUMBER	(	num	11	SENT_81	[p8l8t1364r214b1447],
11	Figs	NNS	O	fig	dep	4	SENT_81	[p8l8t1364r214b1447],
12	.	.	O	.	_	0	SENT_81	[p8l8t1364r214b1447],

1	1	CD	NUMBER	1	_	0	SENT_82	[p8l262t1365r315b1443],
2	,	,	O	,	_	0	SENT_82	[p8l262t1365r315b1443],
3	2	CD	NUMBER	2	num	4	SENT_82	[p8l389t1364r478b1447],
4	)	NN	O	)	appos	1	SENT_82	[p8l389t1364r478b1447],
5	.	.	O	.	_	0	SENT_82	[p8l389t1364r478b1447],

1	The	DT	O	the	det	2	SENT_83	[p8l553t1364r696b1429],
2	patient	NN	O	patient	nsubj	4	SENT_83	[p8l766t1364r1030b1447],
3	was	VBD	O	be	cop	4	SENT_83	[p8l1098t1385r1238b1429],
4	homozygous	JJ	O	homozygous	_	0	SENT_83	[p8l1308t1364r1787b1447],
5	for	IN	O	for	_	0	SENT_83	[p8l1858t1364r1968b1429],
6	the	DT	O	the	det	10	SENT_83	[p8l2038t1364r2151b1429],
7	475delA	NN	O	475delum	nn	10	SENT_83	[p8l6t1463r319b1529],
8	and	CC	O	and	_	0	SENT_83	[p8l358t1463r497b1529],
9	Tl55lC	NN	O	tl55lc	nn	10	SENT_83	[p8l535t1464r834b1529],
10	mutations	NNS	O	mutation	prep_for	4	SENT_83	[p8l871t1463r1253b1529],
11	that	WDT	O	that	nsubjpass	13	SENT_83	[p8l1294t1463r1443b1529],
12	were	VBD	O	be	auxpass	13	SENT_83	[p8l1480t1485r1654b1529],
13	identiﬁed	VBN	O	identiﬁed	rcmod	10	SENT_83	[p8l1693t1463r2043b1529],
14	in	IN	O	in	_	0	SENT_83	[p8l2082t1463r2152b1528],
15	the	DT	O	the	det	17	SENT_83	[p8l7t1564r120b1629],
16	coding	VBG	O	code	amod	17	SENT_83	[p8l150t1563r403b1647],
17	region	NN	O	region	prep_in	13	SENT_83	[p8l432t1564r689b1647],
18	.	.	O	.	_	0	SENT_83	[p8l432t1564r689b1647],

1	Deletion	NN	O	deletion	nsubj	7	SENT_84	[p8l724t1564r1048b1629],
2	of	IN	O	of	_	0	SENT_84	[p8l1079t1564r1162b1629],
3	adenine	NN	O	adenine	prep_of	1	SENT_84	[p8l1183t1563r1473b1629],
4	at	IN	O	at	_	0	SENT_84	[p8l1504t1573r1574b1629],
5	nucleotide	NN	O	nucleotide	prep_at	3	SENT_84	[p8l1603t1563r1991b1629],
6	475	CD	NUMBER	475	num	5	SENT_84	[p8l2022t1565r2149b1629],
7	resulted	VBD	O	result	_	0	SENT_84	[p8l7t1663r302b1729],
8	in	IN	O	in	_	0	SENT_84	[p8l355t1663r425b1728],
9	premature	JJ	O	premature	amod	10	SENT_84	[p8l477t1672r867b1746],
10	termination	NN	O	termination	prep_in	7	SENT_84	[p8l921t1663r1365b1729],
11	at	IN	O	at	_	0	SENT_84	[p8l1419t1672r1489b1729],
12	the	DT	O	the	det	15	SENT_84	[p8l1541t1663r1655b1729],
13	amino	NN	O	amino	nn	15	SENT_84	[p8l1709t1663r1944b1729],
14	acid	NN	O	acid	nn	15	SENT_84	[p8l1999t1663r2152b1729],
15	residue	NN	O	residue	prep_at	10	SENT_84	[p8l6t1763r272b1829],
16	177	CD	NUMBER	177	dobj	7	SENT_84	[p8l321t1765r441b1829],
17	due	JJ	O	due	_	0	SENT_84	[p8l482t1763r615b1829],
18	to	TO	O	to	_	0	SENT_84	[p8l656t1773r728b1829],
19	creating	VBG	O	create	prepc_due_to	16	SENT_84	[p8l770t1764r1071b1847],
20	an	DT	O	a	det	23	SENT_84	[p8l1113t1785r1202b1829],
21	early	JJ	O	early	amod	23	SENT_84	[p8l1241t1764r1424b1846],
22	stop	NN	O	stop	nn	23	SENT_84	[p8l1466t1773r1621b1847],
23	codon	NN	O	codon	dobj	19	SENT_84	[p8l1662t1763r1913b1829],
24	.	.	O	.	_	0	SENT_84	[p8l1662t1763r1913b1829],

1	Nakajima	NNP	PERSON	Nakajima	nsubj	7	SENT_85	[p8l1958t1763r2150b1829, p8l8t1863r214b1946],
2	et	FW	O	et	dep	1	SENT_85	[p8l249t1872r315b1929],
3	al.	FW	O	al.	nn	4	SENT_85	[p8l351t1863r434b1929],
4	(	FW	O	(	dep	1	SENT_85	[p8l476t1863r706b1947],
5	2003	CD	DATE	2003	num	6	SENT_85	[p8l476t1863r706b1947],
6	)	CD	NUMBER	)	dep	4	SENT_85	[p8l476t1863r706b1947],
7	reported	VBD	O	report	_	0	SENT_85	[p8l743t1863r1064b1946],
8	that	IN	O	that	complm	19	SENT_85	[p8l1100t1863r1250b1929],
9	the	DT	O	the	det	11	SENT_85	[p8l1285t1863r1398b1929],
10	475delA	NN	O	475delum	nn	11	SENT_85	[p8l1434t1863r1746b1929],
11	mutation	NN	O	mutation	nsubjpass	19	SENT_85	[p8l1780t1863r2149b1942],
12	,	,	O	,	_	0	SENT_85	[p8l1780t1863r2149b1942],
13	denoting	VBG	O	denote	partmod	11	SENT_85	[p8l7t1963r338b2047],
14	CYP2C8	NN	O	cyp2c8	nn	16	SENT_85	[p8l372t1964r863b2043],
15	*	CD	NUMBER	*	num	16	SENT_85	[p8l372t1964r863b2043],
16	5a	NN	O	5a	dobj	13	SENT_85	[p8l372t1964r863b2043],
17	,	,	O	,	_	0	SENT_85	[p8l372t1964r863b2043],
18	was	VBD	O	be	auxpass	19	SENT_85	[p8l898t1985r1037b2029],
19	detected	VBN	O	detect	ccomp	7	SENT_85	[p8l1072t1963r1381b2029],
20	in	IN	O	in	_	0	SENT_85	[p8l1414t1964r1484b2028],
21	one	CD	NUMBER	one	num	22	SENT_85	[p8l1519t1985r1651b2029],
22	subject	NN	O	subject	prep_in	19	SENT_85	[p8l1685t1963r1946b2047],
23	after	IN	O	after	_	0	SENT_85	[p8l1979t1964r2152b2029],
24	screening	VBG	O	screen	prepc_after	19	SENT_85	[p8l8t2063r357b2146],
25	200	CD	NUMBER	200	num	26	SENT_85	[p8l386t2065r515b2129],
26	subjects	NNS	O	subject	dobj	24	SENT_85	[p8l548t2063r863b2146],
27	,	,	O	,	_	0	SENT_85	[p8l548t2063r863b2146],
28	showing	VBG	O	show	xcomp	7	SENT_85	[p8l898t2063r1207b2146],
29	that	IN	O	that	complm	37	SENT_85	[p8l1238t2063r1387b2129],
30	the	DT	O	the	det	32	SENT_85	[p8l1416t2063r1530b2129],
31	allele	NN	O	allele	nn	32	SENT_85	[p8l1561t2063r1751b2129],
32	frequency	NN	O	frequency	nsubjpass	37	SENT_85	[p8l1781t2063r2153b2146],
33	of	IN	O	of	_	0	SENT_85	[p8l8t2164r90b2229],
34	the	DT	O	the	det	35	SENT_85	[p8l117t2164r231b2229],
35	Variant	JJ	O	variant	prep_of	32	SENT_85	[p8l265t2164r534b2229],
36	was	VBD	O	be	auxpass	37	SENT_85	[p8l568t2185r708b2229],
37	estimated	VBN	O	estimate	ccomp	28	SENT_85	[p8l744t2163r1105b2229],
38	to	TO	O	to	aux	40	SENT_85	[p8l1140t2173r1213b2229],
39	be	VB	O	be	cop	40	SENT_85	[p8l1250t2163r1334b2229],
40	0.0025	CD	NUMBER	0.0025	xcomp	37	SENT_85	[p8l1370t2165r1632b2229],
41	.	.	O	.	_	0	SENT_85	[p8l1370t2165r1632b2229],

1	We	PRP	O	we	nsubj	2	SENT_86	[p8l1671t2166r1796b2229],
2	screened	VBD	O	screen	_	0	SENT_86	[p8l1833t2163r2152b2229],
3	384	CD	NUMBER	384	num	5	SENT_86	[p8l9t2265r136b2329],
4	Japanese	JJ	MISC	japanese	amod	5	SENT_86	[p8l163t2265r499b2346],
5	subjects	NNS	O	subject	dobj	2	SENT_86	[p8l530t2263r822b2346],
6	for	IN	O	for	_	0	SENT_86	[p8l851t2263r961b2329],
7	the	DT	O	the	det	8	SENT_86	[p8l989t2263r1102b2328],
8	Variant	JJ	O	variant	prep_for	2	SENT_86	[p8l1129t2263r1419b2343],
9	;	:	O	;	_	0	SENT_86	[p8l1129t2263r1419b2343],
10	however	RB	O	however	advmod	13	SENT_86	[p8l1449t2263r1786b2342],
11	,	,	O	,	_	0	SENT_86	[p8l1449t2263r1786b2342],
12	we	PRP	O	we	nsubj	13	SENT_86	[p8l1816t2284r1916b2329],
13	failed	VBD	O	fail	parataxis	2	SENT_86	[p8l1944t2263r2151b2329],
14	to	TO	O	to	aux	15	SENT_86	[p8l7t2373r79b2429],
15	detect	VB	O	detect	xcomp	13	SENT_86	[p8l143t2363r366b2429],
16	the	DT	O	the	det	18	SENT_86	[p8l427t2364r541b2429],
17	475delA	NN	O	475delum	nn	18	SENT_86	[p8l602t2363r915b2429],
18	mutation	NN	O	mutation	dobj	15	SENT_86	[p8l974t2364r1322b2429],
19	in	IN	O	in	_	0	SENT_86	[p8l1383t2364r1454b2428],
20	our	PRP$	O	we	poss	22	SENT_86	[p8l1516t2385r1644b2429],
21	sample	NN	O	sample	nn	22	SENT_86	[p8l1707t2364r1966b2447],
22	set	NN	O	set	prep_in	15	SENT_86	[p8l2030t2372r2147b2429],
23	.	.	O	.	_	0	SENT_86	[p8l2030t2372r2147b2429],

1	{	NN	O	{	nn	2	SENT_87	[p8l760t2610r858b2674],
2	E	NN	O	e	_	0	SENT_87	[p8l760t2610r858b2674],
3	}	CD	NUMBER	}	num	4	SENT_87	[p8l760t2610r858b2674],
4	Tl	NN	O	tl	dep	2	SENT_87	[p8l985t2606r1332b2682],
5	.551	CD	NUMBER	.551	num	6	SENT_87	[p8l985t2606r1332b2682],
6	C	NN	O	c	dep	2	SENT_87	[p8l985t2606r1332b2682],

1	uum	NN	O	uum	nn	3	SENT_88	[p8l8t2974r975b3374],
2	‘	CD	NUMBER	‘	num	3	SENT_88	[p8l19t3358r97b3430],
3	A.	NN	O	a.	_	0	SENT_88	[p8l19t3358r97b3430],
4	C	NNP	O	C	nn	6	SENT_88	[p8l136t3391r169b3430],
5	T	NN	O	t	nn	6	SENT_88	[p8l222t3391r255b3427],
6	Q	NNP	O	Q	dep	3	SENT_88	[p8l294t3390r335b3439],
7	;	:	O	;	_	0	SENT_88	[p8l294t3390r335b3439],
8	T	NN	O	t	dep	3	SENT_88	[p8l370t3388r402b3427],
9	.	.	O	.	_	0	SENT_88	[p8l435t3361r709b3442],

1	c	NN	O	c	_	0	SENT_89	[p8l435t3361r709b3442],
2	"	''	O	"	punct	1	SENT_89	[p8l435t3361r709b3442],
3	.	.	O	.	_	0	SENT_89	[p8l435t3361r709b3442],

1	r	NN	O	r	nn	2	SENT_90	[p8l435t3361r709b3442],
2	G	NN	O	g	_	0	SENT_90	[p8l748t3387r785b3424],
3	7	CD	NUMBER	7	number	4	SENT_90	[p8l837t3369r1018b3436],
4	”	CD	NUMBER	”	num	2	SENT_90	[p8l837t3369r1018b3436],
5	"	''	O	"	punct	2	SENT_90	[p8l837t3369r1018b3436],

1	A	DT	O	a	det	6	SENT_91	[p9l54t14r150b58],
2	,	,	O	,	_	0	SENT_91	[p9l54t14r150b58],
3	_	NN	O	_	dep	6	SENT_91	[p9l54t14r150b58],
4	,	,	O	,	_	0	SENT_91	[p9l54t14r150b58],
5	C	NN	O	c	nn	6	SENT_91	[p9l54t14r150b58],
6	T	NN	O	t	_	0	SENT_91	[p9l205t14r238b53],
7	G	NN	O	g	nn	9	SENT_91	[p9l277t14r311b53],
8	TGFCCT	NN	O	tgfcct	nn	9	SENT_91	[p9l366t11r706b62],
9	G	NN	O	g	dep	6	SENT_91	[p9l745t11r781b50],
10	AT	IN	O	at	_	0	SENT_91	[p9l821t11r916b47],
11	ANT	NN	O	ant	nn	13	SENT_91	[p9l1166t14r1261b58],
12	T	NN	O	t	nn	13	SENT_91	[p9l1313t11r1344b50],
13	ALT	NN	O	alt	prep_at	9	SENT_91	[p9l1386t11r1478b50],
14	(	CD	NUMBER	(	number	15	SENT_91	[p9l1518t11r1554b47],
15	3	CD	NUMBER	3	num	19	SENT_91	[p9l1518t11r1554b47],
16	TIC	NN	ORGANIZATION	tic	nn	19	SENT_91	[p9l1596t11r1672b47],
17	CT	NN	ORGANIZATION	ct	nn	19	SENT_91	[p9l1702t8r1794b47],
18	T	NN	ORGANIZATION	t	nn	19	SENT_91	[p9l1846t8r1876b46],
19	C	NN	ORGANIZATION	c	dep	13	SENT_91	[p9l1915t8r1948b46],
20	T	NN	ORGANIZATION	t	nn	21	SENT_91	[p9l1988t8r2021b43],
21	C	NN	O	c	dep	13	SENT_91	[p9l2086t8r2119b43],
22	*	CD	NUMBER	*	num	24	SENT_91	[p9l57t60r431b319],
23	illwl	NN	O	illwl	nn	24	SENT_91	[p9l499t58r1031b322],
24	VWJMM	NNP	O	VWJMM	dep	21	SENT_91	[p9l1107t57r2144b329],
25	.	.	O	.	_	0	SENT_91	[p9l67t336r929b385],

1	aa	NN	O	aa	_	0	SENT_92	[p9l67t336r929b385],
2	.	.	O	.	_	0	SENT_92	[p9l67t336r929b385],

1	cTGTAgr	NNP	O	cTGTAgr	_	0	SENT_93	[p9l67t336r929b385],
2	:	:	O	:	_	0	SENT_93	[p9l67t336r929b385],
3	TG	NN	O	tg	dep	1	SENT_93	[p9l67t336r929b385],
4	.	.	O	.	_	0	SENT_93	[p9l67t336r929b385],

1	.	.	O	.	_	0	SENT_94	[p9l67t336r929b385],

1	~	NN	O	~	_	0	SENT_95	[p9l67t336r929b385],
2	=	JJ	O	=	amod	3	SENT_95	[p9l67t336r929b385],
3	*	CD	NUMBER	*	dep	1	SENT_95	[p9l67t336r929b385],
4	i.T	NN	O	i.t	nn	6	SENT_95	[p9l67t336r929b385],
5	"	''	O	"	punct	6	SENT_95	[p9l1126t328r2100b385],
6	ATTATGTZCTTCTC	NN	O	attatgtzcttctc	dep	1	SENT_95	[p9l1126t328r2100b385],

1	Consanguinity	NN	O	consanguinity	nsubj	11	SENT_96	[p9l10t543r581b625],
2	,	,	O	,	_	0	SENT_96	[p9l10t543r581b625],
3	as	IN	O	as	mark	4	SENT_96	[p9l650t564r723b607],
4	evident	JJ	O	evident	dep	1	SENT_96	[p9l789t543r1061b607],
5	from	IN	O	from	_	0	SENT_96	[p9l1124t543r1307b607],
6	the	DT	O	the	det	8	SENT_96	[p9l1372t543r1485b607],
7	clinical	JJ	O	clinical	amod	8	SENT_96	[p9l1550t543r1815b607],
8	record	NN	O	record	prep_from	4	SENT_96	[p9l1879t543r2141b621],
9	,	,	O	,	_	0	SENT_96	[p9l1879t543r2141b621],
10	might	MD	O	might	aux	11	SENT_96	[p9l7t641r225b723],
11	explain	VB	O	explain	_	0	SENT_96	[p9l250t641r521b723],
12	the	DT	O	the	det	14	SENT_96	[p9l546t641r658b706],
13	homozygous	JJ	O	homozygous	amod	14	SENT_96	[p9l684t641r1161b723],
14	state	NN	O	state	dobj	11	SENT_96	[p9l1189t650r1359b706],
15	of	IN	O	of	_	0	SENT_96	[p9l1387t641r1468b706],
16	the	DT	O	the	det	17	SENT_96	[p9l1485t641r1597b706],
17	patient	NN	O	patient	prep_of	14	SENT_96	[p9l1622t641r1904b723],
18	.	.	O	.	_	0	SENT_96	[p9l1622t641r1904b723],

1	DNA	NN	O	dna	nn	2	SENT_97	[p9l1934t641r2144b705],
2	samples	NNS	O	sample	nsubjpass	13	SENT_97	[p9l10t741r302b823],
3	obtained	VBN	O	obtain	partmod	2	SENT_97	[p9l347t741r674b805],
4	from	IN	O	from	_	0	SENT_97	[p9l717t741r900b805],
5	the	DT	O	the	det	6	SENT_97	[p9l941t741r1054b805],
6	patient	NN	O	patient	poss	8	SENT_97	[p9l1095t741r1415b823],
7	’s	POS	O	’s	_	0	SENT_97	[p9l1095t741r1415b823],
8	son	NN	O	son	prep_from	3	SENT_97	[p9l1460t762r1586b805],
9	and	CC	O	and	_	0	SENT_97	[p9l1630t741r1767b805],
10	daughter	NN	O	daughter	prep_from	3	SENT_97	[p9l1810t741r2145b823],
11	were	VBD	O	be	auxpass	13	SENT_97	[p9l7t860r180b904],
12	also	RB	O	also	advmod	13	SENT_97	[p9l235t839r380b904],
13	examined	VBN	O	examine	_	0	SENT_97	[p9l436t839r794b904],
14	by	IN	O	by	_	0	SENT_97	[p9l848t839r938b921],
15	direct	JJ	O	direct	amod	16	SENT_97	[p9l991t839r1202b904],
16	sequencing	NN	O	sequencing	agent	13	SENT_97	[p9l1258t839r1689b921],
17	;	:	O	;	_	0	SENT_97	[p9l1258t839r1689b921],
18	both	CC	O	both	dep	13	SENT_97	[p9l1745t839r1920b904],
19	were	VBD	O	be	cop	20	SENT_97	[p9l1971t860r2144b904],
20	heterozygous	JJ	O	heterozygous	conj	13	SENT_97	[p9l8t939r504b1021],
21	for	IN	O	for	_	0	SENT_97	[p9l588t939r697b1003],
22	the	DT	O	the	det	24	SENT_97	[p9l779t939r892b1003],
23	475delA	NN	O	475delum	nn	24	SENT_97	[p9l974t939r1285b1003],
24	mutation	NN	O	mutation	prep_for	20	SENT_97	[p9l1366t939r1712b1003],
25	(	CD	NUMBER	(	num	26	SENT_97	[p9l1796t939r1967b1021],
26	Fig	NN	O	fig	nsubj	20	SENT_97	[p9l1796t939r1967b1021],
27	.	.	O	.	_	0	SENT_97	[p9l1796t939r1967b1021],

1	2a	NN	O	2a	_	0	SENT_98	[p9l2006t939r2139b1021],
2	)	NN	O	)	dep	1	SENT_98	[p9l2006t939r2139b1021],
3	.	.	O	.	_	0	SENT_98	[p9l2006t939r2139b1021],

1	C155lT	NN	O	c155lt	nn	4	SENT_99	[p9l10t1038r306b1102],
2	and	CC	O	and	_	0	SENT_99	[p9l354t1037r492b1102],
3	G874T	NN	O	g874t	nn	4	SENT_99	[p9l541t1038r801b1102],
4	variants	NNS	O	variant	nsubjpass	7	SENT_99	[p9l847t1037r1148b1102],
5	were	VBD	O	be	auxpass	7	SENT_99	[p9l1195t1058r1368b1102],
6	newly	RB	O	newly	advmod	7	SENT_99	[p9l1416t1037r1633b1119],
7	identiﬁed	VBN	O	identiﬁed	_	0	SENT_99	[p9l1679t1037r2028b1102],
8	in	IN	O	in	_	0	SENT_99	[p9l2075t1037r2145b1101],
9	this	DT	O	this	det	10	SENT_99	[p9l9t1137r140b1201],
10	study	NN	O	study	prep_in	7	SENT_99	[p9l194t1137r413b1219],
11	.	.	O	.	_	0	SENT_99	[p9l194t1137r413b1219],

1	The	DT	O	the	det	2	SENT_100	[p9l468t1137r611b1201],
2	patient	NN	O	patient	nsubj	4	SENT_100	[p9l660t1137r923b1219],
3	was	VBD	O	be	cop	4	SENT_100	[p9l971t1158r1110b1201],
4	homozygous	JJ	O	homozygous	_	0	SENT_100	[p9l1161t1137r1638b1219],
5	for	IN	O	for	_	0	SENT_100	[p9l1688t1137r1798b1201],
6	Cl55lT	NN	O	cl55lt	nn	7	SENT_100	[p9l1848t1138r2145b1202],
7	variant	NN	O	variant	prep_for	4	SENT_100	[p9l7t1235r296b1313],
8	,	,	O	,	_	0	SENT_100	[p9l7t1235r296b1313],
9	and	CC	O	and	_	0	SENT_100	[p9l328t1235r466b1300],
10	her	PRP$	O	she	poss	11	SENT_100	[p9l493t1235r612b1300],
11	children	NNS	O	child	nsubj	14	SENT_100	[p9l638t1235r942b1300],
12	were	VBD	O	be	cop	14	SENT_100	[p9l969t1256r1142b1300],
13	both	DT	O	both	dep	14	SENT_100	[p9l1170t1235r1343b1300],
14	heterozygous	JJ	O	heterozygous	conj_and	4	SENT_100	[p9l1370t1235r1866b1317],
15	for	IN	O	for	_	0	SENT_100	[p9l1894t1235r2004b1300],
16	the	DT	O	the	det	19	SENT_100	[p9l2031t1235r2144b1300],
17	variant	JJ	O	variant	amod	19	SENT_100	[p9l7t1335r276b1399],
18	(	NN	O	(	nn	19	SENT_100	[p9l332t1335r503b1417],
19	Fig	NN	O	fig	prep_for	14	SENT_100	[p9l332t1335r503b1417],
20	.	.	O	.	_	0	SENT_100	[p9l332t1335r503b1417],

1	2c	JJ	O	2c	amod	2	SENT_101	[p9l542t1335r670b1416],
2	)	NN	O	)	_	0	SENT_101	[p9l542t1335r670b1416],
3	.	.	O	.	_	0	SENT_101	[p9l542t1335r670b1416],

1	The	DT	O	the	det	2	SENT_102	[p9l731t1335r873b1399],
2	patient	NN	O	patient	nsubj	7	SENT_102	[p9l928t1335r1191b1417],
3	and	CC	O	and	_	0	SENT_102	[p9l1247t1334r1384b1399],
4	her	PRP$	O	she	poss	5	SENT_102	[p9l1439t1335r1559b1399],
5	children	NNS	O	child	nsubj	7	SENT_102	[p9l1613t1334r1917b1399],
6	were	VBD	O	be	cop	7	SENT_102	[p9l1971t1356r2144b1399],
7	heterozygous	JJ	O	heterozygous	_	0	SENT_102	[p9l8t1434r504b1516],
8	for	IN	O	for	_	0	SENT_102	[p9l552t1434r661b1499],
9	G874T	NN	O	g874t	prep_for	7	SENT_102	[p9l709t1435r969b1499],
10	in	IN	O	in	_	0	SENT_102	[p9l1016t1434r1086b1498],
11	exon	NN	O	exon	prep_in	7	SENT_102	[p9l1132t1455r1310b1499],
12	6	CD	NUMBER	6	number	13	SENT_102	[p9l1359t1436r1396b1499],
13	(	CD	NUMBER	(	num	14	SENT_102	[p9l1446t1434r1616b1516],
14	Fig	NN	O	fig	dep	7	SENT_102	[p9l1446t1434r1616b1516],
15	.	.	O	.	_	0	SENT_102	[p9l1446t1434r1616b1516],

1	2b	JJ	O	2b	amod	2	SENT_103	[p9l1656t1434r1795b1516],
2	)	NN	O	)	nsubj	8	SENT_103	[p9l1656t1434r1795b1516],
3	,	,	O	,	_	0	SENT_103	[p9l1656t1434r1795b1516],
4	and	CC	O	and	_	0	SENT_103	[p9l1847t1434r1984b1499],
5	the	DT	O	the	det	7	SENT_103	[p9l2031t1434r2144b1499],
6	nucleotide	NN	O	nucleotide	nn	7	SENT_103	[p9l8t1533r395b1598],
7	change	NN	O	change	nsubj	8	SENT_103	[p9l455t1534r716b1616],
8	resulted	VBD	O	result	_	0	SENT_103	[p9l775t1533r1070b1598],
9	in	IN	O	in	_	0	SENT_103	[p9l1129t1534r1199b1597],
10	Ala292	NN	O	ala292	prep_in	8	SENT_103	[p9l1256t1517r1491b1598],
11	to	TO	O	to	_	0	SENT_103	[p9l1550t1542r1623b1598],
12	Pro292	NN	O	pro292	prep_to	8	SENT_103	[p9l1684t1517r1937b1598],
13	.	.	O	.	_	0	SENT_103	[p9l1684t1517r1937b1598],

1	The	DT	O	the	det	4	SENT_104	[p9l2001t1533r2144b1598],
2	nonsynonymous	JJ	O	nonsynonymous	amod	4	SENT_104	[p9l8t1654r628b1715],
3	G874T	NN	O	g874t	nn	4	SENT_104	[p9l665t1634r925b1698],
4	variant	NN	O	variant	nsubj	5	SENT_104	[p9l959t1633r1228b1698],
5	appears	VBZ	O	appear	_	0	SENT_104	[p9l1263t1654r1552b1715],
6	to	TO	O	to	aux	8	SENT_104	[p9l1587t1642r1660b1698],
7	be	VB	O	be	cop	8	SENT_104	[p9l1697t1633r1780b1698],
8	common	JJ	O	common	xcomp	5	SENT_104	[p9l1815t1654r2144b1698],
9	in	IN	O	in	_	0	SENT_104	[p9l8t1733r78b1796],
10	the	DT	O	the	det	12	SENT_104	[p9l117t1733r229b1797],
11	general	JJ	O	general	amod	12	SENT_104	[p9l269t1733r539b1815],
12	population	NN	O	population	prep_in	8	SENT_104	[p9l577t1733r991b1815],
13	because	IN	O	because	mark	20	SENT_104	[p9l1030t1733r1319b1797],
14	seven	CD	NUMBER	seven	num	16	SENT_104	[p9l1361t1754r1560b1797],
15	Japanese	JJ	MISC	japanese	amod	16	SENT_104	[p9l1599t1735r1933b1815],
16	individuals	NNS	O	individual	nsubj	20	SENT_104	[p9l1972t1732r2142b1797, p9l7t1831r274b1896],
17	examined	VBN	O	examine	partmod	16	SENT_104	[p9l308t1831r667b1896],
18	were	VBD	O	be	cop	20	SENT_104	[p9l699t1852r872b1896],
19	all	DT	O	all	dep	20	SENT_104	[p9l908t1831r995b1896],
20	heterozygous	JJ	O	heterozygous	advcl	8	SENT_104	[p9l1029t1831r1545b1913],
21	.	.	O	.	_	0	SENT_104	[p9l1029t1831r1545b1913],

1	All	DT	O	all	det	3	SENT_105	[p9l120t1931r233b1994],
2	14	CD	NUMBER	14	num	3	SENT_105	[p9l293t1932r369b1994],
3	exons	NNS	O	exon	nsubjpass	7	SENT_105	[p9l420t1952r631b1995],
4	of	IN	O	of	_	0	SENT_105	[p9l685t1931r767b1995],
5	OATP2	NN	O	oatp2	prep_of	3	SENT_105	[p9l810t1931r1099b1996],
6	were	VBD	O	be	auxpass	7	SENT_105	[p9l1149t1952r1322b1996],
7	screened	VBN	O	screen	_	0	SENT_105	[p9l1376t1930r1713b2009],
8	,	,	O	,	_	0	SENT_105	[p9l1376t1930r1713b2009],
9	and	CC	O	and	_	0	SENT_105	[p9l1769t1930r1907b1995],
10	three	CD	NUMBER	three	num	12	SENT_105	[p9l1958t1931r2144b1995],
11	nucleotide	NN	O	nucleotide	nn	12	SENT_105	[p9l8t2029r395b2094],
12	variations	NNS	O	variation	nsubjpass	28	SENT_105	[p9l425t2029r821b2107],
13	,	,	O	,	_	0	SENT_105	[p9l425t2029r821b2107],
14	A388G	NN	O	a388g	appos	12	SENT_105	[p9l853t2029r1126b2094],
15	in	IN	O	in	_	0	SENT_105	[p9l1154t2029r1224b2093],
16	exon	NN	O	exon	prep_in	14	SENT_105	[p9l1253t2050r1431b2094],
17	4	CD	NUMBER	4	num	16	SENT_105	[p9l1461t2031r1522b2107],
18	,	,	O	,	_	0	SENT_105	[p9l1461t2031r1522b2107],
19	and	CC	O	and	_	0	SENT_105	[p9l1556t2029r1694b2094],
20	C57lT	NN	O	c57lt	appos	12	SENT_105	[p9l1725t2030r1975b2094],
21	and	CC	O	and	_	0	SENT_105	[p9l2007t2029r2144b2094],
22	C597T	NN	O	c597t	conj_and	14	SENT_105	[p9l10t2130r261b2194],
23	in	IN	O	in	_	0	SENT_105	[p9l298t2129r368b2192],
24	exon	NN	O	exon	prep_in	20	SENT_105	[p9l405t2150r583b2193],
25	5	CD	NUMBER	5	num	24	SENT_105	[p9l624t2131r681b2207],
26	,	,	O	,	_	0	SENT_105	[p9l624t2131r681b2207],
27	were	VBD	O	be	auxpass	28	SENT_105	[p9l720t2150r893b2193],
28	identiﬁed	VBN	O	identiﬁed	conj_and	7	SENT_105	[p9l931t2128r1301b2207],
29	;	:	O	;	_	0	SENT_105	[p9l931t2128r1301b2207],
30	however	RB	O	however	advmod	35	SENT_105	[p9l1341t2129r1677b2207],
31	,	,	O	,	_	0	SENT_105	[p9l1341t2129r1677b2207],
32	all	DT	O	all	det	33	SENT_105	[p9l1719t2129r1806b2193],
33	variants	NNS	O	variant	nsubj	35	SENT_105	[p9l1842t2129r2143b2193],
34	were	VBD	O	be	cop	35	SENT_105	[p9l7t2248r180b2292],
35	silent	JJ	O	silent	parataxis	7	SENT_105	[p9l220t2227r414b2291],
36	and	CC	O	and	_	0	SENT_105	[p9l452t2227r589b2291],
37	were	VBD	O	be	auxpass	39	SENT_105	[p9l625t2248r797b2291],
38	also	RB	O	also	advmod	39	SENT_105	[p9l837t2227r982b2291],
39	observed	VBN	O	observe	parataxis	7	SENT_105	[p9l1022t2227r1355b2292],
40	in	IN	O	in	_	0	SENT_105	[p9l1391t2227r1461b2291],
41	control	NN	O	control	nn	42	SENT_105	[p9l1498t2227r1768b2291],
42	individuals	NNS	O	individual	prep_in	39	SENT_105	[p9l1804t2227r2143b2291, p9l10t2327r126b2391],
43	.	.	O	.	_	0	SENT_105	[p9l1804t2227r2143b2291, p9l10t2327r126b2391],

1	CYP3A4	NN	O	cyp3a4	nsubj	2	SENT_106	[p9l173t2327r511b2391],
2	consists	VBZ	O	consist	_	0	SENT_106	[p9l551t2327r840b2391],
3	of	IN	O	of	_	0	SENT_106	[p9l883t2327r965b2391],
4	13	CD	NUMBER	13	num	5	SENT_106	[p9l1004t2328r1076b2391],
5	exons	NNS	O	exon	prep_of	2	SENT_106	[p9l1120t2348r1331b2391],
6	(	CD	NUMBER	(	num	7	SENT_106	[p9l1373t2327r1668b2409],
7	Lamba	NNP	PERSON	Lamba	dep	5	SENT_106	[p9l1373t2327r1668b2409],
8	et	FW	O	et	nn	9	SENT_106	[p9l1708t2336r1773b2391],
9	al.	FW	O	al.	dobj	2	SENT_106	[p9l1814t2327r1896b2391],
10	2002	CD	DATE	2002	num	11	SENT_106	[p9l1941t2327r2143b2409],
11	)	NN	O	)	nsubj	17	SENT_106	[p9l1941t2327r2143b2409],
12	and	CC	O	and	_	0	SENT_106	[p9l10t2425r147b2490],
13	the	DT	O	the	det	14	SENT_106	[p9l182t2425r294b2489],
14	patient	NN	O	patient	conj_and	11	SENT_106	[p9l327t2425r591b2507],
15	did	VBD	O	do	aux	17	SENT_106	[p9l624t2425r742b2490],
16	not	RB	O	not	neg	17	SENT_106	[p9l775t2434r900b2490],
17	show	VB	O	show	rcmod	9	SENT_106	[p9l935t2425r1126b2490],
18	nucleotide	NN	O	nucleotide	nn	19	SENT_106	[p9l1159t2425r1546b2490],
19	variations	NNS	O	variation	dobj	17	SENT_106	[p9l1580t2425r1974b2490],
20	.	.	O	.	_	0	SENT_106	[p9l1580t2425r1974b2490],

1	CYPZC8	NN	O	cypzc8	nsubj	5	SENT_107	[p9l122t2526r453b2589],
2	is	VBZ	O	be	cop	5	SENT_107	[p9l492t2525r546b2589],
3	a	DT	O	a	det	5	SENT_107	[p9l584t2546r624b2589],
4	pivotal	JJ	O	pivotal	amod	5	SENT_107	[p9l659t2525r922b2607],
5	enzyme	NN	O	enzyme	_	0	SENT_107	[p9l958t2546r1238b2606],
6	in	IN	O	in	_	0	SENT_107	[p9l1274t2525r1344b2588],
7	the	DT	O	the	det	9	SENT_107	[p9l1381t2525r1493b2589],
8	catalyzing	VBG	O	catalyze	amod	9	SENT_107	[p9l1530t2525r1910b2607],
9	pathway	NN	O	pathway	prep_in	5	SENT_107	[p9l1945t2525r2143b2607, p9l7t2644r158b2705],
10	of	IN	O	of	_	0	SENT_107	[p9l190t2623r272b2688],
11	cerivastatin	NN	O	cerivastatin	prep_of	9	SENT_107	[p9l293t2623r727b2688],
12	that	WDT	O	that	nsubjpass	15	SENT_107	[p9l757t2623r907b2688],
13	is	VBZ	O	be	auxpass	15	SENT_107	[p9l936t2623r990b2687],
14	also	RB	O	also	advmod	15	SENT_107	[p9l1023t2623r1168b2688],
15	highlighted	VBN	O	highlight	rcmod	9	SENT_107	[p9l1200t2623r1623b2705],
16	by	IN	O	by	_	0	SENT_107	[p9l1654t2623r1744b2705],
17	the	DT	O	the	det	19	SENT_107	[p9l1775t2623r1888b2687],
18	recent	JJ	O	recent	amod	19	SENT_107	[p9l1919t2632r2145b2687],
19	report	NN	O	report	agent	15	SENT_107	[p9l9t2731r240b2805],
20	showing	VBG	O	show	partmod	19	SENT_107	[p9l287t2722r596b2804],
21	that	IN	O	that	complm	31	SENT_107	[p9l640t2722r789b2787],
22	the	DT	O	the	det	24	SENT_107	[p9l834t2722r947b2787],
23	drug	NN	O	drug	nn	24	SENT_107	[p9l993t2722r1165b2804],
24	gemﬁbrozil	NN	O	gemﬁbrozil	nsubj	31	SENT_107	[p9l1210t2722r1652b2804],
25	,	,	O	,	_	0	SENT_107	[p9l1210t2722r1652b2804],
26	when	WRB	O	when	advmod	27	SENT_107	[p9l1700t2722r1898b2787],
27	interacting	VBG	O	interact	dep	24	SENT_107	[p9l1942t2723r2142b2787, p9l10t2821r236b2903],
28	with	IN	O	with	_	0	SENT_107	[p9l289t2821r454b2886],
29	cerivastatin	NN	O	cerivastatin	prep_with	27	SENT_107	[p9l507t2821r961b2899],
30	,	,	O	,	_	0	SENT_107	[p9l507t2821r961b2899],
31	inhibits	VBZ	O	inhibit	ccomp	20	SENT_107	[p9l1019t2821r1298b2885],
32	CYP2C8	NN	O	cyp2c8	dobj	31	SENT_107	[p9l1356t2822r1686b2886],
33	activity	NN	O	activity	dep	39	SENT_107	[p9l1745t2821r2020b2903],
34	in	IN	O	in	_	0	SENT_107	[p9l2075t2821r2145b2885],
35	human	JJ	O	human	amod	36	SENT_107	[p9l8t2920r269b2985],
36	liver	NN	O	liver	prep_in	33	SENT_107	[p9l303t2920r465b2985],
37	microsome	NN	O	microsome	dep	39	SENT_107	[p9l496t2921r909b2985],
38	(	CD	NUMBER	(	num	37	SENT_107	[p9l944t2921r1194b3003],
39	Wang	NNP	PERSON	Wang	dep	43	SENT_107	[p9l944t2921r1194b3003],
40	et	FW	O	et	nn	41	SENT_107	[p9l1227t2929r1292b2985],
41	al.	FW	O	al.	dep	39	SENT_107	[p9l1326t2920r1408b2985],
42	2002	CD	DATE	2002	num	43	SENT_107	[p9l1447t2921r1669b3002],
43	)	CD	NUMBER	)	dep	31	SENT_107	[p9l1447t2921r1669b3002],
44	.	.	O	.	_	0	SENT_107	[p9l1447t2921r1669b3002],

1	The	DT	O	the	det	2	SENT_108	[p9l1706t2920r1850b2985],
2	patient	NN	O	patient	nsubj	5	SENT_108	[p9l1882t2920r2145b3003],
3	most	RBS	O	most	advmod	4	SENT_108	[p9l7t3028r191b3084],
4	likely	JJ	O	likely	amod	2	SENT_108	[p9l221t3019r423b3101],
5	lacks	VBZ	O	lack	_	0	SENT_108	[p9l453t3019r640b3084],
6	the	DT	O	the	det	8	SENT_108	[p9l672t3019r785b3083],
7	enzyme	NN	O	enzyme	nn	8	SENT_108	[p9l816t3040r1095b3101],
8	activity	NN	O	activity	nsubj	11	SENT_108	[p9l1128t3019r1403b3101],
9	of	IN	O	of	_	0	SENT_108	[p9l1435t3019r1517b3084],
10	CYP2C8	NN	O	cyp2c8	prep_of	8	SENT_108	[p9l1541t3020r1872b3084],
11	due	JJ	O	due	xcomp	5	SENT_108	[p9l1906t3019r2038b3084],
12	to	TO	O	to	_	0	SENT_108	[p9l2070t3028r2143b3084],
13	the	DT	O	the	det	15	SENT_108	[p9l9t3118r122b3183],
14	homozygous	JJ	O	homozygous	amod	15	SENT_108	[p9l152t3118r629b3200],
15	mutation	NN	O	mutation	prep_to	11	SENT_108	[p9l659t3118r1004b3183],
16	of	IN	O	of	_	0	SENT_108	[p9l1036t3118r1118b3183],
17	475delA	NN	O	475delum	prep_of	15	SENT_108	[p9l1139t3118r1450b3183],
18	that	WDT	O	that	nsubj	19	SENT_108	[p9l1480t3118r1629b3183],
19	loses	VBZ	O	lose	rcmod	15	SENT_108	[p9l1659t3118r1834b3183],
20	64	CD	PERCENT	64	num	21	SENT_108	[p9l1868t3120r2033b3184],
21	%	NN	PERCENT	%	dobj	19	SENT_108	[p9l1868t3120r2033b3184],
22	of	IN	O	of	_	0	SENT_108	[p9l2072t3118r2153b3183],
23	the	DT	O	the	det	25	SENT_108	[p9l9t3217r122b3282],
24	protein	NN	O	protein	nn	25	SENT_108	[p9l171t3217r443b3299],
25	structure	NN	O	structure	prep_of	21	SENT_108	[p9l496t3226r847b3282],
26	.	.	O	.	_	0	SENT_108	[p9l496t3226r847b3282],

1	Indeed	RB	O	indeed	advmod	5	SENT_109	[p9l903t3217r1179b3295],
2	,	,	O	,	_	0	SENT_109	[p9l903t3217r1179b3295],
3	our	PRP$	O	we	poss	4	SENT_109	[p9l1234t3238r1362b3282],
4	patient	NN	O	patient	nsubj	5	SENT_109	[p9l1411t3217r1674b3299],
5	showed	VBD	O	show	_	0	SENT_109	[p9l1725t3217r2005b3282],
6	an	DT	O	a	det	8	SENT_109	[p9l2056t3238r2145b3282],
7	elevated	JJ	O	elevated	amod	8	SENT_109	[p9l8t3316r314b3381],
8	level	NN	O	level	dobj	5	SENT_109	[p9l343t3316r509b3381],
9	of	IN	O	of	_	0	SENT_109	[p9l541t3316r622b3381],
10	M-1	NN	O	m-1	prep_of	8	SENT_109	[p9l644t3318r793b3380],
11	and	CC	O	and	_	0	SENT_109	[p9l833t3316r970b3381],
12	a	DT	O	a	det	14	SENT_109	[p9l1001t3338r1041b3381],
13	decreased	VBN	O	decrease	amod	14	SENT_109	[p9l1070t3316r1433b3381],
14	level	NN	O	level	dobj	5	SENT_109	[p9l1463t3316r1629b3381],
15	of	IN	O	of	_	0	SENT_109	[p9l1661t3316r1742b3381],
16	M-23	NN	MISC	m-23	prep_of	14	SENT_109	[p9l1764t3318r1962b3381],
17	that	WDT	O	that	nsubjpass	20	SENT_109	[p9l1996t3316r2145b3381],
18	would	MD	O	would	aux	20	SENT_109	[p10l7t24r240b88],
19	be	VB	O	be	auxpass	20	SENT_109	[p10l279t24r362b88],
20	caused	VBN	O	cause	rcmod	14	SENT_109	[p10l402t24r653b88],
21	by	IN	O	by	_	0	SENT_109	[p10l692t24r782b106],
22	the	DT	O	the	det	23	SENT_109	[p10l821t24r934b88],
23	deﬁciency	NN	O	deﬁciency	agent	20	SENT_109	[p10l974t24r1342b106],
24	of	IN	O	of	_	0	SENT_109	[p10l1382t24r1463b88],
25	CYP2C8	NN	O	cyp2c8	prep_of	23	SENT_109	[p10l1495t25r1825b89],
26	activity	NN	O	activity	nn	28	SENT_109	[p10l1870t24r2145b106],
27	(	CD	NUMBER	(	num	28	SENT_109	[p10l10t122r259b205],
28	Ozaki	NNP	PERSON	Ozaki	dep	25	SENT_109	[p10l10t122r259b205],
29	et	FW	O	et	nn	31	SENT_109	[p10l293t131r358b187],
30	al.	FW	O	al.	nn	31	SENT_109	[p10l393t123r475b187],
31	manuscript	NN	O	manuscript	dep	28	SENT_109	[p10l513t123r937b204],
32	in	IN	O	in	_	0	SENT_109	[p10l970t123r1040b186],
33	preparation	NN	O	preparation	nn	34	SENT_109	[p10l1072t122r1565b205],
34	)	NN	O	)	prep_in	20	SENT_109	[p10l1072t122r1565b205],
35	.	.	O	.	_	0	SENT_109	[p10l1072t122r1565b205],

1	Therefore	RB	O	therefore	advmod	12	SENT_110	[p10l1604t122r1993b200],
2	,	,	O	,	_	0	SENT_110	[p10l1604t122r1993b200],
3	the	DT	O	the	det	4	SENT_110	[p10l2031t122r2144b187],
4	lack	NN	O	lack	nsubj	12	SENT_110	[p10l8t222r161b286],
5	of	IN	O	of	_	0	SENT_110	[p10l197t222r279b286],
6	enzyme	NN	O	enzyme	nn	7	SENT_110	[p10l305t243r584b304],
7	activity	NN	O	activity	prep_of	4	SENT_110	[p10l621t222r896b304],
8	of	IN	O	of	_	0	SENT_110	[p10l933t222r1014b286],
9	CYP2C8	NN	O	cyp2c8	prep_of	7	SENT_110	[p10l1041t223r1372b287],
10	might	MD	O	might	aux	12	SENT_110	[p10l1409t222r1627b304],
11	plausibly	RB	O	plausibly	advmod	12	SENT_110	[p10l1660t222r2001b304],
12	explain	VB	O	explain	_	0	SENT_110	[p10l2036t243r2143b286, p10l7t320r195b402],
13	the	DT	O	the	det	14	SENT_110	[p10l237t320r350b385],
14	etiology	NN	O	etiology	dobj	12	SENT_110	[p10l392t321r693b402],
15	of	IN	O	of	_	0	SENT_110	[p10l735t320r817b385],
16	cerivastatin-induced	JJ	O	cerivastatin-induced	amod	17	SENT_110	[p10l849t320r1611b385],
17	rhabdomyolysis	NN	O	rhabdomyolysis	prep_of	14	SENT_110	[p10l1652t320r2143b402, p10l8t420r160b502],
18	.	.	O	.	_	0	SENT_110	[p10l1652t320r2143b402, p10l8t420r160b502],

1	Because	IN	O	because	mark	11	SENT_111	[p10l220t422r517b484],
2	the	DT	O	the	det	4	SENT_111	[p10l571t420r684b484],
3	allele	NN	O	allele	nn	4	SENT_111	[p10l737t420r927b484],
4	frequency	NN	O	frequency	nsubj	11	SENT_111	[p10l979t420r1349b502],
5	of	IN	O	of	_	0	SENT_111	[p10l1402t420r1484b484],
6	the	DT	O	the	det	7	SENT_111	[p10l1528t420r1640b484],
7	mutation	NN	O	mutation	prep_of	4	SENT_111	[p10l1692t420r2037b484],
8	is	VBZ	O	be	cop	11	SENT_111	[p10l2090t420r2144b484],
9	extremely	RB	O	extremely	advmod	10	SENT_111	[p10l8t518r373b600],
10	low	JJ	O	low	amod	11	SENT_111	[p10l401t519r535b583],
11	(	NN	O	(	advcl	25	SENT_111	[p10l565t519r659b601],
12	<	JJR	O	<	amod	11	SENT_111	[p10l565t519r659b601],
13	0.0000068	CD	NUMBER	0.0000068	dep	12	SENT_111	[p10l682t520r1055b583],
14	in	IN	O	in	dep	13	SENT_111	[p10l1086t519r1156b582],
15	our	PRP$	O	we	poss	17	SENT_111	[p10l1187t540r1314b583],
16	set	NN	O	set	nn	17	SENT_111	[p10l1345t519r1492b601],
17	)	NN	O	)	pobj	14	SENT_111	[p10l1345t519r1492b601],
18	,	,	O	,	_	0	SENT_111	[p10l1345t519r1492b601],
19	the	DT	O	the	det	21	SENT_111	[p10l1525t518r1638b583],
20	homozygous	JJ	O	homozygous	amod	21	SENT_111	[p10l1667t518r2143b600],
21	individuals	NNS	O	individual	nsubj	28	SENT_111	[p10l8t618r420b682],
22	should	MD	O	should	aux	25	SENT_111	[p10l471t618r719b682],
23	be	VB	O	be	cop	25	SENT_111	[p10l768t618r851b682],
24	very	RB	O	very	advmod	25	SENT_111	[p10l898t639r1058b700],
25	rare	JJ	O	rare	_	0	SENT_111	[p10l1105t639r1252b682],
26	and	CC	O	and	_	0	SENT_111	[p10l1303t618r1440b682],
27	might	MD	O	might	aux	28	SENT_111	[p10l1486t618r1705b700],
28	experience	VB	O	experience	conj_and	25	SENT_111	[p10l1752t618r2144b700],
29	little	JJ	O	little	amod	31	SENT_111	[p10l8t716r174b781],
30	clinical	JJ	O	clinical	amod	31	SENT_111	[p10l212t716r477b781],
31	impact	NN	O	impact	dobj	28	SENT_111	[p10l513t716r771b798],
32	despite	IN	O	despite	_	0	SENT_111	[p10l808t716r1067b798],
33	the	DT	O	the	det	34	SENT_111	[p10l1106t716r1219b781],
34	severity	NN	O	severity	prep_despite	28	SENT_111	[p10l1259t716r1543b798],
35	of	IN	O	of	_	0	SENT_111	[p10l1582t716r1663b781],
36	the	DT	O	the	det	37	SENT_111	[p10l1692t716r1805b781],
37	rhabdomyolysis	NN	O	rhabdomyolysis	prep_of	34	SENT_111	[p10l1844t716r2143b781, p10l7t816r352b898],
38	.	.	O	.	_	0	SENT_111	[p10l1844t716r2143b781, p10l7t816r352b898],

1	However	RB	O	however	advmod	5	SENT_112	[p10l400t818r759b894],
2	,	,	O	,	_	0	SENT_112	[p10l400t818r759b894],
3	a	DT	O	a	det	4	SENT_112	[p10l808t837r847b880],
4	possibility	NN	O	possibility	nsubj	5	SENT_112	[p10l888t816r1273b898],
5	remains	VBZ	O	remain	_	0	SENT_112	[p10l1315t816r1609b880],
6	that	IN	O	that	complm	11	SENT_112	[p10l1652t816r1802b880],
7	the	DT	O	the	det	9	SENT_112	[p10l1845t816r1957b880],
8	heterozygous	JJ	O	heterozygous	amod	9	SENT_112	[p10l2001t816r2143b880, p10l8t935r386b996],
9	subject	NN	O	subject	nsubj	11	SENT_112	[p10l421t914r680b996],
10	is	VBZ	O	be	cop	11	SENT_112	[p10l709t914r763b979],
11	susceptible	JJ	O	susceptible	ccomp	5	SENT_112	[p10l797t914r1202b996],
12	to	TO	O	to	_	0	SENT_112	[p10l1233t923r1306b979],
13	the	DT	O	the	det	14	SENT_112	[p10l1339t914r1452b979],
14	administration	NN	O	administration	prep_to	11	SENT_112	[p10l1484t914r2039b979],
15	of	IN	O	of	_	0	SENT_112	[p10l2072t914r2153b979],
16	cerivastatin	NN	O	cerivastatin	prep_of	14	SENT_112	[p10l8t1014r462b1092],
17	,	,	O	,	_	0	SENT_112	[p10l8t1014r462b1092],
18	leading	VBG	O	lead	partmod	14	SENT_112	[p10l527t1014r798b1096],
19	to	TO	O	to	_	0	SENT_112	[p10l861t1023r933b1078],
20	rather	RB	O	rather	advmod	21	SENT_112	[p10l997t1014r1225b1078],
21	mild	JJ	O	mild	amod	22	SENT_112	[p10l1285t1014r1453b1078],
22	myopathy	NN	O	myopathy	prep_to	18	SENT_112	[p10l1513t1014r1914b1096],
23	.	.	O	.	_	0	SENT_112	[p10l1513t1014r1914b1096],

1	This	DT	O	this	det	2	SENT_113	[p10l1981t1014r2144b1078],
2	possibility	NN	O	possibility	nsubjpass	6	SENT_113	[p10l7t1112r392b1194],
3	could	MD	O	could	aux	6	SENT_113	[p10l417t1112r623b1177],
4	not	RB	O	not	neg	6	SENT_113	[p10l649t1121r774b1177],
5	be	VB	O	be	auxpass	6	SENT_113	[p10l799t1112r882b1177],
6	answered	VBN	O	answer	_	0	SENT_113	[p10l910t1112r1258b1177],
7	easily	RB	O	easily	advmod	6	SENT_113	[p10l1284t1112r1491b1194],
8	because	IN	O	because	mark	12	SENT_113	[p10l1516t1112r1806b1177],
9	the	DT	O	the	det	10	SENT_113	[p10l1833t1112r1945b1177],
10	drug	NN	O	drug	nsubjpass	12	SENT_113	[p10l1972t1112r2145b1194],
11	was	VBD	O	be	auxpass	12	SENT_113	[p10l7t1233r146b1276],
12	withdrawn	VBN	O	withdraw	advcl	6	SENT_113	[p10l201t1212r606b1276],
13	from	IN	O	from	_	0	SENT_113	[p10l660t1212r843b1276],
14	the	DT	O	the	det	15	SENT_113	[p10l897t1212r1010b1276],
15	market	NN	O	market	prep_from	12	SENT_113	[p10l1063t1212r1349b1276],
16	.	.	O	.	_	0	SENT_113	[p10l1063t1212r1349b1276],

1	As	IN	O	as	_	0	SENT_114	[p10l1408t1212r1506b1276],
2	CYP2C8	NN	O	cyp2c8	prep_as	3	SENT_114	[p10l1564t1213r1894b1277],
3	plays	VBZ	O	play	_	0	SENT_114	[p10l1951t1212r2143b1294],
4	important	JJ	O	important	amod	5	SENT_114	[p10l8t1310r388b1392],
5	roles	NNS	O	role	iobj	3	SENT_114	[p10l426t1310r601b1375],
6	in	IN	O	in	_	0	SENT_114	[p10l639t1310r710b1374],
7	metabolizing	VBG	O	metabolize	prepc_in	5	SENT_114	[p10l745t1310r1234b1392],
8	therapeutic	JJ	O	therapeutic	amod	9	SENT_114	[p10l1271t1310r1694b1392],
9	drugs	NNS	O	drug	dobj	7	SENT_114	[p10l1732t1310r1937b1392],
10	such	JJ	O	such	_	0	SENT_114	[p10l1979t1310r2145b1375],
11	as	IN	O	as	_	0	SENT_114	[p10l10t1431r82b1474],
12	paclitaxel	NN	O	paclitaxel	prep_such_as	9	SENT_114	[p10l118t1410r498b1492],
13	,	,	O	,	_	0	SENT_114	[p10l118t1410r498b1492],
14	an	DT	O	a	det	16	SENT_114	[p10l540t1431r629b1474],
15	anticancer	JJ	O	anticancer	amod	16	SENT_114	[p10l666t1410r1054b1474],
16	drug	NN	O	drug	appos	12	SENT_114	[p10l1090t1409r1263b1492],
17	(	NNP	O	(	nn	18	SENT_114	[p10l1301t1410r1655b1492],
18	Rahman	NNP	PERSON	Rahman	dep	16	SENT_114	[p10l1301t1410r1655b1492],
19	et	FW	O	et	nn	20	SENT_114	[p10l1691t1419r1756b1474],
20	al.	FW	O	al.	dobj	3	SENT_114	[p10l1793t1410r1875b1474],
21	1994	CD	DATE	1994	num	22	SENT_114	[p10l1925t1410r2141b1492],
22	)	NN	O	)	dep	20	SENT_114	[p10l1925t1410r2141b1492],
23	;	:	O	;	_	0	SENT_114	[p10l1925t1410r2141b1492],
24	troglitazone	NN	O	troglitazone	dep	20	SENT_114	[p10l9t1508r481b1590],
25	,	,	O	,	_	0	SENT_114	[p10l9t1508r481b1590],
26	an	DT	O	a	det	27	SENT_114	[p10l549t1529r638b1573],
27	antidiabetes	NNS	O	antidiabete	appos	24	SENT_114	[p10l701t1508r1152b1573],
28	drug	NN	O	drug	nn	30	SENT_114	[p10l1216t1508r1389b1590],
29	(	CD	NUMBER	(	num	30	SENT_114	[p10l1453t1508r1865b1591],
30	Yamazaki	NNP	PERSON	Yamazaki	nsubj	3	SENT_114	[p10l1453t1508r1865b1591],
31	et	FW	O	et	nn	32	SENT_114	[p10l1928t1517r1993b1573],
32	al.	FW	O	al.	dep	30	SENT_114	[p10l2057t1508r2139b1573],
33	.	.	O	.	_	0	SENT_114	[p10l2057t1508r2139b1573],

1	2000	CD	DATE	2000	num	2	SENT_115	[p10l9t1800r233b1881],
2	)	NN	O	)	ccomp	20	SENT_115	[p10l9t1800r233b1881],
3	;	:	O	;	_	0	SENT_115	[p10l9t1800r233b1881],
4	and	CC	O	and	_	0	SENT_115	[p10l330t1799r468b1864],
5	amiodarone	NN	O	amiodarone	ccomp	20	SENT_115	[p10l562t1799r1034b1878],
6	,	,	O	,	_	0	SENT_115	[p10l562t1799r1034b1878],
7	an	DT	O	a	det	9	SENT_115	[p10l1132t1821r1220b1864],
8	antiarrhythmic	JJ	O	antiarrhythmic	amod	9	SENT_115	[p10l1314t1800r1878b1881],
9	drug	NN	O	drug	nsubjpass	20	SENT_115	[p10l1972t1799r2145b1882],
10	(	NNP	O	(	nn	11	SENT_115	[p10l10t1898r359b1980],
11	Ohyama	NNP	PERSON	Ohyama	dep	9	SENT_115	[p10l10t1898r359b1980],
12	et	FW	O	et	nn	13	SENT_115	[p10l405t1907r470b1963],
13	al.	FW	O	al.	dep	9	SENT_115	[p10l517t1898r599b1963],
14	2000	CD	DATE	2000	num	15	SENT_115	[p10l651t1899r875b1980],
15	)	NN	O	)	dep	13	SENT_115	[p10l651t1899r875b1980],
16	;	:	O	;	_	0	SENT_115	[p10l651t1899r875b1980],
17	attention	NN	O	attention	dep	13	SENT_115	[p10l926t1898r1264b1963],
18	should	MD	O	should	aux	20	SENT_115	[p10l1313t1898r1561b1963],
19	be	VB	O	be	auxpass	20	SENT_115	[p10l1608t1898r1692b1963],
20	paid	VBN	O	pay	_	0	SENT_115	[p10l1737t1898r1901b1980],
21	when	WRB	O	when	advmod	24	SENT_115	[p10l1946t1898r2144b1963],
22	heterozygous	JJ	O	heterozygous	amod	23	SENT_115	[p10l8t1997r504b2079],
23	subjects	NNS	O	subject	nsubj	24	SENT_115	[p10l541t1996r833b2079],
24	take	VBP	O	take	advcl	20	SENT_115	[p10l868t1997r1025b2061],
25	those	DT	O	those	det	26	SENT_115	[p10l1060t1997r1256b2061],
26	drugs	NNS	O	drug	dobj	24	SENT_115	[p10l1291t1996r1517b2079],
27	.	.	O	.	_	0	SENT_115	[p10l1291t1996r1517b2079],

1	Acknowledgements	NNS	O	acknowledgement	nsubjpass	6	SENT_116	[p10l7t2217r600b2286],
2	This	DT	O	this	det	3	SENT_116	[p10l636t2216r772b2271],
3	work	NN	O	work	dep	1	SENT_116	[p10l808t2216r972b2271],
4	has	VBZ	O	have	aux	6	SENT_116	[p10l1008t2216r1111b2271],
5	been	VBN	O	be	auxpass	6	SENT_116	[p10l1149t2216r1293b2271],
6	supported	VBN	O	support	_	0	SENT_116	[p10l1331t2216r1648b2286],
7	by	IN	O	by	_	0	SENT_116	[p10l1684t2216r1760b2285],
8	CREST	NN	O	crest	agent	6	SENT_116	[p10l1798t2217r2046b2271],
9	of	IN	O	of	_	0	SENT_116	[p10l2083t2216r2152b2271],
10	Japan	NNP	ORGANIZATION	Japan	nn	11	SENT_116	[p10l8t2299r195b2367],
11	Science	NNP	ORGANIZATION	Science	prep_of	8	SENT_116	[p10l223t2297r450b2352],
12	and	CC	ORGANIZATION	and	_	0	SENT_116	[p10l477t2297r593b2352],
13	Technology	NNP	ORGANIZATION	Technology	agent	6	SENT_116	[p10l618t2297r991b2367],
14	(	CD	NUMBER	(	num	13	SENT_116	[p10l1017t2297r1136b2367],
15	11	CD	NUMBER	11	num	16	SENT_116	[p10l1017t2297r1136b2367],
16	)	NN	O	)	dep	13	SENT_116	[p10l1017t2297r1136b2367],
17	.	.	O	.	_	0	SENT_116	[p10l1017t2297r1136b2367],

1	We	PRP	O	we	nsubj	2	SENT_117	[p10l1164t2299r1268b2352],
2	thank	VBP	O	thank	_	0	SENT_117	[p10l1294t2297r1477b2352],
3	Miho	NNP	PERSON	Miho	nn	4	SENT_117	[p10l1503t2297r1674b2352],
4	Kakihara	NNP	PERSON	Kakihara	dobj	2	SENT_117	[p10l1701t2297r2004b2352],
5	and	CC	O	and	_	0	SENT_117	[p10l2030t2297r2145b2352],
6	Yoshiko	NNP	PERSON	Yoshiko	nn	7	SENT_117	[p10l7t2376r275b2431],
7	Miwa	NNP	PERSON	Miwa	dobj	2	SENT_117	[p10l306t2376r488b2431],
8	for	IN	O	for	_	0	SENT_117	[p10l516t2376r608b2431],
9	their	PRP$	O	they	poss	11	SENT_117	[p10l636t2376r781b2431],
10	technical	JJ	O	technical	amod	11	SENT_117	[p10l809t2376r1089b2431],
11	assistance	NN	O	assistance	prep_for	4	SENT_117	[p10l1118t2376r1444b2431],
12	.	.	O	.	_	0	SENT_117	[p10l1118t2376r1444b2431],

1	References	NNS	O	reference	_	0	SENT_118	[p10l10t2649r419b2719],

1	Farmer	NNP	O	Farmer	nn	2	SENT_119	[p10l9t2855r245b2908],
2	JA	NNP	O	JA	_	0	SENT_119	[p10l296t2853r384b2908],
3	(	CD	NUMBER	(	num	6	SENT_119	[p10l438t2854r632b2923],
4	2001	CD	DATE	2001	num	6	SENT_119	[p10l438t2854r632b2923],
5	)	NNP	O	)	nn	6	SENT_119	[p10l438t2854r632b2923],
6	Learning	NNP	O	Learning	dep	2	SENT_119	[p10l687t2853r972b2923],
7	from	IN	O	from	_	0	SENT_119	[p10l1024t2853r1178b2908],
8	the	DT	O	the	det	10	SENT_119	[p10l1230t2853r1325b2908],
9	cerivastatin	NN	O	cerivastatin	nn	10	SENT_119	[p10l1379t2853r1743b2908],
10	experience	NN	O	experience	prep_from	6	SENT_119	[p10l1795t2853r2141b2923],
11	.	.	O	.	_	0	SENT_119	[p10l1795t2853r2141b2923],

1	Lancet	NNP	O	Lancet	_	0	SENT_120	[p10l122t2936r336b2989],
2	358	CD	NUMBER	358	num	1	SENT_120	[p10l366t2935r828b2989],
3	:	:	O	:	_	0	SENT_120	[p10l366t2935r828b2989],
4	l383	CD	NUMBER	l383	num	6	SENT_120	[p10l366t2935r828b2989],
5	—	CD	NUMBER	—	num	6	SENT_120	[p10l366t2935r828b2989],
6	l385	NN	O	l385	dep	1	SENT_120	[p10l366t2935r828b2989],

1	Lamba	NNP	PERSON	Lamba	nn	2	SENT_121	[p10l9t3015r233b3070],
2	J	NNP	PERSON	J	dep	29	SENT_121	[p10l256t3017r303b3081],
3	,	,	O	,	_	0	SENT_121	[p10l256t3017r303b3081],
4	Lin	NNP	O	Lin	nn	5	SENT_121	[p10l331t3015r438b3069],
5	Y	NN	O	y	appos	2	SENT_121	[p10l461t3017r533b3081],
6	,	,	O	,	_	0	SENT_121	[p10l461t3017r533b3081],
7	Thummel	NNP	O	Thummel	nn	8	SENT_121	[p10l560t3015r865b3070],
8	K	NNP	O	K	appos	2	SENT_121	[p10l889t3017r964b3081],
9	,	,	O	,	_	0	SENT_121	[p10l889t3017r964b3081],
10	Daly	NNP	PERSON	Daly	nn	11	SENT_121	[p10l992t3015r1145b3085],
11	A	NNP	O	A	appos	2	SENT_121	[p10l1167t3015r1240b3081],
12	,	,	O	,	_	0	SENT_121	[p10l1167t3015r1240b3081],
13	Watkins	NNP	ORGANIZATION	Watkins	nn	14	SENT_121	[p10l1265t3015r1531b3070],
14	P	NN	ORGANIZATION	p	appos	2	SENT_121	[p10l1555t3017r1615b3081],
15	,	,	O	,	_	0	SENT_121	[p10l1555t3017r1615b3081],
16	Strom	NNP	PERSON	Strom	nn	17	SENT_121	[p10l1643t3016r1836b3070],
17	S	NNP	PERSON	S	appos	2	SENT_121	[p10l1862t3016r1915b3081],
18	,	,	O	,	_	0	SENT_121	[p10l1862t3016r1915b3081],
19	Zhang	NNP	PERSON	Zhang	nn	20	SENT_121	[p10l1941t3015r2146b3085],
20	J	NNP	PERSON	J	appos	2	SENT_121	[p10l120t3098r167b3163],
21	,	,	O	,	_	0	SENT_121	[p10l120t3098r167b3163],
22	Schuetz	NNP	PERSON	Schuetz	nn	23	SENT_121	[p10l212t3096r455b3151],
23	E	NNP	O	E	appos	2	SENT_121	[p10l496t3099r541b3150],
24	(	CD	NUMBER	(	num	29	SENT_121	[p10l582t3097r776b3166],
25	2002	CD	DATE	2002	num	29	SENT_121	[p10l582t3097r776b3166],
26	)	NNP	O	)	nn	29	SENT_121	[p10l582t3097r776b3166],
27	Common	NNP	O	Common	nn	29	SENT_121	[p10l819t3097r1116b3151],
28	allelic	JJ	O	allelic	amod	29	SENT_121	[p10l1156t3096r1336b3151],
29	variants	NNS	O	variant	_	0	SENT_121	[p10l1376t3096r1629b3151],
30	of	IN	O	of	_	0	SENT_121	[p10l1671t3096r1740b3151],
31	cytochrome	NN	O	cytochrome	nn	32	SENT_121	[p10l1773t3096r2145b3166],
32	P4503A4	NN	O	p4503a4	prep_of	29	SENT_121	[p10l120t3177r407b3233],
33	and	CC	O	and	_	0	SENT_121	[p10l443t3177r559b3232],
34	their	PRP$	O	they	poss	35	SENT_121	[p10l595t3177r740b3232],
35	prevalence	NN	O	prevalence	conj_and	29	SENT_121	[p10l774t3177r1109b3247],
36	in	IN	O	in	_	0	SENT_121	[p10l1144t3177r1204b3231],
37	different	JJ	O	different	amod	38	SENT_121	[p10l1239t3177r1503b3232],
38	populations	NNS	O	population	prep_in	35	SENT_121	[p10l1538t3177r1931b3247],
39	.	.	O	.	_	0	SENT_121	[p10l1538t3177r1931b3247],

1	Pharmacogenetics	NNS	O	pharmacogenetic	_	0	SENT_122	[p10l1970t3177r2144b3232, p10l119t3258r540b3328],
2	122121-132	CD	NUMBER	122121-132	dep	1	SENT_122	[p10l577t3259r922b3313],

1	Matushima	NNP	LOCATION	Matushima	nn	2	SENT_123	[p10l9t3339r372b3394],
2	S	NNP	LOCATION	S	_	0	SENT_123	[p10l396t3340r449b3405],
3	,	,	O	,	_	0	SENT_123	[p10l396t3340r449b3405],
4	Maeda	NNP	PERSON	Maeda	nn	5	SENT_123	[p10l474t3339r694b3394],
5	K	NNP	PERSON	K	appos	2	SENT_123	[p10l715t3341r790b3405],
6	,	,	O	,	_	0	SENT_123	[p10l715t3341r790b3405],
7	Shitara	NNP	PERSON	Shitara	nn	8	SENT_123	[p10l817t3339r1043b3394],
8	Y	NN	PERSON	y	appos	2	SENT_123	[p10l1064t3341r1136b3405],
9	,	,	O	,	_	0	SENT_123	[p10l1064t3341r1136b3405],
10	Sasaki	NNP	PERSON	Sasaki	nn	11	SENT_123	[p10l1163t3339r1363b3394],
11	M	NNP	O	M	appos	2	SENT_123	[p10l1386t3341r1474b3405],
12	,	,	O	,	_	0	SENT_123	[p10l1386t3341r1474b3405],
13	Suzuki	NNP	PERSON	Suzuki	nn	14	SENT_123	[p10l1500t3339r1713b3394],
14	H	NNP	PERSON	H	appos	2	SENT_123	[p10l1735t3341r1810b3405],
15	,	,	O	,	_	0	SENT_123	[p10l1735t3341r1810b3405],
16	Sugiyama	NNP	PERSON	Sugiyama	nn	17	SENT_123	[p10l1837t3339r2146b3409],
17	Y	NN	PERSON	y	appos	2	SENT_123	[p10l119t3422r175b3474],
18	(	CD	NUMBER	(	num	17	SENT_123	[p10l224t3420r417b3490],
19	2002	CD	DATE	2002	num	21	SENT_123	[p10l224t3420r417b3490],
20	)	CD	NUMBER	)	num	21	SENT_123	[p10l224t3420r417b3490],
21	Estimation	NN	O	estimation	dep	17	SENT_123	[p10l467t3420r814b3474],
22	of	IN	O	of	_	0	SENT_123	[p10l863t3419r931b3474],
23	a	DT	O	a	det	27	SENT_123	[p10l973t3438r1006b3474],
24	double-transfectanted	JJ	O	double-transfectanted	amod	27	SENT_123	[p10l1054t3419r1748b3474],
25	MDCK	NN	O	mdck	nn	27	SENT_123	[p10l1796t3421r2044b3475],
26	II	CD	NUMBER	ii	num	27	SENT_123	[p10l2091t3422r2144b3474],
27	monolayer	NN	O	monolayer	prep_of	2	SENT_123	[p10l119t3501r460b3570],
28	co-expressing	VBG	O	co-express	partmod	2	SENT_123	[p10l515t3501r941b3570],
29	human	JJ	O	human	amod	30	SENT_123	[p10l996t3500r1217b3555],
30	OATP2	NN	O	oatp2	dobj	28	SENT_123	[p10l1273t3501r1516b3556],
31	and	CC	O	and	_	0	SENT_123	[p10l1574t3500r1690b3555],
32	MRP2	NN	O	mrp2	dobj	28	SENT_123	[p10l1746t3502r1973b3555],
33	.	.	O	.	_	0	SENT_123	[p10l1746t3502r1973b3555],

1	Jpn	NNP	O	Jpn	nn	3	SENT_124	[p10l2032t3503r2145b3570],
2	Pharmacol	NNP	O	Pharmacol	nn	3	SENT_124	[p10l120t3581r463b3636],
3	Ther	NNP	O	Ther	_	0	SENT_124	[p10l491t3581r641b3636],
4	30	CD	NUMBER	30	num	3	SENT_124	[p10l672t3582r1106b3636],
5	:	:	O	:	_	0	SENT_124	[p10l672t3582r1106b3636],
6	S44l	NN	O	s44l	dep	3	SENT_124	[p10l672t3582r1106b3636],
7	.	.	O	.	_	0	SENT_124	[p10l672t3582r1106b3636],

1	—	NN	O	—	_	0	SENT_125	[p10l672t3582r1106b3636],
2	.	.	O	.	_	0	SENT_125	[p10l672t3582r1106b3636],

1	S444	NN	O	s444	_	0	SENT_126	[p10l672t3582r1106b3636],

1	Muck	NN	O	muck	nn	2	SENT_127	[p10l9t3662r195b3717],
2	W	NN	O	w	_	0	SENT_127	[p10l236t3664r309b3717],
3	(	CD	NUMBER	(	num	7	SENT_127	[p10l352t3662r546b3732],
4	2000	CD	DATE	2000	num	7	SENT_127	[p10l352t3662r546b3732],
5	)	CD	NUMBER	)	num	7	SENT_127	[p10l352t3662r546b3732],
6	Clinical	JJ	O	clinical	amod	7	SENT_127	[p10l591t3662r833b3717],
7	pharmacokinetics	NNS	O	pharmacokinetic	dep	2	SENT_127	[p10l875t3662r1436b3732],
8	of	IN	O	of	_	0	SENT_127	[p10l1482t3662r1550b3717],
9	cerivastatin	NN	O	cerivastatin	prep_of	7	SENT_127	[p10l1585t3662r1965b3717],
10	.	.	O	.	_	0	SENT_127	[p10l1585t3662r1965b3717],

1	Clin	NN	PERSON	clin	_	0	SENT_128	[p10l2014t3662r2145b3717],

1	Pharmacokinet	NNP	O	Pharmacokinet	_	0	SENT_129	[p10l120t3741r604b3796],
2	39299-1	CD	NUMBER	39299-1	num	3	SENT_129	[p10l634t3743r866b3796],
3	16	CD	NUMBER	16	dep	1	SENT_129	[p10l884t3743r947b3796],

1	Nakajima	NNP	PERSON	Nakajima	nn	2	SENT_130	[p11l7t20r322b90],
2	M	NNP	O	M	dep	31	SENT_130	[p11l354t22r442b87],
3	,	,	O	,	_	0	SENT_130	[p11l354t22r442b87],
4	Fujiki	NNP	PERSON	Fujiki	nn	5	SENT_130	[p11l478t20r666b90],
5	Y	NN	PERSON	y	appos	2	SENT_130	[p11l697t23r770b87],
6	,	,	O	,	_	0	SENT_130	[p11l697t23r770b87],
7	Noda	NNP	PERSON	Noda	nn	8	SENT_130	[p11l804t20r983b75],
8	K	NNP	PERSON	K	appos	2	SENT_130	[p11l1015t23r1090b87],
9	,	,	O	,	_	0	SENT_130	[p11l1015t23r1090b87],
10	Ohtsuka	NNP	PERSON	Ohtsuka	nn	11	SENT_130	[p11l1126t20r1394b76],
11	H	NNP	PERSON	H	appos	2	SENT_130	[p11l1426t23r1502b87],
12	,	,	O	,	_	0	SENT_130	[p11l1426t23r1502b87],
13	Ohkuni	NNP	PERSON	Ohkuni	nn	14	SENT_130	[p11l1537t20r1776b76],
14	H	NNP	PERSON	H	appos	2	SENT_130	[p11l1808t23r1883b87],
15	,	,	O	,	_	0	SENT_130	[p11l1808t23r1883b87],
16	Kyo	NNP	LOCATION	Kyo	nn	17	SENT_130	[p11l1918t23r2053b90],
17	S	NNP	LOCATION	S	appos	2	SENT_130	[p11l2089t22r2142b87],
18	,	,	O	,	_	0	SENT_130	[p11l2089t22r2142b87],
19	Inoue	NNP	PERSON	Inoue	nn	20	SENT_130	[p11l121t104r302b157],
20	M	NNP	O	M	appos	2	SENT_130	[p11l330t104r418b168],
21	,	,	O	,	_	0	SENT_130	[p11l330t104r418b168],
22	Kuroiwa	NNP	PERSON	Kuroiwa	nn	23	SENT_130	[p11l449t102r730b157],
23	Y	NN	PERSON	y	appos	2	SENT_130	[p11l756t104r829b169],
24	,	,	O	,	_	0	SENT_130	[p11l756t104r829b169],
25	Yokoi	NNP	PERSON	Yokoi	nn	26	SENT_130	[p11l858t102r1058b157],
26	T	NN	O	t	appos	2	SENT_130	[p11l1086t104r1132b156],
27	(	CD	NUMBER	(	num	31	SENT_130	[p11l1161t102r1355b172],
28	2003	CD	DATE	2003	num	31	SENT_130	[p11l1161t102r1355b172],
29	)	NNP	O	)	nn	31	SENT_130	[p11l1161t102r1355b172],
30	Genetic	NNP	O	Genetic	nn	31	SENT_130	[p11l1385t102r1626b157],
31	polymorphisms	NNS	O	polymorphism	_	0	SENT_130	[p11l1653t102r2144b172],
32	of	IN	O	of	_	0	SENT_130	[p11l122t183r191b238],
33	CYP2C8	NN	O	cyp2c8	prep_of	31	SENT_130	[p11l239t184r517b238],
34	in	IN	O	in	_	0	SENT_130	[p11l574t183r633b237],
35	Japanese	JJ	MISC	japanese	amod	36	SENT_130	[p11l686t185r967b253],
36	population	NN	O	population	prep_in	33	SENT_130	[p11l1021t183r1385b253],
37	.	.	O	.	_	0	SENT_130	[p11l1021t183r1385b253],

1	Drug	NN	O	drug	_	0	SENT_131	[p11l1445t185r1611b253],
2	Metab	NNP	O	Metab	nn	3	SENT_131	[p11l1665t183r1871b238],
3	Dispos	NNP	O	Dispos	dep	1	SENT_131	[p11l1926t183r2145b253],
4	312687-690	CD	NUMBER	312687-690	dep	1	SENT_131	[p11l123t265r473b319],

1	Ohyama	NNP	PERSON	Ohyama	nn	2	SENT_132	[p11l9t345r278b414],
2	K	NNP	PERSON	K	dep	19	SENT_132	[p11l313t347r389b411],
3	,	,	O	,	_	0	SENT_132	[p11l313t347r389b411],
4	Nakajima	NNP	PERSON	Nakajima	nn	5	SENT_132	[p11l427t345r742b415],
5	M	NNP	O	M	appos	2	SENT_132	[p11l778t347r866b411],
6	,	,	O	,	_	0	SENT_132	[p11l778t347r866b411],
7	Suzuki	NNP	PERSON	Suzuki	nn	8	SENT_132	[p11l907t345r1119b400],
8	M	NNP	PERSON	M	appos	2	SENT_132	[p11l1155t347r1243b411],
9	,	,	O	,	_	0	SENT_132	[p11l1155t347r1243b411],
10	Shimada	NNP	PERSON	Shimada	nn	11	SENT_132	[p11l1284t345r1559b400],
11	N	NNP	O	N	appos	2	SENT_132	[p11l1593t347r1670b411],
12	,	,	O	,	_	0	SENT_132	[p11l1593t347r1670b411],
13	Yamazaki	NNP	PERSON	Yamazaki	nn	14	SENT_132	[p11l1707t345r2031b400],
14	H	NNP	PERSON	H	appos	2	SENT_132	[p11l2067t347r2143b411],
15	,	,	O	,	_	0	SENT_132	[p11l2067t347r2143b411],
16	Yokoi	NNP	PERSON	Yokoi	appos	2	SENT_132	[p11l119t426r318b481],
17	T	NN	O	t	dep	19	SENT_132	[p11l361t428r408b480],
18	(	CD	NUMBER	(	num	17	SENT_132	[p11l453t426r646b496],
19	2000	CD	DATE	2000	dep	22	SENT_132	[p11l453t426r646b496],
20	)	CD	NUMBER	)	dep	19	SENT_132	[p11l453t426r646b496],
21	Inhibitory	JJ	O	inhibitory	amod	22	SENT_132	[p11l691t426r1013b496],
22	effect	NN	O	effect	_	0	SENT_132	[p11l1056t426r1222b481],
23	of	IN	O	of	_	0	SENT_132	[p11l1265t426r1334b481],
24	amiodarone	NN	O	amiodarone	prep_of	22	SENT_132	[p11l1370t426r1749b481],
25	and	CC	O	and	_	0	SENT_132	[p11l1794t426r1910b481],
26	its	PRP$	O	its	prep_of	22	SENT_132	[p11l1952t426r2022b481],
27	Ndeethylated	VBN	MISC	ndeethylate	partmod	22	SENT_132	[p11l2065t429r2144b481, p11l121t507r484b577],
28	metabolite	NN	O	metabolite	dobj	27	SENT_132	[p11l517t507r852b562],
29	on	IN	O	on	_	0	SENT_132	[p11l888t525r966b562],
30	human	JJ	O	human	amod	33	SENT_132	[p11l1000t507r1220b562],
31	cytochrome	NN	O	cytochrome	nn	33	SENT_132	[p11l1254t507r1625b577],
32	P450	NN	O	p450	nn	33	SENT_132	[p11l1660t508r1814b562],
33	activities	NNS	O	activity	prep_on	27	SENT_132	[p11l1849t507r2141b562],
34	:	:	O	:	_	0	SENT_132	[p11l1849t507r2141b562],
35	prediction	NN	O	prediction	dep	22	SENT_132	[p11l119t588r442b658],
36	of	IN	O	of	prep	35	SENT_132	[p11l467t588r536b643],
37	in	FW	O	in	nn	38	SENT_132	[p11l553t588r612b642],
38	vivo	FW	O	vivo	dep	40	SENT_132	[p11l635t588r768b643],
39	drug	NN	O	drug	nn	40	SENT_132	[p11l794t588r940b658],
40	interactions	NNS	O	interaction	dep	36	SENT_132	[p11l963t588r1351b643],
41	.	.	O	.	_	0	SENT_132	[p11l963t588r1351b643],

1	Clin	NNP	O	Clin	nn	2	SENT_133	[p11l1381t588r1512b643],
2	Pharmacol	NNP	O	Pharmacol	_	0	SENT_133	[p11l1536t588r1879b643],
3	49:244253	CD	NUMBER	49:244253	dep	2	SENT_133	[p11l1903t589r2148b643, p11l121t670r226b724],

1	Rahman	NNP	PERSON	Rahman	nn	2	SENT_134	[p11l10t750r282b805],
2	A	NNP	O	A	nsubj	16	SENT_134	[p11l317t750r390b817],
3	,	,	O	,	_	0	SENT_134	[p11l317t750r390b817],
4	Korzekwa	NNP	ORGANIZATION	Korzekwa	nn	5	SENT_134	[p11l429t750r756b805],
5	KR	NNP	ORGANIZATION	KR	appos	2	SENT_134	[p11l793t752r926b817],
6	,	,	O	,	_	0	SENT_134	[p11l793t752r926b817],
7	Grogan	NNP	PERSON	Grogan	nn	8	SENT_134	[p11l967t751r1210b820],
8	J	NNP	PERSON	J	appos	2	SENT_134	[p11l1246t752r1293b817],
9	,	,	O	,	_	0	SENT_134	[p11l1246t752r1293b817],
10	Gonzalez	NNP	PERSON	Gonzalez	nn	11	SENT_134	[p11l1334t750r1630b805],
11	FJ	NNP	O	FJ	appos	2	SENT_134	[p11l1667t752r1763b817],
12	,	,	O	,	_	0	SENT_134	[p11l1667t752r1763b817],
13	Harris	NNP	PERSON	Harris	nn	14	SENT_134	[p11l1803t750r2004b805],
14	JW	NNP	O	JW	appos	2	SENT_134	[p11l2041t752r2146b805],
15	(	CD	NUMBER	(	num	16	SENT_134	[p11l122t832r315b901],
16	1994	CD	DATE	1994	_	0	SENT_134	[p11l122t832r315b901],
17	)	NNP	O	)	nn	19	SENT_134	[p11l122t832r315b901],
18	Selective	JJ	O	selective	amod	19	SENT_134	[p11l369t831r638b886],
19	biotransformation	NN	O	biotransformation	dobj	16	SENT_134	[p11l689t831r1272b886],
20	of	IN	O	of	_	0	SENT_134	[p11l1324t831r1393b886],
21	taxol	NN	O	taxol	prep_of	19	SENT_134	[p11l1436t831r1594b886],
22	to	TO	O	to	_	0	SENT_134	[p11l1644t839r1705b886],
23	6	CD	NUMBER	6	num	24	SENT_134	[p11l1759t833r1791b886],
24	alphahydroxytaxol	NN	O	alphahydroxytaxol	prep_to	16	SENT_134	[p11l1843t831r2144b901, p11l121t912r464b980],
25	by	IN	O	by	_	0	SENT_134	[p11l518t912r594b980],
26	human	JJ	O	human	amod	29	SENT_134	[p11l646t912r866b966],
27	cytochrome	NN	O	cytochrome	nn	29	SENT_134	[p11l920t912r1291b980],
28	P450	NN	O	p450	nn	29	SENT_134	[p11l1345t913r1498b966],
29	2C8	NN	O	2c8	prep_by	24	SENT_134	[p11l1554t913r1695b966],
30	.	.	O	.	_	0	SENT_134	[p11l1554t913r1695b966],

1	Cancer	NN	O	cancer	_	0	SENT_135	[p11l1754t913r1976b966],
2	Res	NNP	O	Res	dep	1	SENT_135	[p11l2031t914r2144b966],
3	54:5543	CD	NUMBER	54:5543	num	2	SENT_135	[p11l123t993r548b1047],
4	—	CD	NUMBER	—	number	5	SENT_135	[p11l123t993r548b1047],
5	5546	CD	DATE	5546	dep	2	SENT_135	[p11l123t993r548b1047],

1	Rossenson	NN	PERSON	rossenson	nn	2	SENT_136	[p11l10t1076r348b1128],
2	R	NN	PERSON	r	_	0	SENT_136	[p11l372t1076r426b1127],
3	(	CD	NUMBER	(	num	6	SENT_136	[p11l450t1074r644b1143],
4	2004	CD	DATE	2004	num	6	SENT_136	[p11l450t1074r644b1143],
5	)	NNP	O	)	nn	6	SENT_136	[p11l450t1074r644b1143],
6	Current	NNP	DATE	Current	dep	2	SENT_136	[p11l670t1074r917b1128],
7	overview	NN	O	overview	dep	6	SENT_136	[p11l942t1073r1222b1128],
8	of	IN	O	of	_	0	SENT_136	[p11l1247t1073r1316b1128],
9	statin-induced	JJ	O	statin-induced	amod	10	SENT_136	[p11l1333t1073r1782b1128],
10	myopathy	NN	O	myopathy	prep_of	2	SENT_136	[p11l1804t1073r2141b1143],
11	.	.	O	.	_	0	SENT_136	[p11l1804t1073r2141b1143],

1	Am	VBP	O	be	_	0	SENT_137	[p11l119t1153r237b1207],
2	J	NN	O	j	nsubj	3	SENT_137	[p11l264t1155r294b1208],
3	Med	VBD	O	med	ccomp	1	SENT_137	[p11l323t1153r467b1208],
4	ll6	CD	NUMBER	ll6	dobj	3	SENT_137	[p11l502t1155r886b1208],
5	:408	CD	NUMBER	:408	num	7	SENT_137	[p11l502t1155r886b1208],
6	—	NN	O	—	nn	7	SENT_137	[p11l502t1155r886b1208],
7	4l6	NN	O	4l6	nsubj	1	SENT_137	[p11l502t1155r886b1208],

1	Staffa	NNP	PERSON	Staffa	nn	2	SENT_138	[p11l10t1234r192b1289],
2	J	NNP	PERSON	J	_	0	SENT_138	[p11l216t1236r263b1300],
3	,	,	O	,	_	0	SENT_138	[p11l216t1236r263b1300],
4	Chang	NNP	PERSON	Chang	nn	5	SENT_138	[p11l293t1234r500b1304],
5	J	NNP	O	J	appos	2	SENT_138	[p11l525t1236r572b1300],
6	,	,	O	,	_	0	SENT_138	[p11l525t1236r572b1300],
7	Green	NNP	PERSON	Green	nn	8	SENT_138	[p11l602t1235r794b1289],
8	L	NNP	PERSON	L	appos	2	SENT_138	[p11l821t1236r866b1288],
9	(	CD	NUMBER	(	num	12	SENT_138	[p11l893t1234r1086b1304],
10	2002	CD	DATE	2002	num	12	SENT_138	[p11l893t1234r1086b1304],
11	)	NNP	O	)	nn	12	SENT_138	[p11l893t1234r1086b1304],
12	Cerivastatin	NNP	O	Cerivastatin	dep	8	SENT_138	[p11l1115t1234r1499b1289],
13	and	CC	O	and	_	0	SENT_138	[p11l1525t1234r1640b1289],
14	reports	NNS	O	report	appos	2	SENT_138	[p11l1666t1241r1889b1304],
15	of	IN	O	of	_	0	SENT_138	[p11l1916t1234r1985b1289],
16	fatal	JJ	O	fatal	amod	17	SENT_138	[p11l2004t1234r2146b1289],
17	rhabdomyolysis	NN	O	rhabdomyolysis	prep_of	14	SENT_138	[p11l120t1315r640b1385],
18	.	.	O	.	_	0	SENT_138	[p11l120t1315r640b1385],

1	N	NN	O	n	nn	3	SENT_139	[p11l673t1317r733b1369],
2	Engl	NNP	O	Engl	nn	3	SENT_139	[p11l760t1315r905b1385],
3	J	NNP	O	J	nsubj	4	SENT_139	[p11l933t1317r963b1370],
4	Med	VBD	O	med	_	0	SENT_139	[p11l992t1315r1136b1370],
5	346:539	CD	NUMBER	346:539	num	6	SENT_139	[p11l1166t1316r1554b1370],
6	—	NN	O	—	dobj	4	SENT_139	[p11l1166t1316r1554b1370],
7	540	CD	NUMBER	540	tmod	4	SENT_139	[p11l1166t1316r1554b1370],

1	Stein	NNP	PERSON	Stein	nn	2	SENT_140	[p11l10t1396r165b1451],
2	E	NNP	O	E	_	0	SENT_140	[p11l240t1398r285b1450],
3	(	CD	NUMBER	(	num	6	SENT_140	[p11l360t1396r553b1465],
4	1998	CD	DATE	1998	num	6	SENT_140	[p11l360t1396r553b1465],
5	)	NNP	O	)	nn	6	SENT_140	[p11l360t1396r553b1465],
6	Cerivastatin	NNP	O	Cerivastatin	dep	2	SENT_140	[p11l630t1396r1013b1451],
7	in	IN	O	in	_	0	SENT_140	[p11l1086t1396r1145b1450],
8	primary	JJ	O	primary	amod	9	SENT_140	[p11l1217t1396r1471b1465],
9	hyperlipidemia	NN	O	hyperlipidemia	prep_in	6	SENT_140	[p11l1544t1395r2033b1465],
10	:	:	O	:	_	0	SENT_140	[p11l1544t1395r2033b1465],
11	a	DT	O	a	det	13	SENT_140	[p11l2112t1414r2146b1450],
12	multicenter	JJ	O	multicenter	amod	13	SENT_140	[p11l119t1477r479b1531],
13	analysis	NN	O	analysis	dep	2	SENT_140	[p11l532t1477r778b1546],
14	of	IN	O	of	_	0	SENT_140	[p11l833t1476r902b1531],
15	eﬂicacy	NN	O	eﬂicacy	prep_of	13	SENT_140	[p11l947t1477r1179b1546],
16	and	CC	O	and	_	0	SENT_140	[p11l1231t1476r1347b1531],
17	safety	NN	O	safety	prep_of	13	SENT_140	[p11l1402t1476r1599b1546],
18	.	.	O	.	_	0	SENT_140	[p11l1402t1476r1599b1546],

1	Am	NNP	O	Am	nn	5	SENT_141	[p11l1654t1476r1772b1531],
2	J	NNP	O	J	nn	5	SENT_141	[p11l1823t1479r1853b1531],
3	Cardiol	NNP	O	Cardiol	nn	5	SENT_141	[p11l1906t1476r2145b1532],
4	82:40	CD	NUMBER	82:40	num	5	SENT_141	[p11l123t1559r464b1613],
5	J	NNP	O	J	_	0	SENT_141	[p11l123t1559r464b1613],
6	—	CD	NUMBER	—	num	7	SENT_141	[p11l123t1559r464b1613],
7	46J	NN	O	46j	dep	5	SENT_141	[p11l123t1559r464b1613],

1	Wang	NNP	PERSON	Wang	nn	2	SENT_142	[p11l7t1641r196b1709],
2	J	NNP	O	J	_	0	SENT_142	[p11l216t1641r246b1694],
3	-	:	O	-	_	0	SENT_142	[p11l250t1640r330b1705],
4	S	NN	O	s	nsubj	22	SENT_142	[p11l250t1640r330b1705],
5	,	,	O	,	_	0	SENT_142	[p11l250t1640r330b1705],
6	Neuvonen	NN	O	neuvonen	nn	7	SENT_142	[p11l352t1641r680b1694],
7	M	NN	O	m	appos	4	SENT_142	[p11l701t1641r789b1705],
8	,	,	O	,	_	0	SENT_142	[p11l701t1641r789b1705],
9	Wen	NNP	LOCATION	Wen	nn	10	SENT_142	[p11l811t1641r957b1694],
10	Z	NNP	LOCATION	Z	appos	4	SENT_142	[p11l978t1641r1042b1705],
11	,	,	O	,	_	0	SENT_142	[p11l978t1641r1042b1705],
12	Backman	NNP	PERSON	Backman	nn	14	SENT_142	[p11l1067t1639r1364b1694],
13	J	NNP	PERSON	J	nn	14	SENT_142	[p11l1385t1641r1415b1694],
14	T	NN	PERSON	t	appos	4	SENT_142	[p11l1418t1641r1482b1705],
15	,	,	O	,	_	0	SENT_142	[p11l1418t1641r1482b1705],
16	Neuvonen	NNP	PERSON	Neuvonen	nn	18	SENT_142	[p11l1505t1641r1832b1694],
17	PJ	NNP	PERSON	PJ	nn	18	SENT_142	[p11l1853t1641r1928b1694],
18	(	NNP	O	(	appos	4	SENT_142	[p11l1950t1639r2144b1709],
19	2002	CD	DATE	2002	num	21	SENT_142	[p11l1950t1639r2144b1709],
20	)	CD	NUMBER	)	num	21	SENT_142	[p11l1950t1639r2144b1709],
21	Gemﬁbrozil	NN	O	gemﬁbrozil	dep	18	SENT_142	[p11l122t1718r499b1773],
22	inhibits	VBZ	O	inhibit	dep	2	SENT_142	[p11l543t1718r777b1773],
23	CYC2C8-mediated	JJ	O	cyc2c8-mediated	amod	25	SENT_142	[p11l825t1718r1431b1774],
24	cerivastatin	NN	O	cerivastatin	nn	25	SENT_142	[p11l1475t1719r1839b1773],
25	metabolism	NN	O	metabolism	dobj	22	SENT_142	[p11l1883t1718r2144b1773, p11l120t1800r248b1854],

1	in	IN	O	in	_	0	SENT_143	[p11l318t1800r377b1854],
2	human	JJ	O	human	amod	4	SENT_143	[p11l447t1799r668b1854],
3	liver	NN	O	liver	nn	4	SENT_143	[p11l738t1800r875b1854],
4	microsomes	NNS	O	microsome	pobj	1	SENT_143	[p11l944t1800r1336b1854],
5	.	.	O	.	_	0	SENT_143	[p11l944t1800r1336b1854],

1	Drug	NN	O	drug	nn	3	SENT_144	[p11l1411t1802r1578b1869],
2	Metab	NNP	O	Metab	nn	3	SENT_144	[p11l1649t1799r1855b1854],
3	Dispos	NNP	O	Dispos	_	0	SENT_144	[p11l1926t1800r2145b1869],
4	30	CD	NUMBER	30	num	3	SENT_144	[p11l123t1882r548b1936],
5	:	:	O	:	_	0	SENT_144	[p11l123t1882r548b1936],
6	l352	CD	NUMBER	l352	num	8	SENT_144	[p11l123t1882r548b1936],
7	—	CD	NUMBER	—	num	8	SENT_144	[p11l123t1882r548b1936],
8	l356	NN	O	l356	dep	3	SENT_144	[p11l123t1882r548b1936],

1	Yamazaki	NN	PERSON	yamazakus	nn	2	SENT_145	[p11l7t1962r331b2017],
2	H	NN	PERSON	h	_	0	SENT_145	[p11l354t1964r429b2029],
3	,	,	O	,	_	0	SENT_145	[p11l354t1964r429b2029],
4	Suzuki	NNP	PERSON	Suzuki	nn	5	SENT_145	[p11l457t1962r669b2017],
5	M	NNP	PERSON	M	conj_and	2	SENT_145	[p11l693t1964r781b2029],
6	,	,	O	,	_	0	SENT_145	[p11l693t1964r781b2029],
7	Shimada	NNP	PERSON	Shimada	nn	8	SENT_145	[p11l809t1962r1084b2017],
8	N	NNP	O	N	conj_and	2	SENT_145	[p11l1106t1964r1182b2029],
9	,	,	O	,	_	0	SENT_145	[p11l1106t1964r1182b2029],
10	Nakajima	NNP	PERSON	Nakajima	nn	11	SENT_145	[p11l1207t1962r1522b2032],
11	M	NNP	O	M	conj_and	2	SENT_145	[p11l1545t1964r1633b2029],
12	,	,	O	,	_	0	SENT_145	[p11l1545t1964r1633b2029],
13	Yokoi	NNP	ORGANIZATION	Yokoi	nn	14	SENT_145	[p11l1657t1962r1856b2017],
14	T	NN	ORGANIZATION	t	conj_and	2	SENT_145	[p11l1879t1964r1926b2016],
15	(	CD	NUMBER	(	num	14	SENT_145	[p11l1950t1962r2144b2032],
16	2000	CD	DATE	2000	num	17	SENT_145	[p11l1950t1962r2144b2032],
17	)	CD	NUMBER	)	dep	14	SENT_145	[p11l1950t1962r2144b2032],
18	In	FW	O	in	nn	20	SENT_145	[p11l121t2045r187b2097],
19	vitro	FW	O	vitro	nn	20	SENT_145	[p11l230t2043r379b2097],
20	effects	NNS	O	effect	dep	14	SENT_145	[p11l424t2043r617b2097],
21	of	IN	O	of	_	0	SENT_145	[p11l663t2042r732b2097],
22	troglitazone	NN	O	troglitazone	prep_of	20	SENT_145	[p11l770t2043r1149b2112],
23	and	CC	O	and	_	0	SENT_145	[p11l1195t2042r1310b2097],
24	its	PRP$	O	its	poss	25	SENT_145	[p11l1354t2043r1424b2097],
25	metabolites	NNS	O	metabolite	conj_and	2	SENT_145	[p11l1468t2042r1831b2097],
26	on	IN	O	on	_	0	SENT_145	[p11l1878t2061r1956b2097],
27	drug	NN	O	drug	nn	29	SENT_145	[p11l2000t2042r2146b2112],
28	oxidation	NN	O	oxidation	nn	29	SENT_145	[p11l122t2123r423b2178],
29	activities	NNS	O	activity	prep_on	25	SENT_145	[p11l482t2124r757b2178],
30	of	IN	O	of	_	0	SENT_145	[p11l818t2123r887b2178],
31	human	JJ	O	human	amod	34	SENT_145	[p11l938t2123r1159b2178],
32	cytochrome	NN	O	cytochrome	nn	34	SENT_145	[p11l1217t2123r1588b2193],
33	P450	NN	O	p450	nn	34	SENT_145	[p11l1647t2125r1801b2179],
34	enzymes	NNS	O	enzyme	prep_of	29	SENT_145	[p11l1861t2142r2140b2193],
35	:	:	O	:	_	0	SENT_145	[p11l1861t2142r2140b2193],
36	comparison	NN	O	comparison	dep	2	SENT_145	[p11l120t2205r492b2275],
37	with	IN	O	with	_	0	SENT_145	[p11l531t2205r669b2260],
38	pioglitazone	NN	O	pioglitazone	prep_with	36	SENT_145	[p11l707t2205r1096b2275],
39	and	CC	O	and	_	0	SENT_145	[p11l1137t2205r1253b2260],
40	rosiglitazone	NN	O	rosiglitazone	conj_and	38	SENT_145	[p11l1293t2205r1713b2275],
41	.	.	O	.	_	0	SENT_145	[p11l1293t2205r1713b2275],

1	Xenobiotica	NNP	O	Xenobiotica	_	0	SENT_146	[p11l1756t2205r2146b2260],
2	30:61	CD	NUMBER	30:61	num	3	SENT_146	[p11l123t2288r398b2341],
3	-70	CD	NUMBER	-70	dep	1	SENT_146	[p11l123t2288r398b2341],

